ID
stringlengths
6
11
CONTEXT
stringlengths
3
140k
NEWS_0
Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that vastly outperform the market - but in the process, they risk under-performance. Investors in The First Bancshares, Inc. (NASDAQ:FBMS) have tasted that bitter downside in the last year, as the share price dropped 20%. That falls noticeably short of the market decline of around 10%. Longer term shareholders haven't suffered as badly, since the stock is down a comparatively less painful 10% in three years. Now let's have a look at the company's fundamentals, and see if the long term shareholder return has matched the performance of the underlying business. View our latest analysis for First Bancshares While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. Unfortunately First Bancshares reported an EPS drop of 2.9% for the last year. This reduction in EPS is not as bad as the 20% share price fall. This suggests the EPS fall has made some shareholders are more nervous about the business. The less favorable sentiment is reflected in its current P/E ratio of 11.76. The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers). We're pleased to report that the CEO is remunerated more modestly than most CEOs at similarly capitalized companies. But while CEO remuneration is always worth checking, the really important question is whether the company can grow earnings going forward. This free interactive report on First Bancshares' earnings, revenue and cash flow is a great place to start, if you want to investigate the stock further. A Different Perspective While the broader market lost about 10% in the twelve months, First Bancshares shareholders did even worse, losing 18% (even including dividends). However, it could simply be that the share price has been impacted by broader market jitters. It might be worth keeping an eye on the fundamentals, in case there's a good opportunity. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 0.2% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. To that end, you should be aware of the 1 warning sign we've spotted with First Bancshares . Story continues If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of companies that have proven they can grow earnings. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_1
Shares of FuelCell Energy Inc. FCEL, +9.79% rose 9.79% to $3.70 Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +2.01% rising 2.01% to 11,364.41 and the Dow Jones Industrial Average DJIA, +0.76% rising 0.76% to 33,629.56. This was the stock's second consecutive day of gains. FuelCell Energy Inc. closed $3.63 below its 52-week high ($7.33), which the company reached on March 11th. Trading volume (14.7 M) eclipsed its 50-day average volume of 10.9 M. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_2
FTI Consulting, Inc. Majdi Al-Madani Joins as Senior Managing Director and Raed Masri Joins as Managing Director RIYADH, Saudi Arabia, Jan. 23, 2023 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of Majdi Al-Madani as a Senior Managing Director in the firm’s Forensic and Litigation Consulting segment and Raed Masri as a Managing Director in the Corporate Finance & Restructuring segment in Riyadh, Saudi Arabia. Mr. Al-Madani has more than 20 years of experience advising on forensic reviews and fraud investigations in a range of sectors, including banking, financial services, real estate, life sciences, maritime, agriculture and construction. He assists corporates and banks on fraud-related matters, antibribery and corruption policy and procedures, and regulatory and compliance matters. Prior to joining FTI Consulting, Mr. Al-Madani was a partner at a global management consulting firm. He previously held leadership roles at two Big Four firms in Saudi Arabia and worked in compliance, audit and management roles at major banks in the region. Mr. Al Madani will be joined by Sara Gassam, an investigations expert who has been appointed as a Director. Ms. Gassam has nine years of experience in investigations and forensic reviews from previous roles with a Big Four firm and an international construction disputes consultancy. She has worked with banks, government entities, multinational companies and family-owned businesses in a variety of sectors, including aviation, construction, pharmaceuticals and entertainment. “Majdi brings valuable experience in the complex issues that our clients face in Saudi Arabia, and we are delighted to have him on board to support our growth ambitions in the region,” said Rory O’Brien, EMEA Head of the Forensic and Litigation Consulting segment at FTI Consulting. “We continue to expand our offering in international markets that are critical to our clients. The arrival of skilled experts such as Majdi and Sara is consistent with that strategy.” Story continues Commenting on his appointment, Mr. Al-Madani said, “FTI Consulting has a long-established presence in the Middle East, and I am excited to contribute to the firm’s ongoing success as it pursues a new phase of growth in Saudi Arabia. Businesses face increasing regulatory and compliance pressure in their efforts to combat fraud and corruption, and I will work alongside my new colleagues to help clients address these complex challenges.” Mr. Masri is a seasoned transactions advisory expert who brings more than 14 years of experience in buy-side and sell-side financial due diligence, valuations, financial feasibility reviews, business planning and IPO-related work. Mr. Masri’s experience spans various countries across the Middle East, including Saudi Arabia, Qatar, Oman, Kuwait and Egypt. Prior to joining FTI Consulting, he was a Director at a Big Four firm. “Raed’s arrival is another important milestone in the development of our presence in Saudi Arabia,” said Vikas Papriwal, Head of the Corporate Finance & Restructuring segment in the Middle East at FTI Consulting. “He brings a deep understanding of the key sectors in which our clients operate, including construction, healthcare, financial services, retail, energy and logistics, and strengthens the transaction services that we provide clients across the region.” FTI Consulting’s offerings in Saudi Arabia are supported by the firm’s wider Middle East capabilities, which include teams of experts in construction solutions, data privacy, forensic and digital investigations, strategy consulting and strategic communications. These hires follow a series of senior-level appointments at FTI Consulting in the Middle East. During 2022, the firm strengthened its Forensic and Litigation Consulting segment with the addition of financial crime experts Abi-gail Marshman, who joined the Abu Dhabi office as Middle East and North Africa Head of the Financial Crime practice; Dan McWilliams and Zarik Nawaz, who joined as Managing Directors in Dubai; and emerging technologies expert Jorge Carrasco, who was appointed as a Managing Director in Dubai. In addition, the arrival of Nilesh Ashar as a Senior Managing Director and Sameep Uchil as a Managing Director earlier this month spearheaded the formation of the firm’s dedicated Tax practice in the United Arab Emirates. About FTI Consulting FTI Consulting, Inc. is a global business advisory firm dedicated to helping organisations manage change, mitigate risk and resolve disputes: financial, legal, operational, political & regulatory, reputational and transactional. With more than 7,500 employees located in 31 countries, FTI Consulting professionals work closely with clients to anticipate, illuminate and overcome complex business challenges and make the most of opportunities. The Company generated $2.78 billion in revenues during fiscal year 2021. In certain jurisdictions, FTI Consulting’s services are provided through distinct legal entities that are separately capitalised and independently managed. For more information, visit www.fticonsulting.com and connect with us on Twitter (@FTIConsulting), Facebook and LinkedIn. FTI Consulting, Inc. 200 Aldersgate Aldersgate Street London, EC1A 4HD Investor Contact: Mollie Hawkes +1.617.747.1791 mollie.hawkes@fticonsulting.com Media Contact: Helen Obi +44 20 7632 5071 helen.obi@fticonsulting.com
NEWS_3
MILL VALLEY, Calif., January 23, 2023--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties ("FCPT" or the "Company"), announced today that it has promoted James Brat to serve as FCPT’s Chief Operations Officer. Mr. Brat joined FCPT at its inception in November 2015 as General Counsel and was promoted to Chief Transaction Officer in January 2020. In Mr. Brat’s over seven years with the Company, FCPT has acquired 624 properties, grown its employee base, and invested significantly in its operations at its headquarters in Mill Valley. "As we have continued to grow, Jim has been integral to the development of our operations, legal, human resources, and property management teams all while overseeing our owned restaurant operations under Kerrow Holdings and assisting in capital raising," said Bill Lenehan, CEO of FCPT. "Jim’s unique skill set encompasses operations, real estate transactions and legal judgment that makes him an important member of FCPT and critical to our effort to drive value for our shareholders." About FCPT FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the ownership, acquisition and leasing of restaurant and retail properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries. Additional information about FCPT can be found on the website at www.fcpt.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005785/en/ Contacts Four Corners Property Trust: Bill Lenehan, 415-965-8031 CEO Gerry Morgan, 415-965-8032 CFO
NEWS_4
Franklin Electric Co., Inc. FORT WAYNE, Ind., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Franklin Electric Co., Inc. (NASDAQ: FELE) announced today that its Board of Directors declared a quarterly cash dividend of $0.225 per share payable February 16, 2023, to shareholders of record on February 2, 2023. This represents a 15 percent increase from the prior quarterly dividend. “This dividend increase will mark the 31st consecutive year that Franklin Electric has increased its dividend, demonstrating its commitment to returning cash to shareholders and confidence in the outlook of the business,” commented Gregg Sengstack, Franklin Electric’s Chairperson and Chief Executive Officer. Franklin Electric is a global leader in the production and marketing of systems and components for the movement of water and fuel. Recognized as a technical leader in its products and services, Franklin Electric serves customers around the world in residential, commercial, agricultural, industrial, municipal, and fueling applications. “Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein, including those relating to market conditions or the Company’s financial results, costs, expenses or expense reductions, profit margins, inventory levels, foreign currency translation rates, liquidity expectations, business goals and sales growth, involve risks and uncertainties, including but not limited to, risks and uncertainties with respect to general economic and currency conditions, various conditions specific to the Company’s business and industry, weather conditions, new housing starts, market demand, competitive factors, changes in distribution channels, supply constraints, effect of price increases, raw material costs, technology factors, integration of acquisitions, litigation, government and regulatory actions, the Company’s accounting policies, future trends, epidemics and pandemics, and other risks which are detailed in the Company’s Securities and Exchange Commission filings, included in Item 1A of Part I of the Company’s Annual Report on Form 10-K for the fiscal year ending December 31, 2021, Exhibit 99.1 attached thereto and in Item 1A of Part II of the Company’s Quarterly Reports on Form 10-Q. These risks and uncertainties may cause actual results to differ materially from those indicated by the forward-looking statements. All forward-looking statements made herein are based on information currently available, and the Company assumes no obligation to update any forward-looking statements. Story continues Contact: Jeffery L. Taylor Franklin Electric Co., Inc. 260.824.2900
NEWS_5
Franklin Electric Co. said Monday it will raise its quarterly dividend to 22.5 cents per share, that represents a 15.3% increase from the prior dividend of 19.5 cents a share. The new dividend will be payable Feb. 16 to shareholders of record on Feb. 2. Shares of the maker of water and fuel movement products was still untraded ahead of Monday’s open. Based on Friday’s stock closing price of $85.09, the new annual dividend rate implies a dividend yield of 1.06%, which compares with the implied yield for the S&P 500 of 1.70%. Franklin Electric’s stock has slipped 0.2% over the past three months, while the S&P 500 has gained 5.9%.
NEWS_6
First Financial Bankshares (NASDAQ:FFIN) Full Year 2022 Results Key Financial Results Revenue: US$515.7m (flat on FY 2021). Net income: US$234.5m (up 3.0% from FY 2021). Profit margin: 46% (up from 44% in FY 2021). EPS: US$1.64 (up from US$1.60 in FY 2021). FFIN Banking Performance Indicators Net interest margin (NIM): 3.29% (down from 3.40% in FY 2021). Cost-to-income ratio: 43.3% (down from 45.8% in FY 2021). Non-performing loans: 0.38% (down from 0.59% in FY 2021). All figures shown in the chart above are for the trailing 12 month (TTM) period First Financial Bankshares Earnings Insights Looking ahead, revenue is forecast to grow 5.5% p.a. on average during the next 2 years, compared to a 6.4% growth forecast for the Banks industry in the US. Performance of the American Banks industry. The company's shares are down 2.0% from a week ago. Balance Sheet Analysis Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We have a graphic representation of First Financial Bankshares' balance sheet and an in-depth analysis of the company's financial position. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_7
Independent Bank Group (IBTX) came out with quarterly earnings of $1.20 per share, missing the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.28 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -6.25%. A quarter ago, it was expected that this bank holding company would post earnings of $1.35 per share when it actually produced earnings of $1.33, delivering a surprise of -1.48%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Independent Bank Group , which belongs to the Zacks Banks - Southeast industry, posted revenues of $153.01 million for the quarter ended December 2022, missing the Zacks Consensus Estimate by 5.20%. This compares to year-ago revenues of $147.74 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Independent Bank Group shares have added about 1.1% since the beginning of the year versus the S&P 500's gain of 3.5%. What's Next for Independent Bank Group? While Independent Bank Group has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Story continues Ahead of this earnings release, the estimate revisions trend for Independent Bank Group: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.19 on $159.28 million in revenues for the coming quarter and $5.17 on $662.7 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Southeast is currently in the bottom 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. First Guaranty Bancshares (FGBI), another stock in the same industry, has yet to report results for the quarter ended December 2022. This bank holding company is expected to post quarterly earnings of $0.54 per share in its upcoming report, which represents a year-over-year change of -22.9%. The consensus EPS estimate for the quarter has been revised 18.6% lower over the last 30 days to the current level. First Guaranty Bancshares' revenues are expected to be $28.16 million, up 2.4% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Independent Bank Group, Inc (IBTX) : Free Stock Analysis Report First Guaranty Bancshares, Inc. (FGBI) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_8
RBB (RBB) came out with quarterly earnings of $0.92 per share, missing the Zacks Consensus Estimate of $0.93 per share. This compares to earnings of $0.79 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -1.08%. A quarter ago, it was expected that this bank holding company would post earnings of $0.85 per share when it actually produced earnings of $0.87, delivering a surprise of 2.35%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. RBB , which belongs to the Zacks Banks - West industry, posted revenues of $41.35 million for the quarter ended December 2022, missing the Zacks Consensus Estimate by 2.72%. This compares to year-ago revenues of $36.38 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. RBB shares have lost about 1% since the beginning of the year versus the S&P 500's gain of 3.5%. What's Next for RBB? While RBB has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Story continues Ahead of this earnings release, the estimate revisions trend for RBB: unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.87 on $42.75 million in revenues for the coming quarter and $3.46 on $171.25 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - West is currently in the bottom 25% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. First Hawaiian (FHB), another stock in the same industry, has yet to report results for the quarter ended December 2022. The results are expected to be released on January 27. This bank holding company is expected to post quarterly earnings of $0.57 per share in its upcoming report, which represents a year-over-year change of +7.6%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. First Hawaiian's revenues are expected to be $216.39 million, up 21% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report RBB Bancorp (RBB) : Free Stock Analysis Report First Hawaiian, Inc. (FHB) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_9
Analyst Report: Five Below, Inc. Five Below is a value-oriented retailer that operated 1,190 stores in the United States as of the end of fiscal 2021. Catering to teen and preteen consumers, its stores feature a wide variety of merchandise, the vast majority of which is priced below $6. The assortment focuses on discretionary items in several categories, particularly leisure (such as sporting goods, toys, and electronics; 48% of fiscal 2021 sales), fashion and home (for example, beauty products and accessories, home goods, and storage solutions; 30% of fiscal 2021 sales), and party and snack (including seasonal goods, candy, and beverages; 22% of fiscal 2021 sales). The chain had stores in 40 states as of the end of fiscal 2021.
NEWS_10
Conference call and webcast to be held on Tuesday, February 7, 2023 DUBUQUE, Iowa, January 23, 2023--(BUSINESS WIRE)--Flexsteel Industries, Inc. (NASDAQ:FLXS) ("Flexsteel" or the "Company"), one of the largest manufacturers, importers and marketers of residential furniture products in the United States, announced today that it will issue its second quarter 2023 financial results after market close on Monday, February 6, 2023. A conference call and audio webcast with analysts and investors will be held on Tuesday, February 7, 2023 at 8:00 a.m. Central Time to discuss the results and answer questions. Live conference call: 866-777-2509 (domestic) or 412-317-5413 (international) Conference call replay available through February 14, 2023: 877-344-7529 (domestic) or 412-317-0088 (international) Replay access code: 1489243 Live and archived webcast: ir.flexsteel.com To pre-register for the earnings conference call and avoid the need to wait for a live operator, investors can visit https://dpregister.com/sreg/10173641/f5410e4582 and enter their contact information. Registered participants will receive their dial-in number upon registration. The second quarter 2023 earnings release can be accessed at ir.flexsteel.com after market close on Monday, February 6, 2023. About Flexsteel Flexsteel Industries, Inc., and Subsidiaries (the "Company") is one of the largest manufacturers, importers, and marketers of residential furniture products in the United States. Product offerings include a wide variety of furniture such as sofas, loveseats, chairs, reclining rocking chairs, swivel rockers, sofa beds, convertible bedding units, occasional tables, desks, dining tables and chairs, kitchen storage, bedroom furniture, and outdoor furniture. A featured component in most of the upholstered furniture is a unique steel drop-in seat spring from which the name "Flexsteel" is derived. The Company distributes its products throughout the United States through its e-commerce channel and direct sales force. Story continues View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005040/en/ Contacts INVESTOR CONTACT: Alejandro Huerta, Flexsteel Industries, Inc. 563-585-8126 investors@flexsteel.com
NEWS_11
Fomento Economico Mexicano MONTERREY, Mexico, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announced today that it has signed, through a wholly-owned subsidiary, an agreement with Concesionaria Vuela Compañía de Aviación, S.A.P.I. de C.V. (“Volaris”), the ultra-low-cost carrier serving Mexico, the United States, Central, and South America to become the first third-party partner of FEMSA’s coalition loyalty program (the “Program”). This Program will offer exclusive benefits for its users, allowing them to accrue and redeem reward points with OXXO, Volaris and future allies. Alejandro Gonzalez-Saúl, Director of Digital@FEMSA’s loyalty strategy, commented: “In Volaris we have found a great ally that will help us benefit millions of customers. Starting this year, our customers will be able to enjoy exclusive rewards with OXXO and Volaris, Mexico’s largest airline. This agreement is only the beginning as we are constantly working to add more partners to allow our customers to do and achieve more with their money.” The terms and conditions applicable to the users of the Program will be published once the implementation of this partnership is finalized. About FEMSA FEMSA is a company that creates economic and social value through companies and institutions and strives to be the best employer and neighbor to the communities in which it operates. It participates in the retail industry through a Proximity Division operating OXXO, a small-format store chain, OXXO Gas, a chain of retail service stations, and Valora, our European retail unit with convenience store and food service operations. In the retail industry it also participates though a Health Division, which includes drugstores and related activities and Digital@FEMSA, which includes Spin by OXXO and OXXO Premia, among other loyalty and digital financial services initiatives. In the beverage industry, it participates through Coca-Cola FEMSA, the largest franchise bottler of Coca-Cola products in the world by volume; and in the beer industry, as the second largest shareholder of Heineken, one of the world’s leading brewers with operations in over 70 countries. FEMSA also participates in the logistics and distribution industry through its Strategic Business Unit, which additionally provides point-of-sale refrigeration and plastic solutions to its business units and third-party clients. Across its business units, FEMSA has more than 320,000 employees in 18 countries. FEMSA is a member of the Dow Jones Sustainability MILA Pacific Alliance, the FTSE4Good Emerging Index and the Mexican Stock Exchange Sustainability Index: S&P/BMV Total México ESG, among other indexes that evaluate its sustainability performance. Story continues About Digital@FEMSA Digital@FEMSA is the technology innovation division that offers digital solutions to simplify the lives of our customers. It is integrated by businesses that leverage technology to create trustworthy and practical tools, such as Spin by OXXO, and by a diverse and multidisciplinary team focused on developing an innovative and differentiated value proposition in the market. Backed by the more than 130 years of experiences and commitment to excellence of FEMSA, this division continues the mission of generating economic and social value, now in the digital community. Investor Contact (52) 818-328-6000 investor@femsa.com.mx femsa.gcs-web.com Media Contact (52) 555-249-6843 comunicacion@femsa.com.mx femsa.com
NEWS_12
BANGKOK, January 23, 2023--(BUSINESS WIRE)--Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced it will release its second quarter fiscal year 2023 financial results for the period ended December 30, 2022 after market close on Monday, February 6, 2023. On that day, management will hold a conference call and webcast at 5:00 p.m. ET to review and discuss the Company’s results. What: Fabrinet Second Quarter Fiscal Year 2023 Financial Results Call When: Monday, February 6, 2023 Time: 5:00 p.m. ET Live Call & Replay: https://investor.fabrinet.com/events-and-presentations/events A recorded version of this webcast will be available approximately two hours after the call and also accessible at https://investor.fabrinet.com/. The webcast will be archived on Fabrinet’s website for a period of one year. About Fabrinet Fabrinet is a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and subsystems, automotive components, medical devices, industrial lasers and sensors. Fabrinet offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, advanced packaging, integration, final assembly and testing. Fabrinet focuses on production of high complexity products in any mix and any volume. Fabrinet maintains engineering and manufacturing resources and facilities in Thailand, the United States of America, the People’s Republic of China, Israel and the United Kingdom. For more information visit: www.fabrinet.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005076/en/ Contacts Investor Contact: Garo Toomajanian ir@fabrinet.com
NEWS_13
F.N.B. (FNB) came out with quarterly earnings of $0.44 per share, beating the Zacks Consensus Estimate of $0.41 per share. This compares to earnings of $0.30 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 7.32%. A quarter ago, it was expected that this financial holding company would post earnings of $0.36 per share when it actually produced earnings of $0.39, delivering a surprise of 8.33%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. F.N.B. , which belongs to the Zacks Banks - Southeast industry, posted revenues of $415.5 million for the quarter ended December 2022, surpassing the Zacks Consensus Estimate by 4.86%. This compares to year-ago revenues of $302.26 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. F.N.B. Shares have lost about 0.9% since the beginning of the year versus the S&P 500's gain of 3.5%. What's Next for F.N.B. While F.N.B. Has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Story continues Ahead of this earnings release, the estimate revisions trend for F.N.B. Mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $0.37 on $398.02 million in revenues for the coming quarter and $1.55 on $1.61 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - Southeast is currently in the bottom 28% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, National Bank Holdings (NBHC), is yet to report results for the quarter ended December 2022. The results are expected to be released on January 24. This holding company for NBH Bank is expected to post quarterly earnings of $0.80 per share in its upcoming report, which represents a year-over-year change of +6.7%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. National Bank Holdings' revenues are expected to be $110.53 million, up 52% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report F.N.B. Corporation (FNB) : Free Stock Analysis Report National Bank Holdings Corporation (NBHC) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_14
Shares of Franco-Nevada Corp. FNV, -0.86% dropped 0.86% to C$194.97 Monday, in what proved to be an otherwise all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, +0.63% rising 0.63% to 20,631.58. Franco-Nevada Corp. closed C$21.35 below its 52-week high (C$216.32), which the company achieved on March 8th. Trading volume of 419,128 shares eclipsed its 50-day average volume of 381,420. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_15
CAMBRIDGE, Mass., January 23, 2023--(BUSINESS WIRE)--Forrester (Nasdaq: FORR) today introduced Forrester Decisions for Partner Ecosystem Marketing, the next generation of its Forrester Decisions for Channel Marketing service. The enhanced service is designed to help marketing leaders modernize their existing partner programs as partner ecosystems further evolve and expand. Forrester data shows that in 2022, nearly half of B2B channel and ecosystem leaders expected annual growth in the number of partners they engaged with. This year, the formation of partner ecosystems will continue to rise and extend beyond transactional or resell motions. These partner ecosystems will also include non-transacting partners that play a vital role in actualizing value across the entire customer lifecycle. This Forrester Decisions service will help partner ecosystem marketing leaders develop, enable, and engage their partners to drive loyalty and amplify revenue growth throughout their ecosystem. Forrester Decisions for Partner Ecosystem Marketing will also help executives, functional leaders, and their teams plan for and pursue their most pressing priorities, including: Formulating a partner ecosystem marketing strategy. Planning and measuring for partner ecosystem success. Optimizing insights-driven partner demand. Modernizing the partner program. Enabling ecosystem partners. Winning mindshare through partner engagement. Building a world-class partner ecosystem marketing team. "B2B organizations are experiencing tremendous shifts across their partner ecosystems," said Maria Chien, VP and research director at Forrester. "Currently, two-thirds of B2B channel and ecosystem leaders report that the orchestration of partner ecosystems is very important or essential to their organization. The Partner Ecosystem Marketing service within our Forrester Decisions portfolio will ensure that marketing leaders have access to the research and tools they need to fully capitalize on their partner ecosystems to drive business growth." Each Forrester Decisions service is built to empower leaders and their teams to move quickly, de-risk decisions, and save time and money through: Bold vision research to stay ahead of shifting customer and market dynamics and plan for the future. Curated tools and frameworks to conquer priorities and deliver on strategies with strategic models and plug-and-play templates. For example, the Forrester Partner Ecosystem Multiplier Model enables marketing leaders to build partner-obsessed organizations that drive alignment between partner ecosystem strategy, buyer and customer needs, partner success, and joint business outcomes. Hands-on guidance to accelerate progress and de-risk decisions with a tailored experience through analyst guidance sessions, peer discussions, and events. Resources: Learn more about Forrester Decisions for Partner Ecosystem Marketing. Explore Forrester’s Planning Guide 2023: Channel Marketing report (client access required). Check out strategy insights for B2B marketing leaders. About Forrester Forrester (Nasdaq: FORR) is one of the most influential research and advisory firms in the world. We help leaders across technology, customer experience, digital, marketing, sales, and product functions use customer obsession to accelerate growth. Through Forrester’s proprietary research, consulting, and events, leaders from around the globe are empowered to be bold at work — to navigate change and put their customers at the center of their leadership, strategy, and operations. Our unique insights are grounded in annual surveys of more than 700,000 consumers, business leaders, and technology leaders worldwide; rigorous and objective research methodologies, including Forrester Wave™ evaluations; 100 million real-time feedback votes; and the shared wisdom of our clients. To learn more, visit Forrester.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005133/en/ Contacts Ira Kantor Forrester Research ikantor@forrester.com
NEWS_16
Forrester Research Inc (NASDAQ: FORR) has launched Forrester Decisions for Partner Ecosystem Marketing, the next generation of its Forrester Decisions for Channel Marketing service. The enhanced service will enable marketing organizations to modernize their existing partner programs. The service will help formulate a partner ecosystem marketing strategy, plan and measure for partner ecosystem success, optimize insights-driven partner demand, modernize the partner program, enable ecosystem partners, win mindshare through partner engagement, and build a world-class partner ecosystem marketing team. "The Partner Ecosystem Marketing service within our Forrester Decisions portfolio will ensure that marketing leaders have access to the research and tools they need to fully capitalize on their partner ecosystems to drive business growth," said Maria Chien, VP and research director at Forrester. Price Action: FORR shares are trading lower by 0.70% at $36.65 on the last check Monday. Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better. This article originally appeared on Benzinga.com © 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
NEWS_17
Pet Retailer Ranked No. 22 in the Franchise 500® Ranking LIVONIA, Mich., Jan. 23, 2023 /PRNewswire/ -- Pet Supplies Plus, the largest independent pet franchise in North America with over 660 stores in 41 states, was named top pet franchise for the ninth year in a row by Entrepreneur's Franchise 500®, the world's first and most comprehensive franchise ranking. Franchise Pet Supplies Plus is focused on making it easier to get better products for your pet. (PRNewsfoto/Pet Supplies Plus) The 43rd annual Entrepreneur Franchise 500® is a highly sought-after honor in the franchise industry. Recognized as an invaluable resource for potential franchisees, the 2022 Franchise 500® ranks Pet Supplies Plus as No. 22 for its outstanding performance in key areas including unit growth, financial strength and stability, support and brand power. Entrepreneur Editor in Chief Jason Feifer shared that, "The companies named to this year's list showed us how being resilient, supportive, and nimble can help navigate extraordinary challenges and also underscore the grit and innovation that define entrepreneurship." The ranking recognition follows the company's latest development deals announced last month, which marked 90 signed franchise agreements for Pet Supplies Plus. Pet Supplies Plus was also included in Franchise Time's Fast & Serious ranking of 40 Smartest-Growing Franchises. Pet Supplies Plus acquired Wag N' Wash in February of 2022, to offer pet parents an unmatched pet grooming and retail experience. Investors can select between two unique business models that both benefit from the same infrastructure support providing best in class purchasing power, supply chain efficiencies and advanced marketing campaigns. "Pet Supplies Plus has been pet-focused and neighbor-centric since our founding over 30 years ago. We are proud to now offer a second concept with Wag N' Wash that also offers neighbors pet services with the same best-in-class, retail experience," said Chris Rowland, CEO of Pet Supplies Plus and Wag N' Wash. To find out more about the franchise opportunities with the lowest royalty fees within the pet category, fill out a 'get started form' for Pet Supplies Plus and Wag N' Wash to speak with a Franchise Development Director. Story continues About Pet Supplies Plus Pet Supplies Plus, a subsidiary of Franchise Group, Inc. (NASDAQ: FRG), is focused on making it easier to get better products and services for your pet. With over 660 locations in 41 states and counting, the stores have a streamlined design making it easy to navigate a wide assortment of natural pet foods, goods, and services. Additionally, www.petsuppliesplus.com provides neighbors with additional shopping options to better meet their pet-shopping needs. Headquartered in Livonia, Michigan, Pet Supplies Plus ranked No. 22 in Entrepreneur magazine's 43rd Annual Franchise 500® list as of 2023, and is ranked as the Top Full-Service Pet Supplies Franchise for the ninth year running for its exceptional performance in areas including financial strength and stability, growth rate and system size. For more information on Pet Supplies Plus franchise opportunities, visit www.petsuppliesplusfranchising.com. About Wag N' Wash Wag N' Wash Natural Pet Food & Grooming, a full-line dog grooming and self-wash specialty retail destination, has a mission to recognize, promote and foster the positive impact that companion pets and their humans have on each other. Wag N' Wash provides full-service grooming, self-wash facilities, baked dog treats, natural food, supplements, and toys. In 2020, Wag N' Wash was ranked on Denver Business Journal's Colorado-Based Franchisors List, Franchise Times Top 200+ List and Included on Franchise Gator's Top 100 Franchisees List for the third year. Today, there are 14 Wag N' Wash locations open across the nation. To learn more about Wag N' Wash, please visit https://www.wagnwashfranchising.com/. Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/pet-supplies-plus-named-top-franchise-in-the-pet-category-for-nine-consecutive-years-by-entrepreneur-magazine-301728209.html SOURCE Pet Supplies Plus
NEWS_18
Analyst Report: Fastly, Inc. Fastly operates a content delivery network, which is necessary for entities to provide faster and more reliable online content. Fastly’s strategy differs from traditional CDNs, which focused on locating servers in as many locations as possible to store copies of files that consumers most use. Fastly has far fewer sites than traditional CDNs, but it houses servers in the most network-dense data centers. Instead of simply storing static content, it allows its customers to program on its platform, enabling edge computing and better service of the more dynamic content that was traditionally not well served by CDNs. Fastly gears its service to the largest, most sophisticated enterprises rather than small companies and generated about two thirds of its revenue in the United States in 2020.
NEWS_19
How far off is Federal Signal Corporation (NYSE:FSS) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by projecting its future cash flows and then discounting them to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. It may sound complicated, but actually it is quite simple! We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. Anyone interested in learning a bit more about intrinsic value should have a read of the Simply Wall St analysis model. See our latest analysis for Federal Signal Crunching The Numbers We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value: 10-year free cash flow (FCF) forecast 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 Levered FCF ($, Millions) US$161.2m US$190.9m US$221.2m US$234.7m US$251.8m US$264.7m US$275.8m US$285.5m US$294.2m US$302.3m Growth Rate Estimate Source Analyst x3 Analyst x2 Analyst x1 Analyst x1 Analyst x1 Est @ 5.12% Est @ 4.18% Est @ 3.52% Est @ 3.06% Est @ 2.73% Present Value ($, Millions) Discounted @ 8.3% US$149 US$163 US$174 US$171 US$169 US$164 US$158 US$151 US$143 US$136 ("Est" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF) = US$1.6b Story continues The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (2.0%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 8.3%. Terminal Value (TV)= FCF 2032 × (1 + g) ÷ (r – g) = US$302m× (1 + 2.0%) ÷ (8.3%– 2.0%) = US$4.9b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$4.9b÷ ( 1 + 8.3%)10= US$2.2b The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is US$3.8b. The last step is to then divide the equity value by the number of shares outstanding. Relative to the current share price of US$50.9, the company appears about fair value at a 18% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. dcf The Assumptions The calculation above is very dependent on two assumptions. The first is the discount rate and the other is the cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Federal Signal as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.3%, which is based on a levered beta of 1.054. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. SWOT Analysis for Federal Signal Strength Debt is not viewed as a risk. Weakness Earnings declined over the past year. Dividend is low compared to the top 25% of dividend payers in the Machinery market. Opportunity Annual earnings are forecast to grow faster than the American market. Current share price is below our estimate of fair value. Threat Revenue is forecast to grow slower than 20% per year. Looking Ahead: Whilst important, the DCF calculation shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Rather it should be seen as a guide to "what assumptions need to be true for this stock to be under/overvalued?" If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. For Federal Signal, we've compiled three pertinent factors you should consider: Risks: Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Federal Signal , and understanding this should be part of your investment process. Future Earnings: How does FSS's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. Simply Wall St updates its DCF calculation for every American stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_20
White Falcon Capital Management LLC, an investment management firm, published its fourth quarter 2022 investor letter – a copy of which can be downloaded here. A quarterly net increase of 2.52% has been recorded by the fund for the fourth quarter of 2022, below the S&P 500 (CAD) Index’s 5.25% gain for the same period. Spare some time to check the fund’s top 5 holdings to have a clue about their top bets for 2022. In its Q3 2022 investor letter, White Falcon Capital Management mentioned Farfetch Limited (NYSE:FTCH) and explained its insights for the company. Founded in 2007, Farfetch Limited (NYSE:FTCH) is a London, United Kingdom-based online luxury fashion retail platform with a $2.3 billion market capitalization. Farfetch Limited (NYSE:FTCH) delivered a 32.98% return since the beginning of the year, while its 12-month returns are down by -70.91%. The stock closed at $6.29 per share on January 20, 2023. Here is what White Falcon Capital Management has to say about Farfetch Limited (NYSE:FTCH) in its Q3 2022 investor letter: "The other half of the portfolio that had negative unrealized and realized losses and the common characteristics they had was that they were either technology stocks or small caps or both! The biggest mistakes in this basket have been Farfetch and CopperLeaf Technologies. Farfetch is the largest scaled e-commerce platform for luxury goods. In addition to being a marketplace, it has a platform solutions business (think Shopify for luxury) as well as a own brands division. Our revenue and margin estimates for Farfetch turned out to be too high when, during an investor day, management lowered their guidance for the business. The business should be able to do 20-30% EBITDA margins in a mature state but that is not looking likely due to lower realized market power and an inflated cost structure." Our calculations show that Farfetch Limited (NYSE:FTCH) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. Farfetch Limited (NYSE:FTCH) was in 50 hedge fund portfolios at the end of the second quarter of 2022, compared to 39 funds in the previous quarter. Farfetch Limited (NYSE:FTCH) delivered a -15.46% return in the past 3 months. In January 2023, we published an article that includes Farfetch Limited (NYSE:FTCH) in 5 Penny Stocks That Will Make You A Millionaire. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters Q4 2022 page. Suggested Articles: Disclosure: None. This article is originally published at Insider Monkey.
NEWS_21
Shares of TechnipFMC PLC FTI, +0.77% inched 0.77% higher to $13.13 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX, +1.19% rising 1.19% to 4,019.81 and the Dow Jones Industrial Average DJIA, +0.76% rising 0.76% to 33,629.56. This was the stock's third consecutive day of gains. TechnipFMC PLC closed $0.07 short of its 52-week high ($13.20), which the company reached on January 17th. The stock outperformed some of its competitors Monday, as Oil States International Inc. OIS, -1.74% fell 1.74% to $8.48. Trading volume (5.6 M) remained 820,587 below its 50-day average volume of 6.4 M.
NEWS_22
Shares of Fortis Inc. FTS, -0.55% shed 0.55% to C$55.56 Monday, in what proved to be an otherwise all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, +0.63% rising 0.63% to 20,631.58. Fortis Inc. closed C$9.70 below its 52-week high (C$65.26), which the company achieved on May 25th. Trading volume of 3.4 M shares eclipsed its 50-day average volume of 2.0 M. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_23
Since 2016, Fulton Bank has made a substantial number of low- to moderate-income home loans through its partnership with Operation HOPE LANCASTER, Pa. & ATLANTA, January 23, 2023--(BUSINESS WIRE)--Operation HOPE recently recognized Fulton Bank, a subsidiary of Fulton Financial Corporation (NASDAQ: FULT), for providing nearly $1 billion in loans to low- and moderate-income homebuyers over the past seven years. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230123005683/en/ "We’re pleased to partner with organizations like Fulton Bank that understand the importance of home ownership in empowering our communities," said John Hope Bryant, Founder, Chairman and CEO of Operation HOPE. "We honored Fulton Bank for their commitment to increasing social mobility at our recent HOPE Global Forum, the largest gathering of its kind, dedicated to expanding financial inclusion for everyone." In 2016, Fulton Bank began collaborating with Operation HOPE, a leading non-profit focused on financial literacy and economic inclusion. Fulton Bank participates in the Closing Cost Assistance Program, which provides grants to buyers to help with the up-front costs of purchasing a home. Fulton also sponsors Operation HOPE financial wellness coaches in six cities throughout its footprint. The coaches provide free education to consumers, focusing on improving their credit and preparing them for the financial aspects of home ownership. Fulton Bank has helped facilitate more than $968 million in loans to more than 5,700 homebuyers under the Closing Cost Assistance Program, and that cumulative total is on track to hit $1 billion in loans in 2023. In addition to homebuyer loans, the bank has donated more than $8 million in grants to make purchasing a home more affordable for low and moderate-income buyers. "Fulton Bank’s purpose is to change lives for the better, and one of the best ways we can do that is by helping people achieve the dream of homeownership," said William "Smokey" Glover, Executive Vice President and Director of Fair and Responsible Banking for Fulton Bank. "We are grateful for our collaboration with Operation HOPE, which enables us to provide valuable financial education along with financing. Both elements are critical to set homebuyers on a path to success." Story continues Operation HOPE recognized Fulton Bank for their ongoing collaboration at the 9th Annual HOPE Global Forums in Atlanta in December, which included nearly 5,000 delegates and attained more than 1 million views online. About Operation HOPE, Inc. Since 1992, Operation HOPE has been moving America from civil rights to "silver rights" with the mission of making free enterprise and capitalism work for the underserved—disrupting poverty for millions of low and moderate-income youth and adults across the nation. Through its community uplift model, HOPE Inside, which received the 2016 Innovator of the Year recognition by American Banker magazine, Operation HOPE has served more than 4 million individuals and directed more than $3.2 billion in economic activity into disenfranchised communities—turning check-cashing customers into banking customers, renters into homeowners, small business dreamers into small business owners, minimum wage workers into living wage consumers, and uncertain disaster victims into financially empowered disaster survivors. For more information: OperationHOPE.org. Follow the HOPE conversation on Twitter, Facebook and Instagram. About Fulton Bank, N.A. Headquartered in Lancaster, Pa., Fulton Bank is a premier community bank in the Mid-Atlantic region. As a subsidiary of Fulton Financial Corporation, a $26 billion financial services holding company, Fulton Bank offers a broad array of products and services at more than 200 financial centers across Pennsylvania, New Jersey, Maryland, Delaware, and Virginia. At Fulton Bank, we seek to change lives for the better by building strong customer relationships, providing significant community support and empowering more than 3,300 employees to do the same. Through the Fulton Forward® initiative, we’re helping build vibrant communities. Learn more at www.FultonBank.com. Fulton Bank, N.A., Member FDIC, Equal Housing Lender. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005683/en/ Contacts Operation HOPE: Lalohni Campbell (404) 593-7145 Fulton Bank: Steve Trapnell (717) 291-2739
NEWS_24
VANCOUVER, BC / ACCESSWIRE / January 23, 2023 / Fury Gold Mines Limited (TSX:FURY)(NYSE American:FURY) ("Fury" or the "Company") is pleased to provide results for the final three 2022 core drill holes at the Eau Claire project located in the Eeyou Istchee Territory in the James Bay region of Quebec. The 2022 drill program successfully expanded the high-grade gold mineralized footprint at the Hinge Target, Gap Zone, and eastern expansion target areas. To date, the eleven holes drilled into the Hinge Target have had a hit rate of nearly 55% above the Eau Claire underground measured and indicated resource grade of 6.3 g/t gold and over 80% above the underground cut-off grade of 2.5 g/t gold. Collectively, these results have provided a clear focus for deposit expansion moving forward into 2023. Drill hole 22EC-059 was drilled oblique to all other drilling at the Hinge Target (at an angle of 150 degrees) and provides confirmation of the current geological interpretation. The hole intercepted eight zones of gold mineralization across 350 metres (m) drilled width including 1.50m of 22.77 g/t gold, 1.50m of 15.30 g/t gold and 1.50m of 6.46 g/t gold (Table 1). The reported intercepts extend the gold mineralization and represent a 100m offset to the west and 150m vertical offset of the defined shallow 850 Zone within the Hinge Target. Notably, the reported intercept of 1.50m of 22.77 g/t gold at a downhole depth of 181.5m, approximately 155m below surface, is one of the shallowest high-grade intercepts to date within the Hinge Target zone. "Fury is pleased to announce the final drill results from our 2022 drill program at Eau Claire, as these results further confirm our thesis that the Eau Claire resource is open for significant expansion. Importantly, we have extended the mineralized footprint of the resource at the Hinge Target, Gap Zone, and eastern expansion, and have intercepted substantial gold grades at the Percival Main zone, located 14 km from Eau Claire, which warrant follow-up work," commented Tim Clark, CEO of Fury. "The results of our program at Eau Claire are extremely encouraging and our 2023 plans are being reviewed and will be announced in the coming weeks." Story continues Western Hinge Target Fury's updated geological interpretation of the controls on mineralization within the Eau Claire resource has led to a focus on the fold geometry at the Hinge Target resulting in an overall increase of approximately 25% to the mineralized footprint (Figure 1). Drill holes 22EC-059 were designed to drill perpendicular to the apex of the fold hinge to test a series of vertically oriented veins, related to folding, as well as to expand upon shallow 850 Zone mineralization within 150 meters of surface. The Hinge target remains open to the west as well as up dip and down dip. Table 1: Eau Claire Drill Results Location Hole ID From To Length (m) Au g/t Hinge Target 22EC-059 123 124 1.00 9.36 181.5 183 1.50 22.77 258 259.5 1.50 6.46 311 312.5 1.50 1.97 371 372.5 1.50 1.91 380 381.5 1.50 15.30 463 465 2.00 2.96 468.5 471.5 3.00 1.64 East Expansion 22EC-060 97.5 99 1.50 1.81 637 639.5 2.50 3.91 649.5 650.5 1.00 3.66 22EC-061 194 195 1.00 2.07 501 502.5 1.50 3.65 581 582.5 1.50 3.06 Main intervals - Au grade*thickness no less than 2 g/t*m with grade is no less than 1 g/t, maximum consecutive dilution 2m. Lengths for exploration drilling are drill indicated core length, as insufficient drilling has been undertaken to determine true widths at this time. Resource Expansion Drilling to the East The 2022 eastern expansion drill program was designed to test for continuity between defined resource blocks along the southeastern margin of the Eau Claire deposit where the Company intercepted significant high-grade gold results from limited 2021 drilling of 23.27 g/t gold over 7.09m, 11.56 g/t gold over 6.04m(see news releases dated May 25, 2021 and March 1, 2021). All six drill holes completed in 2022 intercepted quartz tourmaline veining with associated alteration and include the following intercepts: 2.50m of 3.91 g/t gold from 22EC-060 and 1.50m of 3.65 g/t gold from 22EC-061 (Table 1 and Figure 1). The intercepts extend mineralization 65m and 75m respectively confirming the dip continuity of the defined mineralization along the southeast margin of the Eau Claire deposit. "With every drill hole completed into the Hinge Target, we are increasing our understanding both of the controls on mineralization as well as the potential scale. The 55% hit rate in the Hinge Target above resource grade exceeds the hit rate within the Eau Claire deposit of 35% and gives us confidence that the deposit can be expanded to the west," stated Bryan Atkinson, SVP, Exploration of Fury. Additionally, the Company is announcing that it has engaged with Native Ads Inc. ("Native Ads"), a firm of digital media experts, to execute a comprehensive digital media marketing campaign supporting Fury's ongoing efforts to increase awareness. This comprehensive advertising program is designed to build brand familiarity, general recognition and raise awareness within online investor content platforms. Native Ads will employ state-of-the-art advertising, paid distribution, media buying and content creation to execute this important initiative. Financial terms of the agreement were not released but are customary and non-material. Fury Gold Mines Limited, Friday, January 20, 2023, Press release picture Figure 1: Eau Claire Deposit long section area illustrating the resource block model and locations of the recent Hinge Target drill holes, towards the west. Fury Gold Mines Limited, Friday, January 20, 2023, Press release picture Figure 2: Illustrates the intercepts at the western Fold Hinge Target at the Eau Claire deposit. Fury Gold Mines Limited, Friday, January 20, 2023, Press release picture Figure 3: Illustrates the intercepts at the eastern expansion Target at the Eau Claire deposit. Sampling and Assaying Disclosure Analytical samples for the Drill Program were taken by sawing HQ diameter core into equal halves on site with one half sent to ALS Chemex in Val D'or, Quebec, Canada for preparation and analysis. All samples were assayed using a 50 g nominal weight fire assay with inductively coupled plasma - atomic emission spectrometry finish (Au-ICP22) and multi-element four acid digest ICP-AES/ICP-MS method (ME-MS61). Where Au-ICP22 results were greater than 0.5 ppm Au the assay was repeated with a 50 g nominal weight fire assay with atomic absorption finish (Au-AA24). Samples containing more than 5 ppm by Au-AA24 were re-assayed with 50 g nominal weight fire assay with gravimetric finish (Au-GRA22). QA/QC programs using internal standard samples, field and lab duplicates and blanks indicate good overall accuracy and precision. David Rivard, P.Geo, Exploration Manager at Fury, is a "qualified person" within the meaning of Canadian mineral projects disclosure standards instrument 43-101 and has reviewed and approved the technical disclosures in this press release. About Fury Gold Mines Limited Fury Gold Mines Limited is a well-financed Canadian-focused exploration company positioned in two prolific mining regions across the country and holds a 59.5 million common share position in Dolly Varden Silver Corp (23.5%). Led by a management team and board of directors with proven success in financing and advancing exploration assets, Fury intends to grow its multi-million-ounce gold platform through rigorous project evaluation and exploration excellence. Fury is committed to upholding the highest industry standards for corporate governance, environmental stewardship, community engagement and sustainable mining. For more information on Fury Gold Mines, visit www.furygoldmines.com. For further information on Fury Gold Mines Limited, please contact: Margaux Villalpando, Investor Relations Tel: (844) 601-0841 Email: info@furygoldmines.com Website: www.furygoldmines.com Forward-Looking Information and Additional Cautionary Language This release includes certain statements that may be deemed to be "forward-looking information" or "forward-looking statements" within the meaning of applicable securities laws, which relate to the future operations of the Company and other statements that are not historical facts. Forward-looking information contained in this release primarily relates to statements that suggest that future work at Eau Claire will potentially increase or upgrade the estimated gold resources. Although the Company believes that the assumptions and expectations reflected in those forward-looking statements were reasonable at the time such statements were made, there can be no assurance that such assumptions and expectations will prove to be correct. Exploration is a high-risk enterprise. Readers should refer to the risks discussed in the Company's Annual Information Form and MD&A for the year ended December 31, 2021 and subsequent continuous disclosure filings with the Canadian Securities Administrators available at www.sedar.com and the Company's Annual Report including the Base Shelf Prospectus available at www.sec.gov. Readers should not place heavy reliance on forward-looking information, which inherently can only as of the date made. Cautionary Note to United States Investors Concerning Estimates of Mineral Disclosure The mining and technical disclosure throughout this release is made in accordance with applicable Canadian law and the guidelines set out in the Canadian Institute of Mining, Metallurgy and Petroleum ("CIM"). The Company's descriptions of its projects using applicable CIM terminology, which includes defined terms such as inferred, measured or indicated resources, may not be comparable to similar information about resource grades that would be made public by U.S. companies which are subject to the reporting and disclosure requirements under the United States federal securities laws. SOURCE: Fury Gold Mines Limited View source version on accesswire.com: https://www.accesswire.com/736190/Fury-Drills-Multiple-Zones-of-High-Grade-Gold-at-the-Hinge-Target-including-2277-gt-Gold-over-15-Metres
NEWS_25
Arcimoto The fourth quarter saw record customer deliveries and 20 percent increase over the previous quarter EUGENE, Ore., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Arcimoto, Inc.® (NASDAQ: FUV), makers of rightsized, outrageously fun, ultra-efficient electric vehicles, today announced that it delivered 89 customer vehicles in Q4 2022, its most successful quarter yet. This represents a 20 percent increase over the 73 customer vehicles delivered in Q3 2022. For the year, Arcimoto delivered 228 customer vehicles, which increased the total number of Arcimoto vehicles on the road to more than 500. This comes despite ongoing supply chain issues and funding concerns, which Arcimoto partly addressed with the closing of a $12 million public offering on Jan. 20. Arcimoto also introduced the FUV to a record-high number of new drivers with more than 5,000 demo rides over the course of 2022 through a combination of industry events, private demo drives, and customer rentals. “2022 gives confidence to the Team that with our learned sales KPIs, we can better understand how to appropriately scale marketing and production efforts to achieve profitability,” said Jesse Fittipaldi, Arcimoto Interim CEO. “The fresh financial raise and the proven reasonable marketing effort to sell our product gives the team the fortitude to step into 2023 with practical confidence. We will increase our efforts to build the sales backlog and cost down our products knowing the plan is capital efficient and success is plausible.” For the latest company updates, check out our Q3 Stakeholder Webinar . Follow Arcimoto on YouTube , Facebook , Instagram , Twitter , TikTok , and LinkedIn . Investor information about the company, including press releases, stakeholder webcast replays, and more can be found at http://arcimoto.com/ir . About Arcimoto, Inc. Arcimoto is a pioneer in the design and manufacture of rightsized, ultra-efficient, incredibly fun electric vehicles for everyday mobility. Built on the revolutionary three-wheel Arcimoto Platform, our vehicles are purpose-built for daily driving and local delivery, all at a fraction of the cost and environmental impact of traditional gas-powered vehicles. Based in Eugene, Oregon, the Arcimoto team is dedicated to creating world-class EVs that make the world a better place. For more information, please visit Arcimoto.com . Story continues Safe Harbor / Forward-Looking Statements Except for historical information, all of the statements, expectations, and assumptions contained in this press release are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict and include, without limitation, our expectations as to vehicle deliveries, the establishment of our service and delivery network and our expected rate of production. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors discussed from time to time in documents which we file with the SEC. In addition, such statements could be affected by risks and uncertainties related to, among other things: our ability to manage the distribution channels for our products, including our ability to successfully implement our rental strategy, direct to consumer distribution strategy and any additional distribution strategies we may deem appropriate; our ability to design, manufacture and market vehicle models within projected timeframes given that a vehicle consists of several thousand unique items and we can only go as fast as the slowest item; our inexperience to date in manufacturing vehicles at the high volumes that we anticipate; our ability to maintain quality control over our vehicles and avoid material vehicle recalls; the number of reservations and cancellations for our vehicles and our ability to deliver on those reservations; unforeseen or recurring operational problems at our facility, or a catastrophic loss of our manufacturing facility; our dependence on our suppliers; changes in consumer demand for, and acceptance of, our products: changes in the competitive environment, including adoption of technologies and products that compete with our products; the overall strength and stability of general economic conditions and of the automotive industry more specifically; changes in laws or regulations governing our business and operations; costs and risks associated with potential litigation; and other risks described from time to time in periodic and current reports that we file with the SEC. Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws, we do not undertake any obligation to update any forward-looking statements. Public Relations Contact: pr@arcimoto.com Investor Relations Contact: investor@arcimoto.com
NEWS_26
Vehicle deliveries increased 20% from a small base late last year and a $12 million stock sale last week “partly addressed” a cash crunch, Arcimoto (Nasdaq: FUV) said in a news release on Monday. In a separate 2022 recap distributed over the weekend, which called the year “simultaneously the most successful and challenging year” in its 15-plus-year history, Arcimoto said production remained on hold “as we prepare for our 2023 vehicles.” Sales of new vehicle inventory and used vehicles continued, the company said.
NEWS_27
Arcimoto Inc (NASDAQ: FUV) said it delivered 89 customer vehicles in fourth-quarter fiscal 2022. This represents a 20% increase over the 73 customer vehicles delivered in Q3 2022. For FY22, Arcimoto delivered 228 customer vehicles, which increased the total number of Arcimoto vehicles on the road to more than 500. "2022 gives confidence to the Team that with our learned sales KPIs, we can better understand how to appropriately scale marketing and production efforts to achieve profitability," said Jesse Fittipaldi, Arcimoto Interim CEO. "The fresh financial raise and the proven reasonable marketing effort to sell our product gives the team the fortitude to step into 2023 with practical confidence." Also Read : Arcimoto Nosedives Following $12M Equity Offering Price Action: FUV shares are trading lower by 3.13% at $2.16 on the last check Monday. Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better. This article originally appeared on Benzinga.com © 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
NEWS_28
Strength Seen in Wayfair (W): Can Its 20.3% Jump Turn into More Strength? Wayfair (W) shares soared 20.3% in the last trading session to close at $46.79. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 13.7% gain over the past four weeks. Wayfair extended its rally, driven by its latest decision regarding job cuts. Notably, the company is set to lay off 1,000 workers or 10% of its workforce. This online home goods retailer is expected to post quarterly loss of $1.64 per share in its upcoming report, which represents a year-over-year change of -78.3%. Revenues are expected to be $3.01 billion, down 7.5% from the year-ago quarter. While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. For Wayfair, the consensus EPS estimate for the quarter has been revised 0.6% higher over the last 30 days to the current level. And a positive trend in earnings estimate revision usually translates into price appreciation. So, make sure to keep an eye on W going forward to see if this recent jump can turn into more strength down the road. The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Wayfair is a member of the Zacks Internet - Commerce industry. One other stock in the same industry, Fiverr International (FVRR), finished the last trading session 3.1% higher at $33.93. FVRR has returned 10% over the past month. Fiverr's consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.22. Compared to the company's year-ago EPS, this represents no change. Fiverr currently boasts a Zacks Rank of #3 (Hold). Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Story continues Wayfair Inc. (W) : Free Stock Analysis Report Fiverr International (FVRR) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_29
Zions (ZION) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.34 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 10.84%. A quarter ago, it was expected that this financial holding company would post earnings of $1.58 per share when it actually produced earnings of $1.40, delivering a surprise of -11.39%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Zions , which belongs to the Zacks Banks - West industry, posted revenues of $883 million for the quarter ended December 2022, surpassing the Zacks Consensus Estimate by 1.14%. This compares to year-ago revenues of $753 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Zions shares have added about 4.7% since the beginning of the year versus the S&P 500's gain of 3.5%. What's Next for Zions? While Zions has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Story continues Ahead of this earnings release, the estimate revisions trend for Zions: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.61 on $873.92 million in revenues for the coming quarter and $6.60 on $3.54 billion in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - West is currently in the bottom 25% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. Glacier Bancorp (GBCI), another stock in the same industry, has yet to report results for the quarter ended December 2022. The results are expected to be released on January 26. This bank holding company is expected to post quarterly earnings of $0.73 per share in its upcoming report, which represents a year-over-year change of +58.7%. The consensus EPS estimate for the quarter has been revised 1.1% lower over the last 30 days to the current level. Glacier Bancorp's revenues are expected to be $242.03 million, up 9% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Zions Bancorporation, N.A. (ZION) : Free Stock Analysis Report Glacier Bancorp, Inc. (GBCI) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_30
NORTHAMPTON, MA / ACCESSWIRE / January 23, 2023 / GoDaddy GoDaddy, Monday, January 23, 2023, Press release picture Originally published on GoDaddy Life Tell us a little bit about yourself and what you do at GoDaddy? I am a Senior Software Engineer on the DRI team and work on Domain Control center products. I have been with GoDaddy for over seven years now. I started at GoDaddy right after my Masters in CS in 2015. The past seven years have been amazing - I have really grown into myself! I started calling The United States my home (after moving from India in 2012), become a mom of two little girls, and have had the opportunity to work on so many different projects, here. I have been involved with GDGrad from early on. This is an Employee Resource Group dedicated to building a community for recent graduates. As a mentor to these individuals, I help them onboard and feel comfortable in a corporate environment. I was fortunate enough to travel to Stanford and Pittsburg University back in 2016 and 2017 as part of the recruitment process. This was an extremely fulfilling experience. How does GoDaddy make you feel supported as a woman? I have been the only woman on my team for a very long time now. Even though you might think I would face adversity, I have never felt that I am treated any differently, which is absolutely amazing. GoDaddy is generous with Maternity Leave, giving me time to bond with my babies. GDWIT, which is an Employee Resource for Women, has been a support system through many uncertain times with the pandemic. What is one thing you learned about yourself at work recently? I have always been an IC since I joined GoDaddy. This role is mandatory until you get to level three. After this level, you can choose between IC or a leadership role. However, I got an opportunity to lead a few major projects. This includes TransferIn rewrite and New DOP products! Through this experience, I interacted with major stakeholders crucial to project completion and communicated with Product and Program Managers. In the process, I learned that I am really good at mentoring junior folks, communicating, and resolving issues for various stakeholders. I was given accolades for "Joining Forces" for both projects. Because of these opportunities, I have decided to transition into an Engineering Manager role within this year. Story continues What's something you're actively trying to unlearn at work? I had to unlearn perfectionism. We often think (especially as a woman) that "perfect" work is always better than "good" work, but very often the opposite is true. The time that it would take to perfect a project means that other work will get pushed aside. Good work doesn't always have to be flawless. What is your personal advise for women who are interested in your profession? Be curious and confident. In the tech industry, you always have to be learning. I have been able to learn a plethora of new languages and technologies since joining GoDaddy. It's important to always be working on your tech skills, while understanding your interests. I was a frontend engineer when I started and it didn't suit my interests. So, I transitioned into Backend and absolutely love it. Be confident in sharing your ideas! Be confident in speaking to your manager about which path you want to move towards in your career. I wish I learned this sooner rather than later! What ideas might you bring to the GDWIT group? I was a site lead for the Iowa location for a long time and I saw women and allies really get excited when they found common interests amongst the group. With remote work, it's harder to find commonalities with your coworkers. I would like to create that space in a virtual setting, as well. It would be so neat to have sub groups within GDWIT, where members can chat and discuss topics that interest them. Examples could include: recipes for healthy eating, travel tips, and so on. We can also try to organize events that address these interests. Are you enjoying this series and want to know more about life at GoDaddy? Check out our GoDaddy Life social pages! Follow us to meet our team, learn more about our culture (teams, ERG's, locations), careers, and so much more. You're more than just your day job, so come propel your career with us. Facebook - https://www.facebook.com/GoDaddyLife Instagram - https://www.instagram.com/godaddylife/ LinkedIn - https://www.linkedin.com/showcase/godaddylife Twitter - https://twitter.com/GoDaddyLife TikTok - https://www.tiktok.com/@godaddylife? Career Page - https://careers.godaddy.com/ View additional multimedia and more ESG storytelling from GoDaddy on 3blmedia.com. Contact Info: Spokesperson: GoDaddy Website: https://www.3blmedia.com/profiles/godaddy Email: info@3blmedia.com SOURCE: GoDaddy View source version on accesswire.com: https://www.accesswire.com/736258/Curiosity-and-Confidence-as-a-Woman-in-Tech-Meet-Richa-Gandhi
NEWS_31
How far off is GoodRx Holdings, Inc. (NASDAQ:GDRX) from its intrinsic value? Using the most recent financial data, we'll take a look at whether the stock is fairly priced by taking the expected future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow. Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. For those who are keen learners of equity analysis, the Simply Wall St analysis model here may be something of interest to you. Check out our latest analysis for GoodRx Holdings Scroll to continue with content Ad ADVERTISEMENT Step By Step Through The Calculation We are going to use a two-stage DCF model, which, as the name states, takes into account two stages of growth. The first stage is generally a higher growth period which levels off heading towards the terminal value, captured in the second 'steady growth' period. In the first stage we need to estimate the cash flows to the business over the next ten years. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we discount the value of these future cash flows to their estimated value in today's dollars: 10-year free cash flow (FCF) forecast 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 Levered FCF ($, Millions) US$139.9m US$184.7m US$186.0m US$233.7m US$259.9m US$281.8m US$300.2m US$315.6m US$328.9m US$340.5m Growth Rate Estimate Source Analyst x5 Analyst x5 Analyst x1 Analyst x1 Est @ 11.22% Est @ 8.45% Est @ 6.51% Est @ 5.15% Est @ 4.20% Est @ 3.53% Present Value ($, Millions) Discounted @ 8.4% US$129 US$157 US$146 US$169 US$174 US$174 US$171 US$166 US$159 US$152 ("Est" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF) = US$1.6b Advertisement Advertisement After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.0%. We discount the terminal cash flows to today's value at a cost of equity of 8.4%. Terminal Value (TV)= FCF 2032 × (1 + g) ÷ (r – g) = US$341m× (1 + 2.0%) ÷ (8.4%– 2.0%) = US$5.4b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$5.4b÷ ( 1 + 8.4%)10= US$2.4b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$4.0b. In the final step we divide the equity value by the number of shares outstanding. Relative to the current share price of US$5.3, the company appears quite good value at a 48% discount to where the stock price trades currently. Valuations are imprecise instruments though, rather like a telescope - move a few degrees and end up in a different galaxy. Do keep this in mind. dcf Important Assumptions We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at GoodRx Holdings as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.4%, which is based on a levered beta of 1.067. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. Advertisement SWOT Analysis for GoodRx Holdings Strength Debt is well covered by cash flow. Weakness Interest payments on debt are not well covered. Opportunity Forecast to reduce losses next year. Has sufficient cash runway for more than 3 years based on current free cash flows. Good value based on P/S ratio and estimated fair value. Threat No apparent threats visible for GDRX. Next Steps: Valuation is only one side of the coin in terms of building your investment thesis, and it is only one of many factors that you need to assess for a company. DCF models are not the be-all and end-all of investment valuation. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. If a company grows at a different rate, or if its cost of equity or risk free rate changes sharply, the output can look very different. What is the reason for the share price sitting below the intrinsic value? For GoodRx Holdings, we've compiled three additional aspects you should assess: Advertisement Risks: Be aware that GoodRx Holdings is showing 1 warning sign in our investment analysis , you should know about... Future Earnings: How does GDRX's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other High Quality Alternatives: Do you like a good all-rounder? Explore our interactive list of high quality stocks to get an idea of what else is out there you may be missing! PS. Simply Wall St updates its DCF calculation for every American stock every day, so if you want to find the intrinsic value of any other stock just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_32
Earnings Release Scheduled for Tuesday, February 14, 2023 Before the Market Opens Conference Call Scheduled for Tuesday, February 14, 2023 at 11:00 AM (Eastern Time) BOCA RATON, Fla., January 23, 2023--(BUSINESS WIRE)--The GEO Group, Inc. (NYSE:GEO) ("GEO") will release its fourth quarter 2022 financial results on Tuesday, February 14, 2023 before the market opens. GEO has scheduled a conference call and simultaneous webcast for 11:00 AM (Eastern Time) on Tuesday, February 14, 2023. Hosting the call for GEO will be George C. Zoley, Executive Chairman of the Board, Jose Gordo, Chief Executive Officer, Brian R. Evans, Senior Vice President and Chief Financial Officer, Wayne Calabrese, Senior Vice President and Chief Operating Officer, and James Black, President, GEO Secure Services. To participate in the teleconference, please contact one of the following numbers 5 minutes prior to the scheduled start time: 1-877-250-1553 (U.S.) 1-412-542-4145 (International) In addition, a live audio webcast of the conference call may be accessed on the Webcasts section of GEO's investor relations home page at investors.geogroup.com. A webcast replay will remain available on the website for one year. A telephonic replay will also be available through February 21, 2023. The replay numbers are 1-877-344-7529 (U.S.) and 1-412-317-0088 (International). The passcode for the telephonic replay is 1705386. If you have any questions, please contact GEO at 1-866-301-4436. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005732/en/ Contacts Pablo E. Paez 1-866-301-4436 Executive Vice President, Corporate Relations
NEWS_33
Analyst Report: Guardant Health, Inc. Guardant Health, based in Redwood City, California, provides cancer blood tests and analytics for clinical and research use, and the firm maintains research partnerships with large biopharmaceutical companies. The company offers Guardant 360, a blood-based (liquid biopsy) test for treatment selection in advanced stage cancer, and Guardant Omni, a broader gene panel for immuno-oncology research. The company’s pipeline includes Guardant Reveal (formerly Lunar-1), for cancer recurrence detection in survivors, and Lunar-2, a liquid biopsy for early detection of cancer in higher-risk individuals, with an initial focus on colorectal cancer. Additionally, Guardant offers research development services. The United States accounts for 90% of total revenue, and other markets the remaining 10%.
NEWS_34
NEW YORK, January 23, 2023--(BUSINESS WIRE)--The decision by some top law schools to exit the rankings hasn’t led to anything similar among business schools (yet), but if it did, many admissions officers would welcome it, according to Manhattan Prep/Kaplan’s 2022 business school admissions officers survey*. Among the admissions officers surveyed at 117 full-time MBA programs across the United States, 37 percent believe that "business school rankings have lost some of their prestige over the last couple of years" and 29 percent disagree with that point of view; the remaining 34 percent didn’t express one view or the other. Additionally, 34 percent of business schools "think it would be a positive development, for both business schools and applicants, for business school rankings to no longer exist," while 30 percent disagree; the remaining 36 percent didn’t express one view or the other. These evolving views on the rankings come at a time of significant change on the MBA admissions landscape, with business schools looking for ways to boost their application numbers and many continuing to remain test optional, a COVID-era policy, as a way to accomplish this. It also comes at a time when some business schools and colleges have come under fire for reporting false data to game the rankings, hurting the system’s credibility. Those who held negative views about the rankings shared these reasons: "We should be focusing on fit, not prestige. What program is going to give the student the most positive experience and highest return on investment. We should be in the business of informing, not competing." "The methodology is often so terribly flawed. Some are so poorly done and are done so only to make money. Business schools have accepted that somewhat, but many of today's prospective students seem to have a more critical eye than previous prospects. They tell us the rankings don't have the influence they once had." "The criteria used for ranking is skewed to benefit the schools that already have more students and spend a lot of marketing dollars." "The audience is more aware of the subjectivity of rankings, some schools have chosen not to participate, and some of the rankings have produced questionable results." "Over the years, more than a few admissions officers half-jokingly said that ‘The most sleepless night for business school leaders is the night before the U.S. News rankings come out,’ since for some, their job hangs in the balance," said Stacey Koprince, director of content and curriculum for Manhattan Prep, a sister company of Kaplan. "Whether there’s widespread rebellion against the rankings the way we’ve seen among top law schools remains to be seen. For prospective students our advice is to look at the rankings when deciding where to apply and enroll, as they serve as a useful aggregate of important stats like post-graduate job numbers and starting salaries, but also strongly consider which schools seem like the best fit for you personally and for your professional goals." To schedule an interview with a Manhattan Prep/Kaplan expert about the survey results, journalists can contact Russell Schaffer at russell.schaffer@kaplan.com or 917.822.8190. *Based on the results of a survey conducted by phone and email between September and December 2022 and includes responses from 117 business schools across the United States; among them are 18 of the top 50 schools, as ranked by U.S. News & World Report. About Kaplan Kaplan, Inc. is a global educational services company that helps individuals and institutions advance their goals in an ever-changing world. Our broad portfolio of solutions help students and professionals further their education and careers, universities and educational institutions attract and support students, and businesses maximize employee recruitment and development. Stanley Kaplan founded our company in 1938 with a mission to expand educational opportunities for students of all backgrounds. Today, all of our employees across 27 countries continue Stanley’s mission, working with hundreds of thousands of students and professionals and 12,000 corporate and 4,000 school and university clients worldwide. Kaplan is a subsidiary of Graham Holdings Company (NYSE: GHC). Learn more at https://kaplan.com. Note to editors: Kaplan is a subsidiary of Graham Holdings Company (NYSE: GHC) View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005125/en/ Contacts Press: Russell Schaffer, russell.schaffer@kaplan.com, 917.822.8190 Twitter: @KaplanEdNews
NEWS_35
BATAVIA, N.Y., January 23, 2023--(BUSINESS WIRE)--Graham Corporation (NYSE: GHM), a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy and process industries, announced that it will release its third quarter fiscal year 2023 financial results before financial markets open on Monday, February 6, 2023. The Company will host a conference call and webcast to review its financial and operating results, strategy, and outlook. A question-and-answer session will follow. Third Quarter Fiscal Year 2023 Financial Results Conference Call Monday, February 6, 2022 11:00 a.m. Eastern Time Phone: (201) 689-8560 Internet webcast link and accompanying slide presentation: https://ir.grahamcorp.com/ A telephonic replay will be available from 2:00 p.m. ET on the day of the teleconference through Monday, February 13, 2023 at 11:59 p.m. ET. To listen to the archived call, dial (412) 317-6671 and enter conference ID number 13735007 or access the webcast replay via the Company’s website at www.ir.grahamcorp.com, where a transcript will also be posted once available. ABOUT GRAHAM CORPORATION Graham is a global leader in the design and manufacture of mission critical fluid, power, heat transfer and vacuum technologies for the defense, space, energy and process industries. The Graham Manufacturing and Barber-Nichols’ global brands are built upon world-renowned engineering expertise in vacuum and heat transfer, cryogenic pumps and turbomachinery technologies, as well as its responsive and flexible service and the unsurpassed quality customers have come to expect from the Company’s products and systems. Graham routinely posts news and other important information on its website, www.grahamcorp.com, where additional information on Graham Corporation and its businesses can be found. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005231/en/ Story continues Contacts For more information, contact: Christopher J. Thome Vice President - Finance and CFO Phone: (585) 343-2216 Deborah K. Pawlowski Kei Advisors LLC Phone: (716) 843-3908 dpawlowski@keiadvisors.com
NEWS_36
Shares of Gildan Activewear Inc. GIL, -1.74% dropped 1.74% to C$40.71 Monday, in what proved to be an otherwise all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, +0.63% rising 0.63% to 20,631.58. Gildan Activewear Inc. closed C$12.33 below its 52-week high (C$53.04), which the company achieved on February 9th. Trading volume of 515,787 shares eclipsed its 50-day average volume of 414,203. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_37
La Garrucha deposit adds approx. 1.0 million oz AuEq in the Inferred category and 0.2 million oz AuEq in the Indicated category (see Table 1) Updated Mineral Resource estimate inclusive of La Garrucha positions La Mina with 1.15 million oz AuEq Indicated and 1.45 million oz AuEq Inferred resources DESIGNATED NEWS RELEASE VANCOUVER, BC, Jan. 23, 2023 /CNW/ - GoldMining Inc. (the "Company" or "GoldMining") (TSX: GOLD) (NYSE American: GLDG) is pleased to announce an updated Mineral Resource estimate ("MRE") on its 100% owned La Mina Project located in the Middle Cauca Porphyry Belt, Antioquia, Colombia. The MRE includes a maiden resource estimate on the La Garrucha deposit which incorporates drilling completed by the Company in 2022. Highlights: La Garrucha – New Discovery Indicated Mineral Resources of 0.20 million ounces (Moz) gold equivalent (AuEq) at 0.84 g/t AuEq (7.4 million tonnes (Mt) grading 0.65 g/t gold, 3.14 g/t silver and 0.11% copper) (see Table 1); and Inferred Mineral Resources of 1.02 Moz AuEq at 0.72 g/t AuEq (44.1 Mt grading 0.55 g/t gold, 2.46 g/t silver and 0.10% copper) (see Table 1). La Mina – Combined MRE Indicated Mineral Resources of 1.15 Moz AuEq at 1.06 g/t AuEq, an increase of 16% in ounces and decrease in grade of 3% from 2022 (33.8 Mt grading 0.73 g/t gold, 2.08 g/t silver and 0.21% copper) (see Table 1); and Inferred Mineral Resources of 1.45 Moz AuEq at 0.80 g/t AuEq an increase of 215% in ounces and decrease in grade of 24% from 2022 (56.2 Mt grading 0.58 g/t gold, 2.32 g/t silver and 0.14% copper) (see Table 1). Alastair Still, CEO of GoldMining, commented, "We are extremely pleased that the Company's first exploration drilling program at La Mina has identified a significant discovery at the La Garrucha deposit that has added over 1,000,000 gold equivalent ounces of estimated Inferred Resources and 200,000 gold equivalent ounces of estimated Indicated Resources to an already robust Mineral Resource estimate on our La Mina project. This exciting discovery has exceeded our expectations and builds upon the positive economics set out in our 2022 Preliminary Economic Assessment, which was based on the prior resource estimate for the project, exclusive of La Garrucha. Throughout, our team has maintained high standards of sustainable exploration and demonstrated our commitment to safety, effective stakeholder engagement and environmental stewardship. Story continues With all-inclusive direct drilling costs by the Company at La Garrucha of under US$1.2 million for our recent program, this discovery was made at a very efficient cost per ounce of estimated resource and exemplifies our strategy and progress of unlocking value from our portfolio of gold and gold-copper assets while maintaining a peer-leading balance sheet." Tim Smith, Vice President Exploration of GoldMining, commented, "The updated Mineral Resource estimate at La Garrucha represents an unqualified success for the Company in applying its strategy of identifying the best value accretion opportunities within our diverse portfolio of gold and gold-copper resource assets located throughout the Americas. From inception to execution, the drill program was expertly managed by our team in Colombia and the results demonstrate both the quality and further potential for additional discovery within the La Mina porphyry gold-copper mineral system. On the strength of this updated Mineral Resource estimate, the Company now looks forward to updating the La Mina Preliminary Economic Assessment (PEA) which we expect to complete on or around mid-2023." La Mina Updated Resource Metrics: Indicated Mineral Resource tonnage has increased by 19.5% from the prior estimate, while metal content for gold, silver and copper has increased by 19.7%, 40.7% and 5.9%, respectively compared to the prior resource estimate (see Table 2); Inferred Mineral Resource tonnage has increased 312.5%, while metal content for gold, silver and copper has increased by 265.6%, 442.5%, and 111.0%, respectively compared to the prior resource estimate (see Table 2); The MRE has been updated with metal prices of US$1,700/oz gold, US$21/oz silver, and US$3.50/lb copper, compared to the prior estimate which used metal prices of US$1,600/oz gold, US$21/oz silver, and US$3.25/lb copper; The MRE utilizes pit shells to constrain resources at the La Cantera, La Garrucha and Middle Zone deposits using a 0.30 g/t Au cut-off grade, compared to the prior estimate which used 0.25 g/t Au cut-off grade; Metallurgical work has been conducted for the La Garrucha deposit by ALS in Kamloops, British Columbia from a 100 kg bulk sample collected from drill core; The total La Mina Project area comprises a database of 111 drill holes totaling 40,179 metres with 102 drillholes and 37,256 metres drilled within the three deposits at La Cantera, La Garrucha and Middle Zone; and For the first time, the MRE at La Mina incorporates the La Garrucha deposit which is located within 1 kilometre to the east of the prior mineral resources. Refer to Figure 1. Table 1: La Mina Project Mineral Resource Estimate1-6 (effective date: December 20, 2022). Deposit Grade Contained Metal Cut-off Tonnes Gold Silver Copper Gold Eq Gold Silver Copper Gold Eq Au (g/t) (Mt) (g/t) (g/t) ( %) (g/t) (Moz) (Moz) (Mlbs) (Moz) Indicated Resources La Cantera 0.30 17.61 0.86 2.03 0.31 1.32 0.49 1.15 120.46 0.75 La Garrucha 0.30 7.36 0.65 3.14 0.11 0.84 0.15 0.74 17.76 0.20 Middle Zone 0.30 8.80 0.54 1.28 0.11 0.71 0.15 0.36 21.19 0.20 Total Indicated 33.77 0.73 2.08 0.21 1.06 0.79 2.25 159.41 1.15 Inferred Resources La Cantera 0.30 11.18 0.71 1.85 0.30 1.15 0.26 0.66 72.71 0.41 La Garrucha 0.30 44.11 0.55 2.46 0.10 0.72 0.78 3.49 96.85 1.02 Middle Zone 0.30 0.95 0.47 1.15 0.09 0.61 0.01 0.04 1.87 0.02 Total Inferred 56.23 0.58 2.32 0.14 0.80 1.05 4.19 171.43 1.45 Notes: 1. The Mineral Resource for La Mina is an in-pit constrained resource calculated using a Whittle-Pit algorithm with "reasonable prospects of eventual economic extraction" using the following assumptions: Metal prices of US$1,700/oz Au, US$21/oz Ag and US$3.50/lb Cu; Royalty of 6% NSR, inclusive of government royalties; Pit slopes are 50 degrees; and Mining, processing and G&A costs were used to calculate cut-off of 0.30 g/t Au. 2. Metallurgical recoveries are: 82% for Au, 84% for Cu, and 30% for Ag. 3. Gold-equivalent grades were calculated using the following formula: AuEq = Au (g/t) + [Cu(%) x {Cu Price/Au Price} x 22.0462 x 31.1035] + [Ag (g/t) x {Ag Price/Au Price}]. 4. Mineral resources are classified as Indicated Resources and Inferred Resources and are based on the 2014 CIM Definition Standards on Mineral Resources and Mineral Reserves. 5. Mineral Resources, which are not Mineral Reserves, do not have demonstrated economic viability. There is no certainty that all or any part of the Mineral Resources will be converted to Mineral Reserves. The estimate of mineral resources may be materially affected by environmental permitting, legal, title, taxation, sociopolitical, marketing or other relevant issues. 6. Numbers may not add due to rounding. Table 2: Prior Mineral Resource Estimate1-9. Deposit Grade Contained Metal Cut-off Tonnes Gold Silver Copper Gold Eq Gold Silver Copper Gold Eq Au (g/t) (Mt) (g/t) (g/t) ( %) (g/t) (Moz) (Moz) (Mlbs) (Moz) Indicated Resources La Cantera 0.25 18.02 0.86 2.05 0.32 1.33 0.50 1.19 125.59 0.77 Middle Zone 0.25 10.22 0.50 1.26 0.11 0.67 0.16 0.41 24.94 0.22 Total Indicated 28.25 0.73 1.76 0.24 1.09 0.66 1.60 150.53 0.99 Inferred Resources La Cantera 0.25 12.03 0.69 1.84 0.29 1.12 0.27 0.71 78.19 0.44 Middle Zone 0.25 1.60 0.39 1.17 0.09 0.53 0.02 0.06 3.06 0.03 Total Inferred 13.63 0.65 1.76 0.27 1.05 0.29 0.77 81.25 0.46 Notes: 1. This prior estimate has been replaced and superseded in its entirety by the updated current Mineral Resource estimate disclosed herein. 2. The prior estimate was set out in the NI 43-101 technical report of the Company with an effective date of January 12, 2022. 3. The Mineral Resource for La Mina is an in-pit constrained resource calculated using a Whittle-Pit algorithm with "reasonable prospects of eventual economic extraction" using the following assumptions: Metal prices of US$1,600/oz Au, US$21/oz Ag and US$3.25/lb Cu; Royalty of 2% NSR; Pit slopes are 50 degrees; Mining, processing and G&A costs were used to calculate cut-off of 0.25 g/t Au. 4. Metallurgical recoveries are: 90% for Au, 90% for Cu, and 30% for Ag. 5. Gold-equivalent grades were calculated using the following formula: AuEq = Au (g/t) + [Cu(%)} x {%Recoverable Cu / %Recoverable Au} x {Cu Price/Au Price} x 22.0462 x 31.1035] + [Ag (g/t) x {Ag Price/Au Price}]. 6. The qualified person of the above estimate is Scott Wilson, C.P.G., SME. 7. Mineral resources are classified as Indicated Resources and Inferred Resources and are based on the 2014 CIM Definition Standards. 8. Mineral Resources, which are not Mineral Reserves, do not have demonstrated economic viability. There is no certainty that all or any part of the Mineral Resources will be converted to Mineral Reserves. 9. Numbers may not add due to rounding. The La Mina property consists of two concession contracts and two concession contract applications covering 3,210 hectares located in the Department of Antioquia, Republic of Colombia, some 51 km SW of Medellin. The MRE for La Mina incorporates the La Cantera, La Garrucha and Middle Zone porphyry deposits located within 1 km of each other. Figure 1 - Property Map for La Mina Project (CNW Group/GoldMining Inc.) From late March to mid-August 2022, GoldMining completed a diamond core drilling program comprising five drill holes for 3,485 m at the La Garrucha deposit, a porphyry mineral system which measures over 400 m in strike length by 300 m in width and to at least 775 m below surface where it remains open. Gold and copper mineralization in the La Garrucha porphyry intrusive complex is accompanied by strong potassic alteration, characterized by secondary potassium feldspar and biotite, disseminated and vein magnetite, quartz stockwork veining and both vein-hosted and disseminated sulphides that include pyrite, chalcopyrite and lesser bornite. Lithological, alteration and structural logging of both the new core and re-logging of historic core was completed to compile a three-dimensional geological model. The MRE disclosed herein for the La Mina Project was prepared by Scott Wilson, C.P.G., of Resource Development Associates Inc. and has an effective date of December 20, 2022. The MRE updates and replaces the prior MRE of the Company contained in its technical report titled, "NI 43-101 Technical Report and Preliminary Economic Assessment: GoldMining Inc., La Mina Project, Antioquia, Republic of Colombia" dated effective January 12, 2022. GoldMining will file a technical report for the MRE updates at La Mina in due course. Qualified Persons Scott E. Wilson, CPG is an independent consultant acting as the Qualified Person, as defined in National Instrument 43-101 - Standards of Disclosure for Mineral Projects ("NI 43-101") and has reviewed and approved the MRE summarized in this news release. Mr. Wilson is independent of the Company under NI 43-101. Mr. Wilson has verified the data underlying the information disclosed herein, including sampling, analytical and test data by reviewing the results and procedures undertaken for quality assurance and quality control in a manner consistent with industry practice, and all matters were consistent and accurate according to his professional judgement. There were no limitations on the verification process. Paulo Pereira, P. Geo., President of GoldMining, has supervised the preparation of this news release and has reviewed and approved the scientific and technical information contained herein. Each of Messrs. Wilson and Pereira are Qualified Persons as defined in NI 43-101. About GoldMining Inc. The Company is a public mineral exploration company focused on the acquisition and development of gold assets in the Americas. Through its disciplined acquisition strategy, the Company now controls a diversified portfolio of resource-stage gold and gold-copper projects in Canada, U.S.A., Brazil, Colombia and Peru. The Company also owns more than 21 million shares of Gold Royalty Corp. (NYSE American: GROY). Notice to Readers Disclosure regarding Mineral Resource estimates included herein have been prepared by the Company in accordance with NI 43-101. NI 43-101 is a rule developed by the Canadian Securities Administrators that establishes standards for public disclosure by issuer of scientific and technical information concerning mineral projects. NI 43-101 differs significantly from the disclosure requirements of the United States Securities and Exchange Commission ("SEC") generally applicable to U.S. companies subject to the SEC's disclosure requirements. For example, the terms "Indicated Mineral Resource" and "Inferred Mineral Resource" are defined in NI 43-101 by reference to the guidelines set out in the CIM Definition Standards on Mineral Resources and Mineral Reserves. Shareholders resident in the United States are cautioned that while terms are substantially similar to "indicated mineral resources" and "inferred mineral resources" as defined by the SEC, there are differences in the definitions and standards under applicable SEC Rules and NI 43-101. Accordingly, there is no assurance any mineral resources that the Company may report as "Indicated Mineral Resources" and "Inferred Mineral Resources" under NI 43-101 will be the same as the reserve or resource estimates prepared under rules applicable to United States domestic issuers. Investors are cautioned not to assume that any part or all of mineral resources will ever be converted into reserves. Pursuant to CIM Definition Standards, "Inferred mineral resources" are that part of a mineral resource for which quantity and grade or quality are estimated on the basis of limited geological evidence and sampling. Such geological evidence is sufficient to imply but not verify geological and grade or quality continuity. An inferred mineral resource has a lower level of confidence than that applying to an indicated mineral resource and must not be converted to a mineral reserve. However, it is reasonably expected that the majority of inferred mineral resources could be upgraded to indicated mineral resources with continued exploration. Under Canadian rules, estimates of inferred mineral resources may not form the basis of feasibility or pre-feasibility studies, except in rare cases. Investors are cautioned not to assume that all or any part of an inferred mineral resource is economically or legally mineable. Disclosure of "contained ounces" in a resource is permitted disclosure under Canadian regulations; however, the SEC normally only permits issuers to report mineralization that does not constitute "reserves" by SEC standards as in place tonnage and grade without reference to unit measures. Forward-looking Statements This document contains certain forward-looking statements that reflect the current views and/or expectations of GoldMining with respect to its business plans and strategies, expectations regarding the La Mina Project and its potential and the expected timing of future PEAs. Forward-looking statements are based on the then-current expectations, beliefs, assumptions, estimates and forecasts about the business and the markets in which GoldMining operates. Investors are cautioned that all forward-looking statements involve risks and uncertainties, including: the inherent risks involved in the exploration and development of mineral properties, proposed studies may not confirm GoldMining's expectations for its projects, fluctuating metal prices, unanticipated costs and expenses, risks related to government and environmental regulation, social, permitting and licensing matters, and uncertainties relating to the availability and costs of financing needed in the future. These risks, as well as others, including those set forth in GoldMiningꞌs Annual Information Form for the year ended November 30, 2021, and other filings with Canadian securities regulators and the U.S. Securities and Exchange Commission, could cause actual results and events to vary significantly. Accordingly, readers should not place undue reliance on forward-looking statements and information. There can be no assurance that forward-looking information, or the material factors or assumptions used to develop such forward-looking information, will prove to be accurate. The Company does not undertake any obligations to release publicly any revisions for updating any voluntary forward-looking statements, except as required by applicable securities law. Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/goldmining-triples-gold-equivalent-inferred-resource-estimate-to-1-45-million-ounces-at-la-mina-project-with-la-garrucha-discovery-301727846.html SOURCE GoldMining Inc. Cision View original content to download multimedia: http://www.newswire.ca/en/releases/archive/January2023/23/c3959.html
NEWS_38
Genius Group Ltd. GNS, +45.37% , a Singapore-based education company, set guidance for 2023 on Monday, saying it expects revenue of $48 million to $52 million, up 37% from its 2022 proforma guidance. The company, which captured headlines last week when it said it had appointed a former F.B.I. director to lead a task force investigating alleged illegal trading in its stock that it first disclosed in early January, said it expects the number of students attending its entrepreneur-training courses to climb to 5.7 million to 6.0 million, up 30% from 2022. The company expects to achieve adjusted EBITDA, or earnings before interest, taxes, depreciation and amortization, of $500,000 to $1.0 million. “In 2023 we are expecting Genius Group to continue our strong growth trajectory, and we are focused on managing our costs and achieving positive EBITDA,” Chief Executive Roger Hamilton said in a statement. The stock jumped 15% premarket. On Thursday, the stock soared a record 290% in heavy volume. Hamilton told MarketWatch on Friday about the company’s plan to go after people or groups that have been engaging in naked short selling of its stock.
NEWS_39
“It’s like being robbed in a library, but you can’t shout ‘Thief!’ because there are ‘Silence, please’ signs everywhere.” That’s how Roger Hamilton, chief executive of Genius Group Ltd. GNS, +45.37% , describes the powerlessness he feels as U.S. securities rules prevent him from discussing his company’s share price, even as it comes under attack from a group of naked short sellers. The Singapore-based education company on Thursday announced it had appointed a former FBI director to lead a task force investigating alleged illegal trading in its stock that it first addressed in early January. For context: Genius Group stock rallies more than 200% after it appoints former F.B.I. director to investigate alleged naked short selling The news sent the stock up a record 290% on Thursday, and it climbed another 59% on Friday. Volume of about 270 million shares traded in Thursday’s session crushed the daily average of about 634,000 — another indicator, Hamilton told MarketWatch in an interview Friday, of wrongdoing, given that the company’s float is just 10.9 million shares. “Clearly, that’s far more shares than we created,” he said. Genius Group has evidence from Warshaw Burstein LLP and Christian Levine Law Group, with tracking from Share Intel, that certain individuals and/or companies sold but failed to deliver a “significant” amount of its shares as part of a scheme seeking to artificially depress the stock price. The company is now exploring legal action and is planning an extraordinary general meeting in the coming weeks to get shareholder approval for its planned actions. These include paying a special dividend as a way to flush out bad actors and working with regulators to share information. Share Intel uses tracking software in real time to determine exactly where there are discrepancies in the market and where brokers are opening large positions, Hamilton said. The software can measure the number of shares that are being naked shorted and has found multiple instances where significant amounts of fake shares were being created, said Hamilton. Naked short selling is illegal under Securities and Exchange Commission rules, but that hasn’t stopped the practice, which Hamilton said affects far more companies than is generally known. In regular short trading, an investor borrows shares from someone else, then sells them and waits for the stock price to fall. When that happens the shares are bought cheaper and returned to the prior owner, with the short seller pocketing the difference as profit. In naked short selling, investors don’t bother borrowing the stock first and simply sell shares with a promise to deliver them at a later date. When that promise is not fulfilled, it’s known as failure to deliver. By repeating that process again and again, bad actors can generate massive profits and manipulate a stock’s price lower, with an ultimate goal of driving a company to bankruptcy, at which point all the equity is wiped out and the naked shorts no longer need to be covered. Hamilton said the evidence gathered by Genius Group shows a great deal of the illegal activity is happening on U.S. exchanges, but there’s also activity happening off-exchange and involving dark pools. The company is fighting back “because we want this to stop,” Hamilton told MarketWatch. “They’re taking value away from our shareholders. They’re predators. They’re doing something illegal, and we want it to stop, whether that means getting regulators to enforce existing regulations or put new ones in place.” Public companies have to have committees to monitor and report internal fraud to protect shareholders, he said. But there is no such team looking for external fraud and many retail investors see stocks being manipulated, he said. “Hopefully, regulations will change and regulators will see there are as many, if not more, threats from outside a company,” he said. Genius Group is not alone, said Hamilton. He cited among other examples Torchlight, an oil- and gas-exploration company that decided to merge with Metamaterial Inc. to thwart a naked-short-selling attack. The stock rose from 30 cents to $11 in the six months after the deal was completed, and the company was able to raise about $183 million through a combination of convertible debt and equity. An interview Hamilton conducted with Torchlight’s former CEO, John Brda, can be found below. Then there’s Jeremy Frommer, CEO of Creatd Inc. CRTD, +1.35% , which aims to unlock creativity for creators, brands and consumers, who is behind Ceobloc, a website that aims to end the practice of naked short selling. “Illegal naked short selling is the biggest risk to the health of today’s public markets,” is how the site introduces its mission. On Friday, the stock of Helbiz Inc. HLBZ, +109.13% joined Genius Group in rocketing higher in high volume, after that company said it, too, was taking on naked short sellers. The New York–based maker of e-scooters and e-bicyles said that it was following Genius Group’s example and that it believes “certain individuals and/or companies may have engaged in illegal short selling practices that have artificially depressed the stock price.” The stock had plummeted 64% over the three months through Thursday’s close at 12.31 cents.
NEWS_40
SINGAPORE, January 23, 2023--(BUSINESS WIRE)--Genius Group Limited (NYSE American: GNS) ("Genius Group" or the "Company"), a leading entrepreneur edtech and education group, announces its financial guidance for the financial year ending December 31, 2023. Genius Group’s 2023 financial guidance is heavily weighted towards the second half of the year as we accelerate the integration of our acquired companies and expect growing operating leverage driven by top-line synergies from our EdTech platform and the digitization of our portfolio of products. We believe this will allow Genius Group to accelerate organic growth and provides a clear path to positive EBITDA in 2023. 2023 Financial Guidance: Annual revenue of $48m - $52m, a 37% increase from $35m - $38m 2022 pro forma guidance Number of students (and users) 5.7m - 6.0m, a 30% increase from 4.4m – 4.6m 2022 guidance Adjusted EBITDA of $0.5m - $1.0m Roger Hamilton, CEO of Genius Group, commented: "We are experiencing strong demand for our entrepreneur and investor-related courses, and we are attracting world-class partners, from bestselling authors to social media influencers with large followings who see the value of integrating their in-demand content into our accredited courses. We believe the courses we deliver are counter-cyclical. In challenging economic times, more people seek out education to grow their financial literacy, entrepreneurial, and investing skills. In 2023 we are expecting Genius Group to continue our strong growth trajectory, and we are focused on managing our costs and achieving positive EBITDA. We have a strong management team in place, our integration process of our five acquisitions in 2022 is underway, and we are looking forward to a successful 2023." About Genius Group Genius Group is a world-leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial, and life skills to succeed in today’s market. The group has a group user base of 4.3 million users in 200 countries, ranging from ages 0 to 100. Story continues Non-IFRS Financial Measures The Company has not provided the most directly comparable IFRS financial measure, or a quantitative reconciliation thereto, for its expected 2023 Adjusted EBITDA because at this time we have not yet finalized all the data to be able to reconcile certain forward-looking non-IFRS financial measures to the most comparable IFRS financial measures without unreasonable efforts due to uncertainty in predicting certain items. Reconciliations of non-IFRS measures, such as Adjusted EBITDA, to the most comparable IFRS measures and management’s reasoning for using them, are included in the Company’s earnings press release dated November 30, 2022, which is available in the investor relations section of the Company’s website at ir.geniusgroup.net. Investors are encouraged to read these detailed financial disclosures and reconciliations. Forward-Looking Statements This press release contains certain forward-looking statements within the meaning of the U.S. federal securities laws, including (without limitation) statements regarding our or our management’s expectations, hopes, beliefs, intentions, or strategies regarding the future and other statements that are other than statements of historical fact. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Forward-looking statements are generally identified by the words "believe," "project," "expect," "anticipate," "estimate," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result" and similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are predictions, projections, and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to: the Company’s goals and strategies; the Company’s future business development; changes in demand for online learning; changes in technology; fluctuations in economic conditions; the growth of the online learning industry the United States and the other markets the Company serves or plans to serve; reputation and brand; the impact of competition and pricing; government regulations; and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the Securities and Exchange Commission (the "SEC"). For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that arise after the date hereof. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005258/en/ Contacts Investors: Flora Hewitt, Vice President of Investor Relations and Mergers and Acquisitions Email: investor@geniusgroup.net Media: Adia PR Email: gns@adiapr.co.uk US Investors: Dave Gentry RedChip Companies Inc 1-800-RED-CHIP GNS@redchip.com
NEWS_41
A growing number of small-cap companies are announcing plans to go after naked short sellers, claiming their stocks are being artificially depressed by illegal trading activity. Verb Technology Co. Inc. (VERB) , a provider of interactive video-based sales apps with operations in Newport, California and Lehi, Utah, said Monday it was joining education company Genius Group Ltd. (GNS) e-scooter and e-bike maker Helbiz (HLBZ) and Creatd Inc. (CRTD) which aims to unlock creativity for creators, brands and consumers, in coming up with measures to ensure “greater integrity in the capital markets,” as Chief Executive Rory J. Cutai said in a statement. Genius Group got the ball rolling last week when it said it had appointed a former F.B.I. director to lead a task force investigating alleged illegal trading in its stock that it first disclosed in early January.
NEWS_42
By Brad Sorensen, CFA NYSE:GNS READ THE FULL GNS RESEARCH REPORT Genius Group (NYSE:GNS) continues to grow their business and recently raised their revenue guidance for 2023. To us, this continues to illustrate the positive momentum the cutting-edge entrepreneurial education company has and reinforces our belief that GNS is a stock worth a look by investors. Additionally, we believe that the downturn in overall global economic growth that we’ve seen recently and is likely to continue helps to bolster the prospects for Genuis Group. As economic conditions worsen, and the labor market tightens, which is a clear objective of the Federal Reserve, people often look to educational improvements in order to advance their situation. And a company such as Genius, which provides an innovative experience designed to engage the student is one that should disproportionately benefit from such a move in our view. As mentioned, the company issued 2023 guidance for several numerical metrics: • 2023 revenue is expected to grow to $48-52 million, up 37% from the $35-38 million 2022 pro forma guidance. • The number of students the company expects to have in 2023 rises to 5.7-6.0 million from the 4.4-4.6 million guided to in 2022. • The company also expects 2023 adjusted EBITDA to be in the range of $0.5-1.0 million. Management also updated the integration of the company’s recent acquisitions and noted that continue the process and believe that those acquisitions will contribute positively to the 2023 results. On another subject, Genius has been involved in investigating the potential for illegal manipulation occurring in the company’s stock price, resulting in depressing the price artificially. The initial investigation appeared to garner enough evidence to move on to the next step, which involves several moves by the Genius board: • The company announced that it is advancing to the next stage of the legal process and is exploring legal action against anyone reasonably believed to be involved in market manipulation of GNS stock. Story continues • The board announced plans to pay a special dividend to all shareholders. The company hopes that by doing this those who have participated in market manipulation of the stock may be exposed. o Details of the special dividend will be announced at a later date. • The company is also exploring the possibility of a dual listing. We aren’t going to opine much on this situation as it is still in the legal pipeline and investigation are continuing but we will say that we wholeheartedly support any efforts to dissuade market manipulation and believe that the efforts by Genius management will ultimately benefit shareholders, which we’ve already seen evidence of in a very short time frame—further bolstering the case for investing in GNS stock in our view. SUBSCRIBE TO ZACKS SMALL CAP RESEARCH to receive our articles and reports emailed directly to you each morning. Please visit our website for additional information on Zacks SCR. DISCLOSURE: Zacks SCR has received compensation from the issuer directly, from an investment manager, or from an investor relations consulting firm, engaged by the issuer, for providing research coverage for a period of no less than one year. Research articles, as seen here, are part of the service Zacks SCR provides and Zacks SCR receives quarterly payments totaling a maximum fee of up to $40,000 annually for these services provided to or regarding the issuer. Full Disclaimer HERE.
NEWS_43
Golden Ocean Group (GOGL) closed at $9.33 in the latest trading session, marking a -1.06% move from the prior day. This change lagged the S&P 500's 1.19% gain on the day. Meanwhile, the Dow gained 0.76%, and the Nasdaq, a tech-heavy index, added 0.29%. Prior to today's trading, shares of the shipping company had gained 2.28% over the past month. This has lagged the Transportation sector's gain of 5.66% and the S&P 500's gain of 4.06% in that time. Golden Ocean Group will be looking to display strength as it nears its next earnings release. In that report, analysts expect Golden Ocean Group to post earnings of $0.15 per share. This would mark a year-over-year decline of 84.85%. Our most recent consensus estimate is calling for quarterly revenue of $136.12 million, down 56.49% from the year-ago period. It is also important to note the recent changes to analyst estimates for Golden Ocean Group. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. Golden Ocean Group currently has a Zacks Rank of #3 (Hold). Looking at its valuation, Golden Ocean Group is holding a Forward P/E ratio of 8.35. Its industry sports an average Forward P/E of 5.06, so we one might conclude that Golden Ocean Group is trading at a premium comparatively. The Transportation - Shipping industry is part of the Transportation sector. This industry currently has a Zacks Industry Rank of 24, which puts it in the top 10% of all 250+ industries. Story continues The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. To follow GOGL in the coming trading sessions, be sure to utilize Zacks.com. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Golden Ocean Group Limited (GOGL) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_44
KELOWNA, BC / ACCESSWIRE / January 23, 2023 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that the former President of GW Pharmaceuticals USA, Julian Gangolli, is joining Lexaria Bioscience Corp as a Strategic Advisor. "I am excited to be advising Lexaria Bioscience as it has become an established force in the field of improved drug delivery. As with GW Pharmaceutical's innovations in the cannabinoid field, the potential of Lexaria's disruptive drug delivery technology is significant and I hope to assist Lexaria in its commercial development of DehydraTECH for multiple applications," said Julian Gangolli. "As we intensify our focus during 2023 on commercial execution of our robust DehydraTECH technology portfolio, I am very pleased to welcome Julian with his extensive pharmaceutical experience, to the broadening Lexaria team," said Chris Bunka, CEO of Lexaria. Julian Gangolli was appointed US President of GW Pharmaceuticals in 2015. He oversaw approval by the US Food and Drug Administration of the first and only pure cannabidiol ("CBD") drug ever approved by the FDA, Epidiolex®, and its subsequent successful commercialization in the USA. This commercial success led ultimately to the acquisition of GW Pharmaceuticals by Jazz Pharmaceuticals in 2021 in a $7.2 billion transaction. Mr. Gangolli was previously North American President of Allergan and a member of their Executive Management team that oversaw the sale of Allergan to Actavis in 2015. Mr. Gangolli was a senior member of the Allergan management team from 1998 onwards that transformed Allergan into one of the leading specialty pharmaceutical companies in the US. Stock options valid to purchase 5,000 shares of the Company are being issued to Mr. Gangolli with an exercise price of $2.73 per share, valid for 5 years from the date of issuance. Story continues About Lexaria Bioscience Corp. Lexaria Bioscience Corp.'s patented drug delivery technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream through oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, PDE5 inhibitors and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 28 patents granted and many patents pending worldwide. For more information, please visit www.lexariabioscience.com. CAUTION REGARDING FORWARD-LOOKING STATEMENTS This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the company relating the Company's ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company's ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria's postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law. INVESTOR CONTACT: George Jurcic - Head of Investor Relations ir@lexariabioscience.com Phone: 250-765-6424, ext 202 SOURCE: Lexaria Bioscience Corp. View source version on accesswire.com: https://www.accesswire.com/736187/Former-President-of-GW-Pharmaceuticals-USA-Joins-Lexaria-Bioscience-as-Strategic-Advisor
NEWS_45
Ideally, your overall portfolio should beat the market average. But every investor is virtually certain to have both over-performing and under-performing stocks. At this point some shareholders may be questioning their investment in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND), since the last five years saw the share price fall 58%. Shareholders have had an even rougher run lately, with the share price down 19% in the last 90 days. So let's have a look and see if the longer term performance of the company has been in line with the underlying business' progress. View our latest analysis for Ligand Pharmaceuticals In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time. Over five years Ligand Pharmaceuticals' earnings per share dropped significantly, falling to a loss, with the share price also lower. Since the company has fallen to a loss making position, it's hard to compare the change in EPS with the share price change. But we would generally expect a lower price, given the situation. You can see how EPS has changed over time in the image below (click on the chart to see the exact values). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. It might be well worthwhile taking a look at our free report on Ligand Pharmaceuticals' earnings, revenue and cash flow. What About The Total Shareholder Return (TSR)? We've already covered Ligand Pharmaceuticals' share price action, but we should also mention its total shareholder return (TSR). The TSR attempts to capture the value of dividends (as if they were reinvested) as well as any spin-offs or discounted capital raisings offered to shareholders. Ligand Pharmaceuticals hasn't been paying dividends, but its TSR of -35% exceeds its share price return of -58%, implying it has either spun-off a business, or raised capital at a discount; thereby providing additional value to shareholders. Story continues A Different Perspective While it's certainly disappointing to see that Ligand Pharmaceuticals shares lost 7.3% throughout the year, that wasn't as bad as the market loss of 10%. What is more upsetting is the 6% per annum loss investors have suffered over the last half decade. This sort of share price action isn't particularly encouraging, but at least the losses are slowing. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Consider for instance, the ever-present spectre of investment risk. We've identified 1 warning sign with Ligand Pharmaceuticals , and understanding them should be part of your investment process. There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_46
SAN JOSE, Calif., Jan. 23, 2023 /PRNewswire/ --Lumentum Holdings Inc. ("Lumentum") today announced that it will release its fiscal second quarter 2023 financial results on Thursday, February 9, 2023, before the market opens. Lumentum will hold a conference call the same day at 5:30 a.m. PT/8:30 a.m. ET. A live webcast of the call and the replay will be available in the Investors section of the Lumentum website at http://investor.lumentum.com. To participate via telephone: US: (844) 200-6205 International: (929) 526-1599 Access Code: 440258 The Company recommends participants dial in at least 10 minutes before the scheduled start to minimize potential delays in joining the call. Lumentum also encourages those who plan to dial into the conference call to pre-register: pre-registration link. Callers who pre-register will be given a unique dial-in number and PIN via email to gain immediate access to the call. To listen to a replay via telephone: Dial-In: (866) 813-9403 or (929) 458-6194 Access Code: 369158 Start Date: February 9, 2023, 8:30 a.m. PT End Date: February 16, 2023, 9 p.m. PT The earnings press release will be posted at http://investor.lumentum.com under the "Financial News Releases" section. Additional materials supporting the conference call and earnings release will be posted under the "Events and Presentations" section. About Lumentum Lumentum (NASDAQ: LITE) is a market-leading designer and manufacturer of innovative optical and photonic products enabling optical networking and laser applications worldwide. Lumentum optical components and subsystems are part of virtually every type of telecom, enterprise, and data center network. Lumentum lasers enable advanced manufacturing techniques and diverse applications including next-generation 3D sensing capabilities. Lumentum is headquartered in San Jose, California with R&D, manufacturing, and sales offices worldwide. For more information, visit www.lumentum.com and follow Lumentum on LinkedIn, Twitter, Facebook, Instagram, and YouTube. Story continues Category: Financial Contact Investors: Kathy Ta, 408-750-3853; investor.relations@lumentum.com Media: Christina Itzkowitz, 781-929-0565; media@lumentum.com Cision View original content:https://www.prnewswire.com/news-releases/lumentum-to-announce-fiscal-second-quarter-2023-financial-results-on-february-9-2023-301728579.html SOURCE Lumentum
NEWS_47
BOCA RATON, Fla., January 23, 2023--(BUSINESS WIRE)--Terran Orbital Corporation (NYSE: LLAP) ("Terran Orbital" or the "Company"), a global leader in satellite-based solutions primarily serving the aerospace and defense industries, today announced the Company will host its year-end 2022 results conference call on March 21, 2023 at 11:00 a.m. E.T. The call will discuss Q4 and full-year 2022 results. Participating on the call will be Terran Orbital’s Chief Executive Officer, Marc Bell, and Chief Financial Officer, Gary Hobart, who will discuss operational and financial highlights for the year ended December 31, 2022. Year-end 2022 results will be published prior to the market opening on March 21. US-based participants may access the call at +1 844-200-6205 while international callers may use +1 929-526-1599. The access code is 553921. Participants may also register to view the event here. Additionally, a live webcast and replay will be available under the Events and Presentations section of Terran Orbital’s investor relations website at Terran Orbital Corporation – Events & Presentations. About Terran Orbital Terran Orbital is a leading manufacturer of satellite products primarily serving the aerospace and defense industries. Terran Orbital provides end-to-end satellite solutions by combining satellite design, production, launch planning, mission operations, and on-orbit support to meet the needs of the most demanding military, civil, and commercial customers. Learn more at www.terranorbital.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005730/en/ Contacts Investor Relations Contact Jonathan Siegmann ir@terranorbital.com 949-202-8476 Media Contact Virginia Norder pr@terranorbital.com 949-508-6404
NEWS_48
HOUSTON, January 23, 2023--(BUSINESS WIRE)--Cheniere Energy, Inc. ("Cheniere") (NYSE American: LNG) announced today that it plans to issue its earnings release with respect to fourth quarter and full year 2022 financial results on Thursday, February 23, 2023 before the market opens. Cheniere will host a conference call for investors and analysts at 11:00 a.m. Eastern Time (10:00 a.m. Central Time) that day to discuss fourth quarter and full year results. A listen-only webcast of the call and accompanying slide presentation will be available at www.cheniere.com. After completion of the webcast, a replay will be available on the Cheniere website. About Cheniere Cheniere Energy, Inc. is the leading producer and exporter of liquefied natural gas ("LNG") in the United States, reliably providing a clean, secure, and affordable solution to the growing global need for natural gas. Cheniere is a full-service LNG provider, with capabilities that include gas procurement and transportation, liquefaction, vessel chartering, and LNG delivery. Cheniere has one of the largest liquefaction platforms in the world, consisting of the Sabine Pass and Corpus Christi liquefaction facilities on the U.S. Gulf Coast, with total production capacity of approximately 45 million tonnes per annum ("mtpa") of LNG in operation and an additional 10+ mtpa of expected production capacity under construction. Cheniere is also pursuing liquefaction expansion opportunities and other projects along the LNG value chain. Cheniere is headquartered in Houston, Texas, and has additional offices in London, Singapore, Beijing, Tokyo, and Washington, D.C. For additional information, please refer to the Cheniere website at www.cheniere.com and Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed with the Securities and Exchange Commission. Forward-Looking Statements This press release contains certain statements that may include "forward-looking statements" within the meanings of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements, other than statements of historical or present facts or conditions, included herein are "forward-looking statements." Included among "forward-looking statements" are, among other things, (i) statements regarding Cheniere’s financial and operational guidance, business strategy, plans and objectives, including the development, construction and operation of liquefaction facilities, (ii) statements regarding regulatory authorization and approval expectations, (iii) statements expressing beliefs and expectations regarding the development of Cheniere’s LNG terminal and pipeline businesses, including liquefaction facilities, (iv) statements regarding the business operations and prospects of third-parties, (v) statements regarding potential financing arrangements, (vi) statements regarding future discussions and entry into contracts, and (vii) statements relating to Cheniere’s capital deployment, including intent, ability, extent, and timing of capital expenditures, debt repayment, dividends, share repurchases and execution on the capital allocation plan. Although Cheniere believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. Cheniere’s actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Cheniere’s periodic reports that are filed with and available from the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, Cheniere does not assume a duty to update these forward-looking statements. Story continues View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005687/en/ Contacts Cheniere Energy, Inc. Investors Randy Bhatia, 713-375-5479 Frances Smith, 713-375-5753 Media Relations Eben Burnham-Snyder, 713-375-5764
NEWS_49
Dorian LPG (LPG) closed the most recent trading day at $18.14, moving -1.63% from the previous trading session. This change lagged the S&P 500's 1.19% gain on the day. Elsewhere, the Dow gained 0.76%, while the tech-heavy Nasdaq added 0.29%. Prior to today's trading, shares of the liquified petroleum gas shipping company had lost 5.53% over the past month. This has lagged the Transportation sector's gain of 5.66% and the S&P 500's gain of 4.06% in that time. Wall Street will be looking for positivity from Dorian LPG as it approaches its next earnings report date. On that day, Dorian LPG is projected to report earnings of $1.40 per share, which would represent year-over-year growth of 311.76%. Meanwhile, our latest consensus estimate is calling for revenue of $110.4 million, up 60.93% from the prior-year quarter. Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.01 per share and revenue of $326.26 million. These totals would mark changes of +201.5% and +18.98%, respectively, from last year. Investors might also notice recent changes to analyst estimates for Dorian LPG. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. Based on our research, we believe these estimate revisions are directly related to near-team stock moves. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Dorian LPG is currently sporting a Zacks Rank of #1 (Strong Buy). Story continues Valuation is also important, so investors should note that Dorian LPG has a Forward P/E ratio of 4.6 right now. For comparison, its industry has an average Forward P/E of 5.06, which means Dorian LPG is trading at a discount to the group. The Transportation - Shipping industry is part of the Transportation sector. This group has a Zacks Industry Rank of 24, putting it in the top 10% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Dorian LPG Ltd. (LPG) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_50
LPL Financial Holdings, Inc. CHARLOTTE, N.C., Jan. 23, 2023 (GLOBE NEWSWIRE) -- LPL Financial LLC announced today that two teams of financial advisors who serve a combined $275 million in advisory, brokerage and retirement plan assets* have joined LPL’s employee advisor channel, Linsco by LPL Financial (“Linsco”). Chris Corcoran CRPC®, joins from Merrill Lynch and will be the first tenant in a new Linsco office in Houston, Texas. Additionally, Matt Jackson and Adam Callender CRPC®, join LPL from Truist and will work remotely from Northeast Florida. About Memorial Financial Advisors of LPL Financial With nearly 25 years of industry experience, Corcoran’s mission is to be transparent and honest in his work to help clients make sensible decisions that move them closer to their financial goals. He works primarily with oil and gas engineers and other self-made clients. “I entered financial services because I saw the impact it has on a person’s life. I found that many people don’t have the experience or inclination to create a plan for their financial future, but with the right guidance and processes in place, they are better prepared to send their children to college, retire comfortably and distribute wealth to the next generation,” Corcoran said. “I’ve spent two decades building a relationship-driven practice where I do my best to provide great experiences, financial education and timely advice, all actionable and simple to understand.” With the move to LPL, Corcoran launches Memorial Financial Advisors of LPL Financial, named after the affluent, suburban Memorial area of Houston. About Jackson Callender Group Wealth Management Powered by LPL Financial With a combined 22 years of financial services experience, Jackson and Callender have worked together since 2006, having shifted from the mortgage industry to wealth management in 2010. The advisors specialize in retirement planning, investment solutions and appropriate risk management strategies, and they are joined by Registered Client Service Associate Tiffany Nessmith. Story continues “Our process begins by understanding each client’s goals and learning about their family and interests,” Jackson said. “Then, we tailor a combination of strategies for each client, helping them understand and adjust for the impact of key events in the market as they work toward financial success.” Why Linsco by LPL? Both teams turned to Linsco by LPL in their quest to enhance the service experience for clients and operate on their own terms, with the freedom and flexibility to focus on what’s best for their clients and business. Linsco by LPL serves financial advisors seeking the core tenets of independence, including owning their client relationships and having flexibility to run their practice, their way. With Linsco, advisors benefit from the support from an experienced branch management team, dedicated marketing consultant, technology consultant and service team, freeing up more time for advisors to focus on helping their clients. As the anchor tenant in the new Houston Linsco office, Corcoran hopes to set the tone for an open, welcoming and friendly environment. He looks forward to the next phase of his career. “I’ve met with every large financial services firm over the past two years, and with LPL I feel like I’ve found a true partner to help me create a practice on my own terms,” Corcoran said. “I wanted to be a W2 employee so I didn’t have to worry about real estate or running the business, but I also wanted flexibility to control my own practice. Linsco combines the best of both worlds. I’ve always said I’m going to do what’s best for my clients and ensure they have great experiences, and this move supports that mission.” The Jackson Callender Group echoed that sentiment. “We spoke with seven firms during our due diligence process, but LPL stood out as the best place where we can service our clients and grow our business,” Callender said. “Linsco is a nice blend of what we were looking for. It empowers us to make our own decisions, while also giving us a technology upgrade, easier processes and dedicated support to help with operations so we can keep focus on helping our clients.” Scott Posner, LPL Executive Vice President, Business Development, added, “We welcome these teams to the Linsco community and are honored that Chris, Matt and Adam recognized that LPL can help them take their practice to the next level. Linsco advisors enjoy all the benefits of being an LPL employee, along with autonomy to manage their practice on their own terms. At LPL, we understand that advisors want the freedom and flexibility to provide personalized financial guidance and differentiated service experiences. We are deeply committed to supporting them with integrated capabilities, robust resources and business solutions designed to help their practice thrive. We wish nothing but success for Memorial Financial Advisors and Jackson Callender Wealth Management and look forward to an exciting journey ahead with these teams.” Related Learn more about Memorial Financial Advisors of LPL Financial Learn more about Jackson Callender Group Wealth Management Powered by LPL Financial Advisors, find an LPL business development representative near you. About LPL Financial LPL Financial (Nasdaq: LPLA) was founded on the principle that the firm should work for the advisor, and not the other way around Today, LPL is a leader in the markets we serve**, supporting more than 21,000 financial advisors, including advisors at approximately 1,100 institution-based investment programs and at approximately 500 registered investment advisor ("RIA") firms nationwide. We are steadfast in our commitment to the advisor-centered model and the belief that Americans deserve access to personalized guidance from a financial advisor. At LPL, independence means that advisors have the freedom they deserve to choose the business model, services, and technology resources that allow them to run their perfect practice. And they have the freedom to manage their client relationships, because they know their clients best. Simply put, we take care of our advisors, so they can take care of their clients. *Value approximated based on asset and holding details provided to LPL from year-end 2022. **Top RIA custodian (Cerulli Associates, 2020 U.S. RIA Marketplace Report); No. 1 Independent Broker-Dealer in the U.S. (Based on total revenues, Financial Planning magazine 1996-2022); among third-party providers of brokerage services to banks and credit unions, No. 1 in AUM Growth from Financial Institutions; No. 1 in Market Share of AUM from Financial Institutions; No. 1 in Market Share of Revenue from Financial Institutions; No. 1 on Financial Institution Market Share; No. 1 on Share of Advisors. (2021-2022 Kehrer Bielan Research & Consulting Annual TPM Report). Fortune 500 as of June 2021. LPL Financial and its affiliated companies provide financial services only from the United States. Securities and advisory services offered through LPL Financial LLC, an SEC-registered broker-dealer and investment advisor. Member FINRA/SIPC. Throughout this communication, the terms “financial advisors” and “advisors” are used to refer to registered representatives and/or investment advisor representatives affiliated with LPL Financial LLC. We routinely disclose information that may be important to shareholders in the “Investor Relations” or “Press Releases” section of our website. Connect with Us! https://twitter.com/lpl https://www.linkedin.com/company/lpl-financial https://www.facebook.com/LPLFinancialLLC https://www.youtube.com/user/lplfinancialllc Media Contact: Media.relations@LPLFinancial.com (704) 996-1840
NEWS_51
Long term investing can be life changing when you buy and hold the truly great businesses. While the best companies are hard to find, but they can generate massive returns over long periods. Just think about the savvy investors who held Lattice Semiconductor Corporation (NASDAQ:LSCC) shares for the last five years, while they gained 987%. If that doesn't get you thinking about long term investing, we don't know what will. It's also good to see the share price up 41% over the last quarter. We love happy stories like this one. The company should be really proud of that performance! So let's assess the underlying fundamentals over the last 5 years and see if they've moved in lock-step with shareholder returns. View our latest analysis for Lattice Semiconductor To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement. During the five years of share price growth, Lattice Semiconductor moved from a loss to profitability. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here. Given that the company made a profit three years ago, but not five years ago, it is worth looking at the share price returns over the last three years, too. We can see that the Lattice Semiconductor share price is up 248% in the last three years. During the same period, EPS grew by 88% each year. This EPS growth is higher than the 51% average annual increase in the share price over the same three years. So you might conclude the market is a little more cautious about the stock, these days. Of course, with a P/E ratio of 63.88, the market remains optimistic. The image below shows how EPS has tracked over time (if you click on the image you can see greater detail). We like that insiders have been buying shares in the last twelve months. Having said that, most people consider earnings and revenue growth trends to be a more meaningful guide to the business. Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.. A Different Perspective It's good to see that Lattice Semiconductor has rewarded shareholders with a total shareholder return of 33% in the last twelve months. However, the TSR over five years, coming in at 61% per year, is even more impressive. The pessimistic view would be that be that the stock has its best days behind it, but on the other hand the price might simply be moderating while the business itself continues to execute. It is all well and good that insiders have been buying shares, but we suggest you check here to see what price insiders were buying at. Lattice Semiconductor is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_52
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades. Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us. Below, we take a look at Life Time Group Holdings, Inc. (LTH), a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score. It's also important to note that Style Scores work as a complement to the Zacks Rank, our stock rating system that has an impressive track record of outperformance. Life Time Group Holdings, Inc. Currently has a Zacks Rank of #2 (Buy). Our research shows that stocks rated Zacks Rank #1 (Strong Buy) and #2 (Buy) and Style Scores of A or B outperform the market over the following one-month period. You can see the current list of Zacks #1 Rank Stocks here >>> Set to Beat the Market? In order to see if LTH is a promising momentum pick, let's examine some Momentum Style elements to see if this company holds up. Looking at a stock's short-term price activity is a great way to gauge if it has momentum, since this can reflect both the current interest in a stock and if buyers or sellers have the upper hand at the moment. It's also helpful to compare a security to its industry; this can show investors the best companies in a particular area. Story continues For LTH, shares are up 35.44% over the past week while the Zacks Medical Services industry is up 6.29% over the same time period. Shares are looking quite well from a longer time frame too, as the monthly price change of 45.91% compares favorably with the industry's 10.69% performance as well. While any stock can see a spike in price, it takes a real winner to consistently outperform the market. Over the past quarter, shares of Life Time Group Holdings, Inc. Have risen 63.21%, and are up 10.56% in the last year. In comparison, the S&P 500 has only moved 8.85% and -9.95%, respectively. Investors should also pay attention to LTH's average 20-day trading volume. Volume is a useful item in many ways, and the 20-day average establishes a good price-to-volume baseline; a rising stock with above average volume is generally a bullish sign, whereas a declining stock on above average volume is typically bearish. LTH is currently averaging 486,451 shares for the last 20 days. Earnings Outlook The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes. Please note that estimate revision trends remain at the core of Zacks Rank as well. A nice path here can help show promise, and we have recently been seeing that with LTH. Over the past two months, 2 earnings estimates moved higher compared to none lower for the full year. These revisions helped boost LTH's consensus estimate, increasing from -$0.15 to -$0.11 in the past 60 days. Looking at the next fiscal year, 2 estimates have moved upwards while there have been no downward revisions in the same time period. Bottom Line Taking into account all of these elements, it should come as no surprise that LTH is a #2 (Buy) stock with a Momentum Score of B. If you've been searching for a fresh pick that's set to rise in the near-term, make sure to keep Life Time Group Holdings, Inc. On your short list. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Life Time Group Holdings, Inc. (LTH) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_53
Investors in Lumen Technologies, Inc. LUMN need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 17, 2023 $1.00 Call had some of the highest implied volatility of all equity options today. What is Implied Volatility? Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy. What do the Analysts Think? Clearly, options traders are pricing in a big move for Lumen shares, but what is the fundamental picture for the company? Currently, Lumen is a Zacks Rank #4 (Sell) in the Technology Services industry that ranks in the Bottom 41% of our Zacks Industry Rank. Over the last 60 days, no analysts have increased their earnings estimates for the current quarter, while two analysts have revised their estimates downward. The net effect has taken our Zacks Consensus Estimate for the current quarter from 15 cents per share to 13 cents in that period. Given the way analysts feel about Lumen right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected. Looking to Trade Options? Check out the simple yet high-powered approach that Zacks Executive VP Kevin Matras has used to close recent double and triple-digit winners. In addition to impressive profit potential, these trades can actually reduce your risk. Story continues Click to see the trades now >> Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Lumen Technologies, Inc. (LUMN) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_54
Theodore and LuxUrban to Collaborate on "LuxUrban by Theodore" Experience MIAMI, January 23, 2023--(BUSINESS WIRE)--LuxUrban Hotels Inc. (Nasdaq: LUXH) (or "the Company"), which utilizes a long-term lease, asset-light business model to acquire and manage a growing portfolio of short-term rental properties in major metropolitan cities, announced today that internationally renowned artist Bradley Theodore will serve as the Company’s first brand ambassador. The relationship will be built around Theodore’s bold, colorful, and iconic approach to art, and will feature the promotion of his original works through a variety of activities designed to enhance the LuxUrban experience. "Bradley Theodore is an incredible artist who has collaborated with some of the world’s most recognized and respected brands, and we are thrilled to have this opportunity to incorporate his vision into the LuxUrban experience," said Brian Ferdinand, Chairman and CEO. "In its best and purest form, travel - like art - should be a transcendent experience; it should stir your emotions while affording the time to be still and discover the beauty that resides just below the surface of everyday life. Working with Bradley, we will create an intersection between art and hospitality that provides LuxUrban guests with an unforgettable travel experience." Theodore is a Turks and Caicos born, New York-based contemporary artist who began his career creating large-format street art and is now internationally renowned for his portraits of prominent figures using his hallmark kaleidoscopic skeletal style. Theodore has exhibited his work in galleries across the world and has collaborated with popular artists and brands on projects for Puma, Moët , Rolls-Royce, LEGO, and Moleskin. He has served as the Official Artist of the U.S. Open, was the subject of an independent film, and created a limited edition of bottles for HAIG Whisky and David Beckham. Additional information can be found at https://www.bradleytheodore.com/. Theodore will have studio space at certain LuxUrban properties, and it is anticipated that his sculptures and artwork will be displayed in the lobby and select guest rooms of LuxUrban properties in Miami Beach, Los Angeles, and New York City beginning in March 2023. Guests will have the opportunity to purchase pieces by Theodore. There are also plans for Theodore to host an Art Basel event at LuxUrban’s recently acquired Townhouse Hotel in Miami’s South Beach later this year. "One of my greatest passions is traveling, so being able to share my artwork with LuxUrban’s guests at the Company’s newly acquired high-end properties is exciting," said Theodore. "I’ve chosen to align myself with LuxUrban given their rapid growth in key destination cities and their enthusiasm to incorporate an arts and cultural center experience for their diverse clientele." LuxUrban Hotels Inc. LuxUrban Hotels Inc. utilizes a long-term lease, asset-light business model to acquire and manage a growing portfolio of short-term rental properties in major metropolitan cities. The Company’s future growth focuses primarily on seeking to create "win-win" opportunities for owners of dislocated hotels, including those impacted by COVID-19 travel restrictions, while providing LuxUrban Hotels favorable operating margins. LuxUrban Hotels operates these properties in a cost-effective manner by leveraging technology to identify, acquire, manage, and market them globally to business and vacation travelers through dozens of third-party sales and distribution channels, and the Company’s own online portal. Guests at the LuxUrban Hotels properties are provided high quality service under the Company’s consumer brand, LuxUrbanTM. Forward Looking Statements This press release contains forward-looking statements, including with respect to the activities associated with the Company’s collaboration with Bradley Theodore, expected closing of noted lease transactions and continued closing on additional leases for properties in the Company’s pipeline, as well the Company’s anticipated ability to commercialize efficiently and profitably the properties it leases and will lease in the future. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those set forth under the caption "Risk Factors" in the prospectus forming part of the Company’s effective Registration Statement on Form S-1 (File No. 333-267821). Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as "plans", "expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may contain statements that certain actions, events or results "may", "could", "would", "might" or "will be taken", "will continue", "will occur" or "will be achieved". Forward-looking information may relate to anticipated events or results including, but not limited to business strategy, leasing terms, high-level occupancy rates, and sales and growth plans. The financial projections provided herein are based on certain assumptions and existing and anticipated market, travel and public health conditions, all of which may change. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005466/en/ Contacts LuxUrban Hotels Inc. Shanoop Kothari Chief Financial Officer shanoop@luxurbanhotels.com The Equity Group Inc. Devin Sullivan Managing Director (212) 836-9608 dsullivan@equityny.com David Shayne Analyst (212) 836-9628 dshayne@equityny.com
NEWS_55
LAVA Therapeutics N.V. UTRECHT, The Netherlands and PHILADELPHIA, Jan. 23, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. ( Nasdaq: LVTX ), an immuno-oncology company focused on developing its proprietary Gammabody™ platform of bispecific gamma-delta T cell engagers to transform the treatment of cancer, today announced that clinical data from a Phase 1/2a study in patients with therapy refractory metastatic castration resistant prostate cancer will be presented at the upcoming American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) in San Francisco from February 16-18, 2023. The details of the poster presentation are as follows: Abstract #: 153 Abstract Title: Early dose escalation of LAVA-1207, a novel bispecific gamma-delta T cell engager (Gammabody™), in metastatic castration-resistant prostate cancer (mCRPC) patients Session Title: Poster Session A: Prostate Cancer Poster Board #: E13 Session Date: Thursday, February 16, 2023 Session Times: 11:30 AM-1:00 PM PT and 5:45 PM-6:45 PM PT Presenter: Niven Mehra, Radboud University Medical Center, Department of Medical Oncology MD, PhD About LAVA Therapeutics LAVA Therapeutics N.V. is a clinical-stage immuno-oncology company utilizing its proprietary Gammabody™ platform to develop a portfolio of bispecific gamma-delta T cell engagers for the potential treatment of solid and hematologic malignancies. The Company utilizes bispecific antibodies engineered to selectively kill cancer cells by triggering Vγ9Vδ2 (Vgamma9 Vdelta2) T cell antitumor effector functions upon cross-linking to tumor-associated antigens. LAVA-051, the Company’s lead candidate for the treatment of multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia, is enrolling patients in a Phase 1/2a clinical study (NCT04887259). A Phase 1/2a clinical study to evaluate LAVA-1207 in patients with metastatic castration-resistant prostate cancer (mCRPC) is also enrolling (NCT05369000). For more information, please visit www.lavatherapeutics.com, and follow us on LinkedIn, Twitter and YouTube. Story continues LAVA’s Cautionary Note on Forward-Looking Statements This press release contains forward-looking statements, including in respect to the company’s anticipated growth and clinical developments plans, and the timing and results of clinical trials. Words such as “anticipate,” “believe,” “could,” “will,” “may,” “expect,” “should,” “plan,” “intend,” “estimate,” “potential” and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. These forward-looking statements are based on LAVA’s expectations and assumptions as of the date of this press release and are subject to various risks and uncertainties that may cause actual results to differ materially from these forward-looking statements. Forward-looking statements contained in this press release include, but are not limited to, statements about the preclinical and clinical data, clinical development and scope of clinical trials, and the potential use of our product candidates to treat various tumor targets. Many factors, risks and uncertainties may cause differences between current expectations and actual results including, among other things, the timing and results of our research and development programs and preclinical and clinical trials, our ability to obtain regulatory approval for and commercialize our product candidates, our ability to leverage our initial programs to develop additional product candidates using our Gammabody™ platform, and the failure of LAVA’s collaborators to support or advance collaborations or our product candidates. The COVID-19 pandemic may disrupt our business and that of the third parties on which we depend, including delaying or otherwise disrupting our clinical trials and preclinical studies, manufacturing and supply chain, or impairing employee productivity. In addition, there may be adverse effects on our business condition and results from general economic and market conditions and overall fluctuations in the United States and international equity markets, including deteriorating market conditions due to investor concerns regarding inflation and hostilities between Russia and Ukraine. LAVA assumes no obligation to update any forward-looking statements contained herein to reflect any change in expectations, even as new information becomes available. CONTACTS Investor Relations ir@lavatherapeutics.com Argot Partners (IR/Media) 212-600-1902 lava@argotpartners.com
NEWS_56
When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase stock, like in Luxfer Holdings PLC's (NYSE:LXFR) instance, it's good news for shareholders. Although we don't think shareholders should simply follow insider transactions, we would consider it foolish to ignore insider transactions altogether. See our latest analysis for Luxfer Holdings The Last 12 Months Of Insider Transactions At Luxfer Holdings The Independent Chairman of the Board Patrick Mullen made the biggest insider purchase in the last 12 months. That single transaction was for US$100k worth of shares at a price of US$16.12 each. So it's clear an insider wanted to buy, even at a higher price than the current share price (being US$16.02). It's very possible they regret the purchase, but it's more likely they are bullish about the company. We always take careful note of the price insiders pay when purchasing shares. As a general rule, we feel more positive about a stock if insiders have bought shares at above current prices, because that suggests they viewed the stock as good value, even at a higher price. Luxfer Holdings insiders may have bought shares in the last year, but they didn't sell any. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! Luxfer Holdings is not the only stock that insiders are buying. For those who like to find winning investments this free list of growing companies with recent insider purchasing, could be just the ticket. Luxfer Holdings Insiders Bought Stock Recently We saw some Luxfer Holdings insider buying shares in the last three months. Independent Non-Executive Director Richard Hipple bought US$41k worth of shares in that time. We like it when there are only buyers, and no sellers. But in this case the amount purchased means the recent transaction may not be very meaningful on its own. Story continues Insider Ownership I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. From our data, it seems that Luxfer Holdings insiders own 2.1% of the company, worth about US$9.3m. Overall, this level of ownership isn't that impressive, but it's certainly better than nothing! So What Do The Luxfer Holdings Insider Transactions Indicate? Our data shows a little insider buying, but no selling, in the last three months. That said, the purchases were not large. On a brighter note, the transactions over the last year are encouraging. We'd like to see bigger individual holdings. However, we don't see anything to make us think Luxfer Holdings insiders are doubting the company. While we like knowing what's going on with the insider's ownership and transactions, we make sure to also consider what risks are facing a stock before making any investment decision. To assist with this, we've discovered 1 warning sign that you should run your eye over to get a better picture of Luxfer Holdings. But note: Luxfer Holdings may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_57
When monopoly power is the prize, competition becomes dangerous for both companies and consumers. This was one of several conclusions in a preprint paper published in the National Bureau of Economic Research. Economists from MIT, the University of Hong Kong, and the University of Pennsylvania used a theoretical model to study how firms try to take each other down to become superstar companies that can charge higher prices with less competition. Read more Before companies settle into a peaceful tacit collusion, the economists found, they may engage in predatory pricing wars to push another firm out of the market. These wars have nothing to do with making business better or improving products for customers, and instead are aimed at bankrupting the competition. What follows is a a Q&A with Hui Chen, a finance professor at MIT and one of the paper’s authors. The conversation has been edited for length and clarity. Quartz: What was the impetus for this paper? There are two sets of facts that motivated us to study this phenomenon. The first one is a more macro level: This rise of superstar firms in the US, and to some extent in other countries as well. Industry concentration has risen in the majority of the industries in the US for the last 20 to 30 years. On top of that, there’s also evidence suggesting that these large, superstar firms, they have really long lasting power. This gives them room for what we call collusive competition or implicit collusion. Without entering into explicit collusive agreements, which are illegal, they can economically motivate each other to charge higher prices and enjoy higher profit margins. Implicit collusion until this point has only been studied at a relatively simple static framework. In particular, the interaction of [implicit collusion] with financial conditions of the firm has not been explored before. Story continues The second fact that motivated us was observing some new internet companies competing. The one we like to talk about is competition of mobile bike providers in China. An interesting example is two companies called Mobike and Ofo. These two companies, basically, were trying to grow their market share very aggressively. They would try to price very aggressively on their services—in this case, mobile bikes—and they charge very little. And then they borrow very heavily and try to grab as much market share as possible. The consumers benefit a lot, but [the companies] are putting tremendous competition pressure on each other. Mobike got acquired by a larger internet company, and the other one went bankrupt. In this case there was not any kind of peaceful implicit collusion, but they went after each other as financial trouble started to emerge. They not only didn’t take a step back, but they went even more gung ho and cut prices even more to try to kick their opponent out of the market and after that enjoy more pricing power. That also motivated us. The fact that it’s not just competition, but also predatory price behavior to try to force your competition out of the market. That’s another reason that we thought bringing in the financial risk of these firms into this type of collusive competition was important. So if an industry hasn’t settled into tacit collusion, then firms will try to vie for market influence? These kinds of incentives are driving firms to not compete in a calm way but rather be ultra aggressive. They’re even willing to endure some short term losses in exchange for the higher market share The more calm equilibrium is where major players—think about Uber and Lyft—they enter into more of a calm partnership. They both agree to not go after each other too aggressively and both can live in a relatively stable environment so they don’t have to sacrifice their pricing power too much. When is it more likely for firms to participate in the ultra competitive model versus tacit collusion? Yeah, first of all, economic equilibrium is good for companies but not necessarily good for customers. That’s one thing to clarify. Within the framework of our model, it’s primarily determined by the entry threat. If an incumbent exits the market and a new entrant comes in, do they present a bigger threat than the incumbents who already survived competition? Let’s say that Uber managed to kick out Lyft. For the sake of discussion, let’s also imagine that there are limited licenses that the government is willing to issue for these ride sharing apps. The question then becomes, is the new competitor going to be many times financially stronger than Lyft, or will they be small and non-threatening? That matters a lot. Because if it’s the former, why would I want to kick out Lyft and invite a hundred pound gorilla? I would much rather keep a relatively weak incumbent and that would push me toward being more accommodative with Lyft. In fact, our model shows if Lyft gets in trouble for some kind of idiosyncratic reason, not only would you not see Uber step up competition, but they would actually step back and be more friendly to help Lyft survive the episode. But if they see no entry threat, then the exact opposite would happen. As soon as they see weakness, that could trigger a price war between the two firms. If you’re thinking like the regulator and want to deter this price war and monopoly power, then encouraging the entry of stronger players is going to be good. How can regulators make entry easier? Because our paper didn’t get into the welfare analysis very deeply, I’m only speculating here. If you think about the consumer, in the short run the price wars do benefit customers because they can have low prices, but let’s not be confused about this because in the long run these firms are hoping to become a monopoly. Consumer welfare will suffer in the long run. For that reason, I think the regulators should find ways to discourage these types of price wars. So if there are regulatory hurdles that prevent new entrants, we should try to loosen and maybe even get rid of them. The example we like to think about when presenting this paper is examples where government licenses are limited. Think about telecommunication and other markets where there are limited licenses available for players. Relaxing those restrictions could be helpful. Of course, there are going to be reasons for why there were a limited number of licenses in the first place, so there’s going to be a question of balancing the trade-off there. More from Quartz Sign up for Quartz's Newsletter. For the latest news, Facebook, Twitter and Instagram. Click here to read the full article.
NEWS_58
We can readily understand why investors are attracted to unprofitable companies. For example, Merrimack Pharmaceuticals (NASDAQ:MACK) shareholders have done very well over the last year, with the share price soaring by 168%. But while history lauds those rare successes, those that fail are often forgotten; who remembers Pets.com? Given its strong share price performance, we think it's worthwhile for Merrimack Pharmaceuticals shareholders to consider whether its cash burn is concerning. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. The first step is to compare its cash burn with its cash reserves, to give us its 'cash runway'. See our latest analysis for Merrimack Pharmaceuticals Does Merrimack Pharmaceuticals Have A Long Cash Runway? A cash runway is defined as the length of time it would take a company to run out of money if it kept spending at its current rate of cash burn. In September 2022, Merrimack Pharmaceuticals had US$13m in cash, and was debt-free. In the last year, its cash burn was US$1.5m. Therefore, from September 2022 it had 8.9 years of cash runway. While this is only one measure of its cash burn situation, it certainly gives us the impression that holders have nothing to worry about. Depicted below, you can see how its cash holdings have changed over time. How Is Merrimack Pharmaceuticals' Cash Burn Changing Over Time? Because Merrimack Pharmaceuticals isn't currently generating revenue, we consider it an early-stage business. So while we can't look to sales to understand growth, we can look at how the cash burn is changing to understand how expenditure is trending over time. It seems likely that the business is content with its current spending, as the cash burn rate stayed steady over the last twelve months. Admittedly, we're a bit cautious of Merrimack Pharmaceuticals due to its lack of significant operating revenues. So we'd generally prefer stocks from this list of stocks that have analysts forecasting growth. Can Merrimack Pharmaceuticals Raise More Cash Easily? Even though it has reduced its cash burn recently, shareholders should still consider how easy it would be for Merrimack Pharmaceuticals to raise more cash in the future. Companies can raise capital through either debt or equity. Many companies end up issuing new shares to fund future growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations. Merrimack Pharmaceuticals has a market capitalisation of US$158m and burnt through US$1.5m last year, which is 0.9% of the company's market value. That means it could easily issue a few shares to fund more growth, and might well be in a position to borrow cheaply. Is Merrimack Pharmaceuticals' Cash Burn A Worry? As you can probably tell by now, we're not too worried about Merrimack Pharmaceuticals' cash burn. For example, we think its cash runway suggests that the company is on a good path. On this analysis its cash burn reduction was its weakest feature, but we are not concerned about it. After considering a range of factors in this article, we're pretty relaxed about its cash burn, since the company seems to be in a good position to continue to fund its growth. Readers need to have a sound understanding of business risks before investing in a stock, and we've spotted 2 warning signs for Merrimack Pharmaceuticals that potential shareholders should take into account before putting money into a stock. Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies, and this list of stocks growth stocks (according to analyst forecasts) Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_59
By Rohith Nair, Aadi Nair and Manasi Pathak Jan 23 (Reuters) - Chelsea's record sale last year has proved to the Glazer family that now is the right time to sell Manchester United, industry experts told Reuters, with any deal for the Premier League club having the potential to be the biggest in sporting history. British billionaire and long-time United fan Jim Ratcliffe's company INEOS has entered the bidding process to buy the record 20-times English champions after he failed to acquire Chelsea, who were sold for $5.2 billion in May. United have not won the league in a decade, with the unpopular Glazers the target of several fan protests, but they are still an attractive prospect, according to Neil Joyce, CEO & co-founder of CLV Group. The club is one of the world's biggest sporting brands and generated 689 million euros ($750.94 million) in revenue in 2021-22. "Chelsea getting sold in 2022 means a rate has been established on the value of a Premier League club," Joyce said. "If you use the traditional method of valuing a club, which could be anywhere between eight to 10 times the revenue, that kind of $5 billion number is probably on the lower end of it." The Glazers bought United for 790 million pounds in 2005 in a highly-leveraged deal which has been criticised for loading debt onto the club. NOT 'RATIONAL MARKET' United's net debt grew nearly 23% to 515 million pounds in September, but that will not deter potential investors, according to Joyce and Spencer Harris, Associate Professor of Sport Management at the University of Colorado. "In a rational market, debts of this type would directly influence bids and price," Harris said. "But the Premier League generally and Manchester United specifically do not represent a rational market." The club's valuation as a public company peaked at $4.3 billion in 2018 but Joyce said new owners could capitalise on the global fanbase to increase commercial revenue by $200 million and add $1-2 billion to the actual valuation. Story continues "If you're looking at United as a medium-term investment, I don't think there's that huge risk against the valuation they're at today," he added. "If anything, you could argue they're potentially undervalued if you look at the $5 billion mark." OLD TRAFFORD INVESTMENT The Chelsea deal involved the new owners paying 2.5 billion pounds ($3.10 billion) to purchase shares while committing a further 1.75 billion pounds to invest in the club, particularly the stadium. Tim Bridge, lead partner in Deloitte's Sports Business Group, said United remain a significant asset but require a lot of investment to return to the top of the pyramid, starting with their Old Trafford stadium. The biggest club stadium in England seats around 75,000 fans but is considered a relic compared to modern European arenas. Media reports suggest it would cost one to two billion pounds to renovate. "Compared to other leading clubs, investment into capital projects such as the stadium, the training ground at Carrington and continued investment into the playing squad is very significant," Bridge said. "There is likely a need for any new investor to consider these at United in the future. So it may well be that the Glazers just feel this is the right time (to sell)." United have returned to the top four under new manager Erik ten Hag to give the fans renewed hope of competing in the title race for the first time in years. But Bridge said their resurgence would not help the Glazers drive up the price. "Any credible investor will look at the long-term picture rather than short-term optics," he added. "Should they push forward and qualify for the Champions League, then that gives a significant revenue boost and is something investors will keep a keen eye on." ($1 = 0.9175 euros)($1 = 0.8060 pounds) (Reporting by Rohith Nair, Aadi Nair and Manasi Pathak in Bengaluru, editing by Ed Osmond)
NEWS_60
Jan 23 (Reuters) - Arsenal confirmed they are deadly serious about winning the Premier League title by beating Manchester United 3-2 on Sunday to reach 50 points at the halfway mark of the season - a tally which usually leads to ending the season as champions. The victory, clinched by Eddie Nketiah's stoppage-time strike, saw Arsenal become only the fifth team in Premier League history to hit 50 points from their first 19 games. Three of the previous four teams to hit that milestone went on to lift the crown. Manchester City romped to the title in 2017-18 after taking 55 points in the first half of the season, as did Liverpool in 2019-20, while Chelsea became champions in 2005-06 after hitting 51 points. Only Liverpool in 2018-19 failed to take the title after hitting 51 points from 19 matches, being edged by Manchester City after squandering a seven-point lead. Arsenal have a smaller advantage over City than Liverpool did, leading Pep Guardiola's side by five points, and they have played one game fewer. Arsenal visit City in the FA Cup on Friday before a league showdown between the two teams at the Emirates Stadium on Feb. 15 which could have a huge say in whether the Gunners lift their first Premier League crown in 19 years or are pegged back by City, who have won four of the last five titles. City lost some momentum by losing the derby to Manchester United last weekend but proved they will not easily surrender their crown by storming back from two goals down to beat Tottenham Hotspur 4-2 on Thursday before Sunday's thumping 3-0 win over Wolverhampton Wanderers. Former United midfielder Roy Keane said Arsenal were in the driving seat. "The momentum is with them, there's good experience, youth and pace. They had good options off the bench - they're in a great place," Keane said on Sky Sports. "If you had said at the start of the season they'd be where they are, you wouldn't have believed it. It will take a lot to stop them." Story continues But his old team mate and fellow pundit Gary Neville said City should not be counted out just yet. "They (Arsenal) need to now go on and prove to us that they can win the title, which is going to be really tough. They've still got to play Manchester City twice and they've got them on their shoulders," he said. "They're a massive powerhouse, Manchester City and Pep Guardiola. You can imagine them sitting there tonight not being too fazed by this." (Reporting by Richard Martin Editing by Christian Radnedge)
NEWS_61
Daily Spotlight: Higher Rates Spell End to Housing Sector Growth The housing industry was an important contributor to the U.S. economic recovery from the pandemic, but high prices and high interest rates lately have priced millions of prospective homebuyers out of the market. The National Association of Realtors recently reported that existing home sales fell for an eleventh consecutive month in December 2022, totaling 4.0 million at a seasonally adjusted annual rate (down 34% from December 2021). The Commerce Department reported that new one-family homes were selling at a 640,000/year pace in November -- down from 756,000 a year earlier. Meanwhile, a leading indicator for the industry, housing permits, has turned lower as well. According to the Census Bureau, permits were being authorized in December at a 1.3 million annual rate, down 30% from 1.9 million in December 2021. Housing prices are finally starting to cool. The S&P/Case-Shiller National Home Price Index for October 2022 showed that the average price has risen "only" 9.2% year-over-year -- and is down 3% from the peak in June. The high prices and high mortgage rates (the average rate on a 30-year fixed-rate mortgage was recently 6.15%) have made the market unaffordable for buyers, including the millions of Millennials who are starting families. This month, KB Home, a builder in the S&P Midcap index, reported that fourth-quarter home orders were down 80% from the prior year and the cancellation rate jumped to 68% of gross orders (from 13% a year earlier). One bright spot this month is that the National Association of Home Builders reported that builder sentiment rose by four points, to 35, after a string of 12 consecutive monthly declines. While it is too early to tell if this is a turning point, it does seem clear that the housing sector will not be supportive of U.S. economic growth until pricing pressures and mortgage rates ease further.
NEWS_62
Simultaneous Use of Masimo O3® Regional Oximetry, NomoLine® Capnography, SedLine® Brain Function Monitoring, and rainbow® Pulse CO-Oximetry Helped Clinicians Determine that Maintaining Higher End-tidal Carbon Dioxide (EtCO 2 ) Improved Cerebral Oxygenation, Leading to Improved Outcomes NEUCHATEL, Switzerland, January 23, 2023--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a prospective, single-blinded, randomized controlled study published in the Journal of Anesthesia & Intensive Care Medicine in which Dr. Mona Mohamed Mogahed and colleagues at Tanta University in Tanta, Egypt and The King Fahd General Hospital in Jeddah, Saudi Arabia, sought to evaluate the impact of varying ventilation strategies on the cerebral oxygenation of patients undergoing video-assisted thoracoscopic surgery (VATS). To monitor the variety of physiological parameters needed to undertake such an evaluation, they turned to the multi-modal Masimo Root® patient monitoring and connectivity platform, which is designed to allow clinicians to streamline their ability to keep track of numerous modalities, simultaneously, using a single, intuitive monitor. The technologies involved included O3® regional oximetry, capnography with NomoLine® sampling lines, SedLine® brain function monitoring, and multiple rainbow® Pulse CO-Oximetry measurements. Using Root and Masimo monitoring technologies, the researchers were able to determine that maintaining higher end-tidal carbon dioxide (EtCO 2 ) improved baseline regional cerebral oxygenation (rSO 2 ), with impacts on early postoperative cognitive function that included improvements in Aldrete scores and mini mental status exam (MMSE) scores.1 This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230122005047/en/ Masimo Root® (Graphic: Business Wire) Noting the increased risk of hypoxemia during one-lung ventilation (OLV) as part of VATS, which can lead to postoperative neurocognitive dysfunctions, the authors hypothesized that increasing EtCO 2 could be a "convenient and powerful" way to manage cerebral desaturation during the surgery. They enrolled 70 patients, ages 18-65, undergoing elective VATS requiring OLV, between September 2021 and September 2022 at The King Fahd General Hospital, Jeddah. All patients were operated on by the same surgical team. The patients were randomly divided into two groups: in the first, EtCO 2 was maintained at 32-38 mmHg (group I) and in the second, at 39-45 mmHg (group II). During the procedure, monitored parameters included oxygen saturation (Masimo SET® SpO 2 ), heart rate (HR), and noninvasive hemoglobin (Masimo SpHb®) via an RD rainbow SET® fingertip sensor; EtCO 2 via capnometer and NomoLine sampling line; noninvasive blood pressure (NIBP), body temperature, and rSO 2 via O3 near-infrared spectroscopy (NIRS) sensors monitoring both brain hemispheres; and Masimo Patient State Index (PSi™), a processed EEG parameter used to help clinicians maintain appropriate sedation, via SedLine. Outcomes included Aldrete scores and MMSE scores assessed at 3 and 24 hours after surgery. Story continues The researchers found that the percentage of change in rSO 2 differed significantly between groups (p < 0.05), on both sides of the brain, with the higher values, over time, in Group II, in direct relation with the higher EtCO 2 maintained in that group. In the right hemisphere, the difference became significant at the fourth time interval [T4] at which rSO 2 was recorded, p = 0.0012, and maintained significance for the remainder of surgery [T4-T13], p < 0.001. In the left hemisphere, the difference became significant at T2, p = 0.09, and remained significant [T3-13], p < 0.001. Aldrete scores were significantly higher in Group II upon arrival at the post-anesthesia care unit (PACU) (p = 0.013) and 15 minutes after arrival (p = 0.03), then became comparable. MMSE scores were significantly higher in Group II 3 hours after surgery (p = 0.0009), but not at 24 hours after surgery. The researchers concluded, "Adjusting the ventilator parameters to develop EtCO 2 of 39-45 mmHg improved cerebral oxygenation more than EtCO 2 of 32-38 mmHg, that play[s] a protective role in the brain, causing significant impact on the early postoperative cognitive function in patients with OLV undergoing VATS." Regarding the use of Masimo Root and associated monitoring technologies, they noted that they "preferred using it as it can display several clinical measurements [at] the same time, such as HR, BP, temperature, SpO 2 , EtCO 2 , PSi, and rSO 2 ." @Masimo | #Masimo About Masimo Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins, Denon, Marantz, and Polk Audio. Our mission is to improve life, improve patient outcomes, and reduce the cost of care. Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, introduced in 1995, has been shown in over 100 independent and objective studies to outperform other pulse oximetry technologies.2 Masimo SET® has also been shown to help clinicians reduce severe retinopathy of prematurity in neonates,3 improve CCHD screening in newborns,4 and, when used for continuous monitoring with Masimo Patient SafetyNet™ in post-surgical wards, reduce rapid response team activations, ICU transfers, and costs.5-8 Masimo SET® is estimated to be used on more than 200 million patients in leading hospitals and other healthcare settings around the world,9 and is the primary pulse oximetry at 9 of the top 10 hospitals as ranked in the 2022-23 U.S. News and World Report Best Hospitals Honor Roll.10 In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi), and Oxygen Reserve Index (ORi™). In 2013, Masimo introduced the Root® Patient Monitoring and Connectivity Platform, built from the ground up to be as flexible and expandable as possible to facilitate the addition of other Masimo and third-party monitoring technologies; key Masimo additions include Next Generation SedLine® Brain Function Monitoring, O3® Regional Oximetry, and ISA™ Capnography with NomoLine® sampling lines. Masimo’s family of continuous and spot-check monitoring Pulse CO-Oximeters® includes devices designed for use in a variety of clinical and non-clinical scenarios, including tetherless, wearable technology, such as Radius-7®, Radius PPG®, and Radius VSM™, portable devices like Rad-67®, fingertip pulse oximeters like MightySat® Rx, and devices available for use both in the hospital and at home, such as Rad-97®. Masimo hospital and home automation and connectivity solutions are centered around the Masimo Hospital Automation™ platform, and include Iris® Gateway, iSirona™, Patient SafetyNet, Replica®, Halo ION®, UniView®, UniView :60™, and Masimo SafetyNet®. Its growing portfolio of health and wellness solutions includes Radius Tº® and the Masimo W1™ watch. Additional information about Masimo and its products may be found at www.masimo.com. Published clinical studies on Masimo products can be found at www.masimo.com/evidence/featured-studies/feature/. ORi, RPVi, and Radius VSM have not received FDA 510(k) clearance and are not available for sale in the United States. The use of the trademark Patient SafetyNet is under license from University HealthSystem Consortium. References Mogahed MM, Alnoamani TS, Elkahwagy MS. The Ventilatory Influence on Cerebral Oxygenation in Patients Undergoing Video Assisted Thoracoscopic Surgery. J Anest & Inten Care Med. 12(3). December 2022. DOI: 10.19080/JAICM.202212.555837. Published clinical studies on pulse oximetry and the benefits of Masimo SET® can be found on our website at http://www.masimo.com. Comparative studies include independent and objective studies which are comprised of abstracts presented at scientific meetings and peer-reviewed journal articles. Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm Infants through Changes in Clinical Practice and SpO 2 Technology. Acta Paediatr. 2011 Feb;100(2):188-92. de-Wahl Granelli A et al. Impact of pulse oximetry screening on the detection of duct dependent congenital heart disease: a Swedish prospective screening study in 39,821 newborns. BMJ. 2009;Jan 8;338. Taenzer A et al. Impact of pulse oximetry surveillance on rescue events and intensive care unit transfers: a before-and-after concurrence study. Anesthesiology. 2010:112(2):282-287. Taenzer A et al. Postoperative Monitoring – The Dartmouth Experience. Anesthesia Patient Safety Foundation Newsletter. Spring-Summer 2012. McGrath S et al. Surveillance Monitoring Management for General Care Units: Strategy, Design, and Implementation. The Joint Commission Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302. McGrath S et al. Inpatient Respiratory Arrest Associated With Sedative and Analgesic Medications: Impact of Continuous Monitoring on Patient Mortality and Severe Morbidity. J Patient Saf. 2020 14 Mar. DOI: 10.1097/PTS.0000000000000696. Estimate: Masimo data on file. http://health.usnews.com/health-care/best-hospitals/articles/best-hospitals-honor-roll-and-overview. Forward-Looking Statements This press release includes forward-looking statements as defined in Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in connection with the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, among others, statements regarding the potential effectiveness of Masimo Root®, O3®, NomoLine®, SedLine®, rainbow®, RD rainbow SET®, SpHb®, SET®, and PSi™. These forward-looking statements are based on current expectations about future events affecting us and are subject to risks and uncertainties, all of which are difficult to predict and many of which are beyond our control and could cause our actual results to differ materially and adversely from those expressed in our forward-looking statements as a result of various risk factors, including, but not limited to: risks related to our assumptions regarding the repeatability of clinical results; risks related to our belief that Masimo's unique noninvasive measurement technologies, including Masimo Root, O3, NomoLine, SedLine, rainbow®, RD rainbow SET, SpHb, SET®, and PSi, contribute to positive clinical outcomes and patient safety; risks that the researchers’ conclusions and findings may be inaccurate; risks related to our belief that Masimo noninvasive medical breakthroughs provide cost-effective solutions and unique advantages; risks related to COVID-19; as well as other factors discussed in the "Risk Factors" section of our most recent reports filed with the Securities and Exchange Commission ("SEC"), which may be obtained for free at the SEC's website at www.sec.gov. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. All forward-looking statements included in this press release are expressly qualified in their entirety by the foregoing cautionary statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. We do not undertake any obligation to update, amend or clarify these statements or the "Risk Factors" contained in our most recent reports filed with the SEC, whether as a result of new information, future events or otherwise, except as may be required under the applicable securities laws. View source version on businesswire.com: https://www.businesswire.com/news/home/20230122005047/en/ Contacts Media Contact: Masimo Evan Lamb 949-396-3376 elamb@masimo.com
NEWS_63
UNION (dpa-AFX) - The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.00 A.M. ET). In the Green Pliant Therapeutics, Inc. (PLRX) is up over 80% at $40.58. Appreciate Holdings, Inc. (SFR) is up over 30% at $2.15. ShiftPixy, Inc. (PIXY) is up over 14% at $13.41. Independence Contract Drilling, Inc. (ICD) is up over 14% at $5.95. Genius Group Limited (GNS) is up over 11% at $3.62. Pineapple Energy Inc. (PEGY) is up over 10% at $2.69. Can-Fite BioPharma Ltd. (CANF) is up over 9% at $5.27. Vir Biotechnology, Inc. (VIR) is up over 8% at $30.00. Wayfair Inc. (W) is up over 7% at $50.39. Ellomay Capital Ltd. (ELLO) is up over 7% at $17.87. PagSeguro Digital Ltd. (PAGS) is up over 7% at $9.52. Satixfy Communications Ltd. (SATX) is up over 6% at $8.49. In the Red Cosmos Health Inc. (COSM) is down over 11% at $4.73. HTG Molecular Diagnostics, Inc. (HTGM) is down over 6% at $3.84. Bed Bath & Beyond Inc. (BBBY) is down over 6% at $3.12. RXO, Inc. (RXO) is down over 5% at $16.00. Copyright(c) 2023 RTTNews.com. All Rights Reserved Copyright RTT News/dpa-AFX PLIANT THERAPEUTICS-Aktie komplett kostenlos handeln - auf Smartbroker.de
NEWS_64
White Falcon Capital Management LLC, an investment management firm, published its fourth quarter 2022 investor letter – a copy of which can be downloaded here. A quarterly net increase of 2.52% has been recorded by the fund for the fourth quarter of 2022, below the S&P 500 (CAD) Index’s 5.25% gain for the same period. Spare some time to check the fund’s top 5 holdings to have a clue about their top bets for 2022. In its Q3 2022 investor letter, White Falcon Capital Management mentioned Maxar Technologies Inc. (NYSE:MAXR) and explained its insights for the company. Founded in 2017, Maxar Technologies Inc. (NYSE:MAXR) is a Westminster, Colorado-based space technology company with a $3.8 billion market capitalization. Maxar Technologies Inc. (NYSE:MAXR) delivered a -0.83% return since the beginning of the year, while its 12-month returns are up by 91.67%. The stock closed at $51.31 per share on January 20, 2023. Here is what White Falcon Capital Management has to say about Maxar Technologies Inc. (NYSE:MAXR) in its Q3 2022 investor letter: "Half of the portfolio had positive realized and unrealized gains for the year. Out of these, EPAM Systems and Maxar were the largest positive contributors to performance. In addition, our weight in the commodity sector, including the precious metals hedge, produced substantial positive returns. Maxar Technologies provides satellite images to the defense and corporate sector. The company was going to launch its new and improved Legion satellites but was faced with delays due to which investors lost patience and sold the stock. We saw a good quality company beset by temporary delays with strong FCF available for less than 10x EBITDA and bought the stock at an average price of C$35 per share. In December, Advent, a Private Equity firm, announced that they are going to buy-out Maxar and take it private at above C$70 per share. We sold our position and redeployed the cash into other attractive opportunities." Story continues Aerospace Our calculations show that Maxar Technologies Inc. (NYSE:MAXR) fell short and didn’t make it on our list of the 30 Most Popular Stocks Among Hedge Funds. Maxar Technologies Inc. (NYSE:MAXR) was in 16 hedge fund portfolios at the end of the second quarter of 2022, compared to 15 funds in the previous quarter. Maxar Technologies Inc. (NYSE:MAXR) delivered a 150.17% return in the past 3 months. In January 2023, we published an article that includes Maxar Technologies Inc. (NYSE:MAXR) in 12 Best Performing Growth Stocks in 2022. You can find other investor letters from hedge funds and prominent investors on our hedge fund investor letters Q4 2022 page. Suggested Articles: Disclosure: None. This article is originally published at Insider Monkey.
NEWS_65
ATLANTA, Jan. 23, 2023 /PRNewswire/ -- MetroCity Bankshares, Inc. ("MetroCity" or the "Company") (NASDAQ: MCBS), holding company for Metro City Bank (the "Bank"), today reported net income of $13.2 million, or $0.52 per diluted share, for the fourth quarter of 2022, compared to $16.9 million, or $0.66 per diluted share, for the third quarter of 2022, and $17.4 million, or $0.68 per diluted share, for the fourth quarter of 2021. For the year ended December 21, 2022, the Company reported net income of $65.6 million, or $2.55 per diluted share, compared to $61.7 million, or $2.39 per diluted share, for the year ended December 31, 2021. MetroCity Logo (PRNewsfoto/MetroCity Bankshares) Fourth Quarter 2022 Highlights: Annualized return on average assets was 1.54%, compared to 2.07% for the third quarter of 2022 and 2.33% for the fourth quarter of 2021. Annualized return on average equity was 14.97%, compared to 20.56% for the third quarter of 2022 and 24.80% for the fourth quarter of 2021. Efficiency ratio of 40.3%, compared to 36.4% for the third quarter of 2022 and 33.7% for the fourth quarter of 2021. Total assets increased by $78.1 million, or 2.3%, to $3.43 billion from the previous quarter. Total loans increased by $77.4 million, or 2.6%, to $3.06 billion from the previous quarter. Total deposits increased by $96.0 million, or 3.7%, to $2.67 billion from the previous quarter. Full Year 2022 Highlights: Return on average assets was 2.06%, compared to 2.51% for 2021. Return on average equity was 20.48%, compared to 23.55% for 2021. Efficiency ratio of 36.3%, compared to 35.1% for 2021. Total assets increased by $320.4 million, or 10.3%, to $3.43 billion from $3.11 billion at December 31, 2021. Total loans increased by $550.6 million, or 22.0%, to $3.06 billion from $2.51 billion at December 31, 2021. Total deposits increased by $403.8 million, or 17.8%, to $2.67 billion from $2.26 billion at December 31, 2021. Results of Operations Net Income Net income was $13.2 million for the fourth quarter of 2022, a decrease of $3.7 million, or 22.0%, from $16.9 million for the third quarter of 2022. This decrease was primarily due to a decrease in net interest income of $838,000 and a decrease in noninterest income of $3.3 million, offset by a decrease in noninterest expense of $309,000 and a decrease in income tax expense of $649,000. Net income decreased by $4.3 million, or 24.5%, in the fourth quarter of 2022 compared to net income of $17.4 million for the fourth quarter of 2021. This decrease was due to a decrease in net interest income of $671,000 and a decrease in noninterest income of $5.7 million, offset by a decrease in provision for loan losses of $1.7 million, a decrease in noninterest expense of $133,000 and a decrease in provision for income taxes of $247,000. Story continues Net income was $65.6 million for the year ended December 31, 2022, an increase of $3.9 million, or 6.3%, from $61.7 million for the year ended December 31, 2021. This increase was due to an increase in net interest income of $15.4 million and a decrease in provision for loan losses of $9.7 million, offset by a decrease in noninterest income of $14.6 million, an increase in noninterest expense of $1.9 million and an increase in provision for taxes of $4.7 million. Net Interest Income and Net Interest Margin Interest income totaled $43.9 million for the fourth quarter of 2022, an increase of $5.6 million, or 14.7%, from the previous quarter, primarily due to a $124.2 million increase in average loan balances coupled with a 39 basis points increase in the loan yield. As compared to the fourth quarter of 2021, interest income for the fourth quarter of 2022 increased by $13.1 million, or 42.4%, primarily due to an increase in average loan balances of $562.7 million coupled with a 57 basis points increase in the loan yield. Interest expense totaled $15.0 million for the fourth quarter of 2022, an increase of $6.5 million, or 76.2%, from the previous quarter, primarily due to a 113 basis points increase in deposit costs and a 26 basis points increase in borrowing costs coupled with a $118.7 million increase in average interest-bearing deposits and a $27.7 million increase in average borrowings. As compared to the fourth quarter of 2021, interest expense for the fourth quarter of 2022 increased by $13.8 million, or 1,113.2%, due to a 234 basis points increase in deposit costs and a 175 basis points increase in borrowing costs coupled with a $419.1 million increase in average interest-bearing deposits. The net interest margin for the fourth quarter of 2022 was 3.58% compared to 3.84% for the previous quarter, a decrease of 26 basis points. The yield on average interest-earning assets for the fourth quarter of 2022 increased by 49 basis points to 5.43% from 4.94% for the previous quarter, while the cost of average interest-bearing liabilities for the fourth quarter of 2022 increased by 98 basis points to 2.49% from 1.51% for the previous quarter. Average earning assets increased by $130.9 million from the previous quarter, primarily due to an increase in average loans of $124.2 million and an increase in average total investments of $6.7 million. Average interest-bearing liabilities increased by $146.4 million from the previous quarter as average interest-bearing deposits increased by $118.7 million and average borrowings increased by $27.7 million. As compared to the same period in 2021, the net interest margin for the fourth quarter of 2022 decreased by 57 basis points to 3.58% from 4.15%, primarily due to a 225 basis point increase in the cost of average interest-bearing liabilities of $2.39 billion, offset by a 111 basis point increase in the yield on average interest-earning assets of $3.21 billion. Average earning assets for the fourth quarter of 2022 increased by $376.5 million from the fourth quarter of 2021, primarily due to a $562.7 million increase in average loans, offset by a $186.0 million decrease in average interest-earning cash accounts. Average interest-bearing liabilities for the fourth quarter of 2022 increased by $357.1 million from the fourth quarter of 2021, driven by an increase in average interest-bearing deposits of $419.1 million, offset by a decrease in average borrowings of $62.0 million. Noninterest Income Noninterest income for the fourth quarter of 2022 was $1.8 million, a decrease of $3.3 million, or 64.8%, from the third quarter of 2022, primarily due to lower mortgage loan fees, lower gains on sale of Small Business Administration ("SBA") loans and a significant decrease in SBA servicing income. Mortgage loan originations totaled $88.0 million during the fourth quarter 2022 compared to $255.7 million during the third quarter of 2022. During the fourth quarter of 2022, we recorded a $1.2 million fair value adjustment charge on our SBA servicing asset which had a $0.04 per share impact on our diluted earnings per share for the quarter. Compared to the same period in 2021, noninterest income for the fourth quarter of 2022 decreased by $5.7 million, or 76.1%, primarily due to much lower gains on sale of SBA loans, mortgage loan fees and mortgage and SBA servicing income. Noninterest income for the year ended December 31, 2022 totaled $19.2 million, a decrease of $14.6 million, or 43.2%, from the year ended December 31, 2021, primarily due to lower mortgage loan fees from lower volume, gains on sale of SBA loans and SBA servicing income, offset by increases in gains on sale of mortgage loans, service charges on deposit accounts and other income. Beginning in the second quarter of 2022, we elected to stop selling the guaranteed portion of our SBA loans since the sales premiums offered by third party investors had significantly declined compared to prior year. As of December 31, 2022, approximately $137.8 million of the $299.3 million of SBA loan balances outstanding on our books had SBA guarantees. During the year ended December 31, 2022, we also recorded a $3.1 million fair value adjustment charge on our SBA servicing asset compared to a $619,000 fair value gain during the year ended December 31, 2021. Mortgage loan originations totaled $833.6 million during the year ended December 31, 2022 compared to $1.20 billion during the year ended December 31, 2021. Mortgage loan sales totaled $94.9 million during the year ended December 31, 2022 compared to no mortgage loan sales during the year ended December 31, 2021. Noninterest Expense Noninterest expense for the fourth quarter of 2022 totaled $12.4 million, a decrease of $309,000, or 2.4%, from $12.7 million for the third quarter of 2022. This decrease was primarily attributable to lower commissions from lower loan volume and lower loan and other real estate owned related expenses, partially offset by higher employee salaries and benefits. Compared to the fourth quarter of 2021, noninterest expense during the fourth quarter of 2022 decreased by $133,000, or 1.1%, primarily due to lower commissions, FDIC deposit insurance premiums, and loan related expenses, partially offset by higher employee salaries and benefits. Noninterest expense for the year ended December 31, 2022 totaled $50.4 million, an increase of $1.9 million, or 4.0%, from $48.4 million for the year ended December 31, 2021. This increase was primarily attributable to higher employee salaries and benefits, FDIC deposit insurance premiums, professional fees, communication expenses and fair value losses on our equity investments, offset by lower commissions due to lower loan volume, occupancy and equipment expenses, and loan and other real estate owned related expenses. The Company's efficiency ratio was 40.3% for the fourth quarter of 2022 compared to 36.4% and 33.7% for the third quarter of 2022 and fourth quarter of 2021, respectively. For the year ended December 31, 2022, the efficiency ratio was 36.3% compared with 35.1% for the year ended December 31, 2021. Income Tax Expense The Company's effective tax rate for the fourth quarter of 2022 was 32.6%, compared to 29.3% for the third quarter of 2022 and 27.5% for the fourth quarter of 2021. The effective tax rate for the year ended December 31, 2022 was 28.1% compared to 25.3% for the year ended December 31, 2021. The elevated effective tax rate during the fourth quarter of 2022, as well as the year ended December 31, 2022, was due to the re-allocation of state income tax apportionment schedules for prior year's tax returns. Balance Sheet Total Assets Total assets were $3.43 billion at December 31, 2022, an increase of $78.1 million, or 2.3%, from $3.35 billion at September 30, 2022, and an increase of $320.4 million, or 10.3%, from $3.11 billion at December 31, 2021. The $78.1 million increase in total assets at December 31, 2022 compared to September 30, 2022 was primarily due to increases in loans of $77.4 million and federal funds sold of $12.9 million, partially offset by a decrease in cash and due from banks of $13.1 million. The $320.4 million increase in total assets at December 31, 2022 compared to December 31, 2021 was primarily due to increases in loans of $550.6 million, federal funds sold of $19.7 million, bank owned life insurance of $9.7 million and other assets of $32.4 million, partially offset by a $281.6 million decrease in cash and due from banks. Loans Loans held for investment were $3.06 billion at December 31, 2022, an increase of $77.4 million, or 2.6%, compared to $2.98 billion at September 30, 2022, and an increase of $550.6 million, or 22.0%, compared to $2.51 billion at December 31, 2021. The increase in loans at December 31, 2022 compared to September 30, 2022 was primarily due to a $48.6 million increase in commercial real estate loans, a $32.2 million increase in residential mortgages and a $480,000 increase in commercial and industrial loans, offset by a $3.5 million decrease in construction and development loans. Included in commercial and industrial loans are PPP loans totaling $713,000 as of December 31, 2022. PPP loans totaled $1.6 million as of September 30, 2022 and $31.0 million as of December 31, 2021. There were no loans classified as held for sale at December 31, 2022, September 30, 2022 or December 31, 2021. Deposits Total deposits were $2.67 billion at December 31, 2022, an increase of $96.0 million, or 3.7%, compared to total deposits of $2.57 billion at September 30, 2022, and an increase of $403.8 million, or 17.8%, compared to total deposits of $2.26 billion at December 31, 2021. The increase in total deposits at December 31, 2022 compared to September 30, 2022 was due to a $203.5 million increase in time deposits, a $22.3 million increase in interest-bearing demand deposits and a $9.7 million increase in noninterest-bearing deposits, offset by a $136.4 million decrease in money market accounts and a $3.2 million decrease in savings accounts. Noninterest-bearing deposits were $612.0 million at December 31, 2022, compared to $602.2 million at September 30, 2022 and $592.4 million at December 31, 2021. Noninterest-bearing deposits constituted 22.9% of total deposits at December 31, 2022, compared to 23.4% at September 30, 2022 and 26.2% at December 31, 2021. Interest-bearing deposits were $2.05 billion at December 31, 2022, compared to $1.97 billion at September 30, 2022 and $1.67 billion at December 31, 2021. Interest-bearing deposits constituted 77.1% of total deposits at December 31, 2022, compared to 76.6% at September 30, 2022 and 73.8% at December 31, 2021. Asset Quality The Company recorded a credit provision for loan losses of $1.2 million during the fourth quarter of 2022, compared to a $1.7 million credit provision recorded during the third quarter of 2022 and a $546,000 provision expense recorded during the fourth quarter of 2021. The credit provision recorded during the fourth quarter of 2022 was due to the continued release of additional reserves allocated for the uncertainties in our loan portfolio caused by the ongoing COVID-19 pandemic. Annualized net charge-offs to average loans for the fourth quarter of 2022 was a net recovery of 0.01%, compared 0.00% for the third quarter of 2022 and net charge-offs of 0.01% for the fourth quarter of 2021. The Company implemented the provisions of the current expected credit losses accounting standard issued by the Financial Accounting Standards Board in the Accounting Standards Update No. 2016-13 on January 1, 2023. The allowance for loan losses was accounted for under the incurred loss model as of December 31, 2022. Nonperforming assets totaled $24.5 million, or 0.71% of total assets, at December 31, 2022, a decrease of $8.0 million from $32.5 million, or 0.97% of total assets, at September 30, 2022, and an increase of $9.1 million from $15.4 million, or 0.50% of total assets, at December 31, 2021. The decrease in nonperforming assets at December 31, 2022 compared to September 30, 2022 was due to a $7.6 million decrease in nonaccrual loans and a $518,000 decrease in accruing troubled debt restructurings, offset by a $180,000 increase in loans past due ninety days and still accruing. Allowance for loan losses as a percentage of total loans was 0.45% at December 31, 2022, compared to 0.50% at September 30, 2022 and 0.67% at December 31, 2021. Allowance for loan losses as a percentage of nonperforming loans was 68.88% at December 31, 2022, compared to 53.25% and 143.69% at September 30, 2022 and December 31, 2021, respectively. About MetroCity Bankshares, Inc. MetroCity Bankshares, Inc. is a Georgia corporation and a registered bank holding company for its wholly-owned banking subsidiary, Metro City Bank, which is headquartered in the Atlanta, Georgia metropolitan area. Founded in 2006, Metro City Bank currently operates 19 full-service branch locations in multi-ethnic communities in Alabama, Florida, Georgia, New York, New Jersey, Texas and Virginia. To learn more about Metro City Bank, visit www.metrocitybank.bank. Forward-Looking Statements Statements in this press release regarding future events and our expectations and beliefs about our future financial performance and financial condition, as well as trends in our business and markets, constitute "forward-looking statements" within the meaning of, and subject to the protections of, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements are not historical in nature and may be identified by references to a future period or periods by the use of the words "believe," "expect," "anticipate," "intend," "plan," "estimate," "project," "outlook," or words of similar meaning, or future or conditional verbs such as "will," "would," "should," "could," or "may." The forward-looking statements in this press release should not be relied on because they are based on current information and on assumptions that we make about future events and circumstances that are subject to a number of known and unknown risks and uncertainties that are often difficult to predict and beyond our control. As a result of those risks and uncertainties, and other factors, our actual financial results in the future could differ, possibly materially, from those expressed in or implied by the forward-looking statements contained in this press release and could cause us to make changes to our future plans. Factors that might cause such differences include, but are not limited to: the impact of current and future economic conditions, particularly those affecting the financial services industry, including the effects of declines in the real estate market, high unemployment rates, inflationary pressures, elevated interest rates and slowdowns in economic growth, as well as the financial stress on borrowers as a result of the foregoing; the impact of the ongoing COVID-19 pandemic and related variants on the Company's assets, business, cash flows, financial condition, liquidity, prospects and results of operations; changes in the interest rate environment, including changes to the federal funds rate; changes in prices, values and sales volumes of residential and commercial real estate; developments in our mortgage banking business, including loan modifications, general demand, and the effects of judicial or regulatory requirements or guidance; competition in our markets that may result in increased funding costs or reduced earning assets yields, thus reducing margins and net interest income; interest rate fluctuations, which could have an adverse effect on the Company's profitability; legislation or regulatory changes which could adversely affect the ability of the consolidated Company to conduct business combinations or new operations; changes in tax laws; significant turbulence or a disruption in the capital or financial markets and the effect of a fall in stock market prices on our investment securities; the effects of war or other conflicts including the impacts related to or resulting from Russia's military action in Ukraine; and adverse results from current or future litigation, regulatory examinations or other legal and/or regulatory actions, including as a result of the Company's participation in and execution of government programs related to the ongoing COVID-19 pandemic and related variants. Therefore, the Company can give no assurance that the results contemplated in the forward-looking statements will be realized. Additional information regarding these and other risks and uncertainties to which our business and future financial performance are subject is contained in the sections titled "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors" in the Company's most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q on file with the U.S. Securities and Exchange Commission (the "SEC"), and in other documents that we file with the SEC from time to time, which are available on the SEC's website, http://www.sec.gov. In addition, our actual financial results in the future may differ from those currently expected due to additional risks and uncertainties of which we are not currently aware or which we do not currently view as, but in the future may become, material to our business or operating results. Due to these and other possible uncertainties and risks, readers are cautioned not to place undue reliance on the forward-looking statements contained in this press release or to make predictions based solely on historical financial performance. Any forward-looking statement speaks only as of the date on which it is made, and we do not undertake any obligation to update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. All forward-looking statements, express or implied, included in this press release are qualified in their entirety by this cautionary statement. Contacts Farid Tan Lucas Stewart President Chief Financial Officer 770-455-4978 678-580-6414 faridtan@metrocitybank.bank lucasstewart@metrocitybank.bank
NEWS_66
Over the past several years, violent crime has been on the rise in many of the biggest cities in the U.S. It was a key campaigning topic during the 2022 midterms, with the murder rate increasing by 30% between 2019-2020. While various models reveal conflicting data as to whether all types of violent crime are up nationally, voters have sounded the subject as one of their most important issues. Six in 10 voters put violent crime as one of their top voting issues in October 2022.
NEWS_67
RENO, Nev., January 23, 2023--(BUSINESS WIRE)--Modiv Inc. ("Modiv" or the "Company") (NYSE:MDV), an internally managed real estate investment trust ("REIT") that acquires, owns and manages a portfolio of single-tenant net-lease real estate properties, today announced that it will report fourth quarter and fiscal year 2022 financial results before the market opens on Thursday, February 23, 2023. Management will host a conference call the same day at 8:00 a.m. Pacific Time (11:00 a.m. Eastern Time) to discuss the results. Live conference call: 877-514-3620 at 8:00 a.m. Pacific Time, Thursday, February 23 Webcast: To listen to the webcast, either live or archived, use this link https://event.choruscall.com/mediaframe/webcast.html?webcastid=mAokDz4P or visit the investor relations page of Modiv’s website at www.modiv.com. About Modiv Modiv Inc. is an internally managed REIT that acquires, owns and manages a portfolio of single-tenant net-lease real estate. The Company actively acquires industrial manufacturing properties with long-term leases to mission critical tenants that fuel the national economy. Driven by an investor-first focus, the Modiv name reflects its commitment to providing investors with Monthly Dividends. As of September 30, 2022, Modiv had a $545 million real estate portfolio (based on estimated fair value) comprised of 3.2 million square feet of aggregate leasable area. For more information, please visit: www.modiv.com. Forward-looking Statements Certain statements contained in this press release, other than historical facts, may be considered forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include, but are not limited to, statements regarding our plans, strategies and prospects, both business and financial. Such forward-looking statements are subject to various risks and uncertainties, including but not limited to those described under the section entitled "Risk Factors" in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 23, 2022. Accordingly, there are or will be important factors that could cause actual outcomes or results to differ materially from those indicated in these statements. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this press release and in the Company’s other filings with the SEC. Any forward-looking statements herein speak only as of the time when made and are based on information available to the Company as of such date and are qualified in their entirety by this cautionary statement. The Company assumes no obligation to revise or update any such statement now or in the future, unless required by law. Story continues View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005673/en/ Contacts Investor Inquiries: Margaret Boyce, Financial Profiles, Inc. mboyce@finprofiles.com 310-622-8247
NEWS_68
MercadoLibre (MELI) closed the most recent trading day at $1,095, moving -0.28% from the previous trading session. This change lagged the S&P 500's 1.19% gain on the day. Elsewhere, the Dow gained 0.76%, while the tech-heavy Nasdaq added 0.29%. Prior to today's trading, shares of the operator of an online marketplace and payments system in Latin America had gained 25.02% over the past month. This has outpaced the Retail-Wholesale sector's gain of 8.04% and the S&P 500's gain of 4.06% in that time. Wall Street will be looking for positivity from MercadoLibre as it approaches its next earnings report date. In that report, analysts expect MercadoLibre to post earnings of $2.11 per share. This would mark year-over-year growth of 329.35%. Meanwhile, our latest consensus estimate is calling for revenue of $2.94 billion, up 38.08% from the prior-year quarter. It is also important to note the recent changes to analyst estimates for MercadoLibre. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook. Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. The Zacks Consensus EPS estimate has moved 4.35% higher within the past month. MercadoLibre currently has a Zacks Rank of #1 (Strong Buy). Looking at its valuation, MercadoLibre is holding a Forward P/E ratio of 74.13. Its industry sports an average Forward P/E of 21.82, so we one might conclude that MercadoLibre is trading at a premium comparatively. Story continues The Internet - Commerce industry is part of the Retail-Wholesale sector. This group has a Zacks Industry Rank of 32, putting it in the top 13% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Zacks.com. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report MercadoLibre, Inc. (MELI) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_69
Shares of MFA Financial Inc. MFA, were unchanged Monday, on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index COMP, +2.01% rising 2.01% to 11,364.41 and the Dow Jones Industrial Average DJIA, +0.76% rising 0.76% to 33,629.56. MFA Financial Inc. closed $7.39 short of its 52-week high ($18.80), which the company reached on February 1st. The stock underperformed when compared to some of its competitors Monday, as PennyMac Mortgage Investment Trust PMT, +0.20% rose 0.20% to $14.86, Invesco Mortgage Capital Inc. IVR, +0.07% rose 0.07% to $14.26, and AGNC Investment Corp. AGNC, +0.43% rose 0.43% to $11.58. Trading volume (1.1 M) remained 210,907 below its 50-day average volume of 1.3 M. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_70
Shares of Manulife Financial Corp. MFC, +0.27% inched 0.27% higher to C$25.57 Monday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, +0.63% rising 0.63% to 20,631.58. Manulife Financial Corp. closed C$2.52 short of its 52-week high (C$28.09), which the company achieved on February 10th. Trading volume of 11.6 M shares eclipsed its 50-day average volume of 7.6 M. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_71
LONDON, January 23, 2023--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Micro Focus International plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 20/01/2023 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" N/A 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 10p Ordinary Share Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: (2) Cash-settled derivatives: 3,445,329 1.01 0 0 (3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0 0 0 TOTAL: 3,445,329 1.01 0 0 All interests and all short positions should be disclosed. Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). Story continues (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: 0 Details, including nature of the rights concerned and relevant percentages: 0 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit 10p Ordinary Share Equity Swap Increasing a long position 4914 530.8 10p Ordinary Share Equity Swap Increasing a long position 441 530 10p Ordinary Share Equity Swap Increasing a long position 1442 530 10p Ordinary Share Equity Swap Increasing a long position 260 530 10p Ordinary Share Equity Swap Increasing a long position 3027 530.2 10p Ordinary Share Equity Swap Increasing a long position 1593 530 10p Ordinary Share Equity Swap Increasing a long position 14316 530 10p Ordinary Share Equity Swap Increasing a long position 42 530 10p Ordinary Share Equity Swap Increasing a long position 32 530 10p Ordinary Share Equity Swap Increasing a long position 1409 530.2 10p Ordinary Share Equity Swap Increasing a long position 67 530.2 10p Ordinary Share Equity Swap Increasing a long position 29 530.1 10p Ordinary Share Equity Swap Increasing a long position 1361 530.2 10p Ordinary Share Equity Swap Increasing a long position 33 530.1 10p Ordinary Share Equity Swap Increasing a long position 249 530.2 10p Ordinary Share Equity Swap Increasing a long position 441 530 10p Ordinary Share Equity Swap Increasing a long position 180 530.2 10p Ordinary Share Equity Swap Increasing a long position 226 530.2 10p Ordinary Share Equity Swap Increasing a long position 448 530 10p Ordinary Share Equity Swap Increasing a long position 269 530 10p Ordinary Share Equity Swap Increasing a long position 3988 530.8 10p Ordinary Share Equity Swap Increasing a long position 27 530 10p Ordinary Share Equity Swap Increasing a long position 140 530 10p Ordinary Share Equity Swap Increasing a long position 260 530 10p Ordinary Share Equity Swap Reducing a long position 1271 530.4 10p Ordinary Share Equity Swap Reducing a long position 4475 530.2 10p Ordinary Share Equity Swap Reducing a long position 210 530 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit 0 0 0 0 0 (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 0 0 0 0 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? NO Date of disclosure: 23/01/2023 Contact name: Stuart Brown Telephone number: 00442070722969 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005366/en/ Contacts Qube Research & Technologies LTD
NEWS_72
LONDON, January 23, 2023--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1. KEY INFORMATION (a) Full name of discloser: Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Micro Focus International plc (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: (e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 20th January 2023 (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" No 2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security. (a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any) Class of relevant security: 10p ordinary (GB00BJ1F4N75) ADR (US5948374039) Interests Short positions Number % Number % (1) Relevant securities owned and/or controlled: 13,028 0.004% (2) Cash-settled derivatives: 9,222,030 2.718% 8,304 0.002% (3) Stock-settled derivatives (including options) and agreements to purchase/sell: TOTAL: 9,235,058 2.722% 8,304 0.002% All interests and all short positions should be disclosed. Story continues Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions). (b) Rights to subscribe for new securities (including directors’ and other employee options) Class of relevant security in relation to which subscription right exists: Details, including nature of the rights concerned and relevant percentages: 3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and other monetary amounts should be stated. (a) Purchases and sales Class of relevant security Purchase/sale Number of securities Price per unit (USD) US5948374039 Purchase 95 6.53 US5948374039 Purchase 297 6.54 US5948374039 Sale 15 6.52 (b) Cash-settled derivative transactions Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit (GBP) GB00BJ1F4N75 Equity Swap Reducing a long position 4,993 5.30 GB00BJ1F4N75 Equity Swap Reducing a long position 13,668 5.30 GB00BJ1F4N75 Equity Swap Increasing a long position 157 5.30 GB00BJ1F4N75 Equity Swap Increasing a long position 2,282 5.30 GB00BJ1F4N75 Equity Swap Increasing a long position 55 5.30 GB00BJ1F4N75 Equity Swap Reducing a long position 385 5.30 GB00BJ1F4N75 Equity Swap Reducing a long position 1 5.30 GB00BJ1F4N75 Equity Swap Reducing a long position 663 5.30 (c) Stock-settled derivative transactions (including options) (i) Writing, selling, purchasing or varying Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit (USD) Type e.g. American, European etc. Expiry date Option money paid/ received per unit (ii) Exercise Class of relevant security Product description e.g. call option Exercising/ exercised against Number of securities Exercise price per unit (d) Other dealings (including subscribing for new securities) Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable) 4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" NONE (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" NONE (c) Attachments Is a Supplemental Form 8 (Open Positions) attached? No Date of disclosure: 23rd January 2023 Contact name: Roisin Nagle Telephone number: +44 203 192 8746 Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129. The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005443/en/ Contacts Millennium Partners, L.P.
NEWS_73
Shares of Magna International Inc. MG, +2.39% rose 2.39% to C$87.57 Monday, in what proved to be an all-around favorable trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, +0.63% rising 0.63% to 20,631.58. Magna International Inc. closed C$18.63 below its 52-week high (C$106.20), which the company achieved on February 2nd. Trading volume of 556,969 shares remained below its 50-day average volume of 696,541. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_74
Airspan 6-series integrates with Federated Wireless AFC to bring game-changing range, speed, capacity and automation to shared spectrum Wi-Fi 6E deployments BOCA RATON, Fla. & ARLINGTON, Va., January 23, 2023--(BUSINESS WIRE)--Airspan Networks Inc., a subsidiary of Airspan Networks Holdings Inc. (NYSE American: MIMO), a U.S.-based provider of ground-breaking, disruptive software and hardware for mobile and fixed wireless network operators, has today announced its selection of Federated Wireless, private wireless and shared spectrum leader, as Automated Frequency Coordination (AFC) service provider for Airspan’s new Fixed Wireless Access (FWA) 6-series line of products: A6, C6x and B6x. AFC forms a critical component of the new Wi-Fi 6E ecosystem, particularly for the outdoor, standard-power access point segment that Airspan’s 6-series addresses. AFC shields incumbent 6 GHz operations from RF interference by checking a database of registered users to ensure that new wireless devices do not impact existing users. By using the AFC service, Wi-Fi 6E access points are permitted to transmit high power levels, referred to as "standard power," thereby covering more area and affording FWA network providers greater performance and efficiency. Airspan will test and fully integrate Federated Wireless’ AFC into the Airspan 6 series product line. This will enable a fully automated and zero-touch process to deploy these new, higher power radios in the Wi-Fi 6E spectrum, simplifying the deployment process for network providers. The new Airspan 6-series line of products together with AFC change the game for the FWA market. 6 Gbps aggregated speeds, interference cancelation with noise immunity, auto channel/auto power/rate adaptation and GPS Auto Synch to support adjacent and overlapping channels are a few of the best-in-class features that combine to realize the A6, C6x, and B6x mission of providing cost-effective "wireless-fiber" solutions. "Our relationship with Federated Wireless has advanced CBRS SAS service innovation," said Henrik Smith-Petersen, chief sales & marketing officer at Airspan. "The Federated Wireless AFC service is best-of-breed in the market; for us it was a natural step to partner with them again. Our new 6-series product line is fully integrated with Federated Wireless’ AFC which further simplifies and accelerates deployment of FWA services in the new Wi-Fi 6E spectrum." Federated Wireless has been conditionally approved as an AFC system operator by the U.S. Federal Communications Commission (FCC). Their history of providing a leading Spectrum Access System (SAS) for CBRS mid-band clients enabled this natural extension into 6 GHz spectrum management. "The AFC service ecosystem and marketplace is expanding at a rapid pace, and we are thrilled to be at the nexus of that evolution with market leaders like Airspan," said Chris Swan, chief commercial officer for Federated Wireless. "The integration of our AFC with Airspan’s 6-series offers fast and easy deployment of high power, high-performance wireless systems from pioneers and leaders in the wireless industry." About Airspan Airspan Networks Holdings Inc. (NYSE American: MIMO) is a U.S.-based provider of groundbreaking, disruptive software and hardware for 5G networks, and a pioneer in end-to-end Open RAN solutions that provide interoperability with other vendors. As a result of innovative technology and significant R&D investments to build and expand 5G solutions, Airspan believes it is well-positioned with 5G indoor and outdoor, Open RAN, private networks for enterprise customers and industrial use applications, fixed wireless access (FWA), and CBRS solutions to help mobile network operators of all sizes deploy their networks of the future, today. With over one million cells shipped to 1,000 customers in more than 100 countries, Airspan has global scale. For more information, visit www.airspan.com. About Federated Wireless Founded in 2012, Federated Wireless is the leading innovator of private wireless and shared spectrum services. The company’s partner ecosystem includes more than 100 solution and edge partners, all dedicated to collaboration in advance development and deployment of shared spectrum services and private wireless. Federated Wireless’ customer base includes companies spanning telecommunications, government, logistics, manufacturing, energy, hospitality, education, retail, office space, municipal and residential verticals, with use cases ranging from Private Wireless and Industrial IoT to network densification and mobile offload. For more information, visit: federatedwireless.com, LinkedIn, Twitter, or our blog. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005612/en/ Contacts Airspan Press Contact: Media Contact: mediarelations@airspan.com Investor Relations Contact: Brett Scheiner +1 561-893-8660 IR@airspan.com Federated Wireless Press Contact: Kim Haneke Federated Wireless khaneke@federatedwireless.com +1.858.228.7249
NEWS_75
Barnwell Industries, Inc. Agrees to Reconstitute Its Board and Extend Standstill Agreement HONOLULU, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Barnwell Industries, Inc. (NYSE-American: BRN) (“Barnwell” or the “Company”) announce today that it has entered into a cooperation and support agreement (the “Agreement”) with its two largest stockholders, Alexander C. Kinzler, who beneficially owns approximately 9.3% of the Company’s outstanding common stock, and MRMP-Managers LLC, Ned L. Sherwood Revocable Trust, and Ned L. Sherwood (collectively, the “MRMP Stockholders”), who beneficially own approximately 19.6% of the Company’s outstanding common stock. The Agreement extends for two years the standstill terms of the previous agreement entered into with the MRMP Stockholders in 2021, ending the potential of a proxy contest at the 2023 annual meeting of stockholders (the “2023 Annual Meeting”). Pursuant to the terms of the Agreement, among other things, the Company has agreed to promptly appoint Joshua S. Horowitz and Laurance Narbut to serve on its Board of Directors (the “Board”), subject to certain customary board procedures. The Board has determined that each of Mr. Horowitz and Narbut are independent under applicable NYSE rules and regulations. Mr. Horowitz is a Portfolio Manager at Palm Management (US) LLC. He has held senior positions at Inverlochy Capital, an asset management firm, and Berggruen Holdings, the family office of Nicolas Berggruen. He began his career at Crossway Partners, a value strategy investment partnership. Mr. Horowitz holds a BS in Management, magna cum laude, from Binghamton University and also studied at the Bath School of Management in the United Kingdom. Mr. Horowitz previously served as a Director of The Lincoln General Insurance Company (private), as well as 1347 Capital Corp (Nasdaq: TFSC), and is currently a Director and Chair of the Finance Committee of Limbach Holdings (Nasdaq: LMB), a $500m mechanical engineering concern. He was formerly on the Board of 1347 Property Insurance Holdings, Inc. (Nasdaq: PIH) and Minim, Inc. (Nasdaq: MINM), and Interim Chairman of the Board of Birner Dental Management Services, Inc. (OTC: BDMS), where he led the Company’s sale to Mid Atlantic Dental Partners. Mr. Horowitz also was a Board Observer at Biomerica, Inc. (Nasdaq: BMRA). Story continues Mr. Narbut is the founder and Managing Partner of Acceleration Resources. Mr. Narbut has held senior positions at Passport Capital, Richmond Financial, SUN Capital Partners, Credit Suisse First Boston, and Parthenon Group. At Passport Capital, Mr. Narbut was a portfolio manager for the energy strategy, investing across multiple funds and focused on upstream oil & gas and energy service investments. Mr. Narbut attended Harvard Business School and the University of Pennsylvania Pursuant to the terms of the Agreement, the Company has agreed to nominate Mr. Kinzler, Barnwell’s CEO and President, Kenneth Grossman, Douglas Woodrum, and Messrs. Horowitz and Narbut as candidates for election to the Board at the 2023 Annual Meeting and the 2024 annual meeting of stockholders (the “2024 Annual Meeting”) and Mr. Kinzler and the MRMP Stockholders have agreed to vote their respective shares of common stock of the Company in favor of the election of the Company’s slate at the 2023 Annual Meeting and 2024 Annual Meeting. Pursuant to the terms of the Agreement, the Company also has terminated the previously enacted Tax Benefits Preservation Plan, although the MRMP Stockholders have agreed to limit their beneficial and economic ownership of the Company to 28% of the outstanding common stock of the Company for the next 12 months and 30% for the subsequent 12-month period. Mr. Grossman, the newly appointed Chairman of the Board, said, “We are gratified to have found common ground and alignment with our two largest stockholders to avoid the distraction and cost of another proxy contest. In addition to demonstrating the commitment of the incoming Board to act in the long-term interests of all stockholders, I believe this extension of the previous cooperation and support agreement continues the significant progress the Company has made over the past several years toward strengthening and streamlining its governance and operations.” Mr. Sherwood said “I am pleased that agreement has been reached. I am positive that the prospective new Board members along with the remaining members will add new dynamism and excellent leadership in the future. Eliminating the significant distractions and overhead costs related to our past discord should benefit the Company and all stockholders.” Additional Information. Barnwell intends to file a proxy statement and proxy card with United States Securities and Exchange Commission (the “SEC”) in connection with its solicitation of proxies for its 2023 Annual Meeting. Details concerning the nominees of Barnwell's Board of Directors for election at the 2023 Annual Meeting will be included in the proxy statement. BARNWELL STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT (AND ANY AMENDMENTS AND SUPPLEMENTS THERETO) AND ACCOMPANYING PROXY CARD WHEN THEY BECOME AVAILABLE AS THEY WILL CONTAIN IMPORTANT INFORMATION. Stockholders may obtain the proxy statement, any amendments or supplements to the proxy statement and other documents as and when filed by Barnwell with the SEC without charge from the SEC’s website at www.sec.gov . Barnwell, its directors and certain of its executive officers may be deemed to be participants in connection with the solicitation of proxies from Barnwell’s stockholders in connection with the matters to be considered at the 2023 Annual Meeting. Information regarding the ownership of Barnwell’s directors and executive officers in Barnwell stock is included in their SEC filings on Forms 3, 4, and 5, which can be found through the SEC’s website at www.sec.gov. Information also can be found in Barnwell’s other SEC filings. More detailed and updated information regarding the identity of potential participants, and their direct or indirect interests, by security holdings or otherwise, will be set forth in the proxy statement and other materials to be filed with the SEC. These documents can be obtained free of charge from the sources indicated above. The information contained in this press release contains “forward-looking statements,” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. A forward-looking statement is one which is based on current expectations of future events or conditions and does not relate to historical or current facts. These statements include various estimates, forecasts, projections of Barnwell’s future performance, statements of Barnwell’s plans and objectives, and other similar statements. Forward-looking statements include phrases such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “predicts,” “estimates,” “assumes,” “projects,” “may,” “will,” “will be,” “should,” or similar expressions. Although Barnwell believes that its current expectations are based on reasonable assumptions, it cannot assure that the expectations contained in such forward-looking statements will be achieved. Forward-looking statements involve risks, uncertainties and assumptions which could cause actual results to differ materially from those contained in such statements. The risks, uncertainties and other factors that might cause actual results to differ materially from Barnwell’s expectations are set forth in the “Forward-Looking Statements,” “Risk Factors” and other sections of Barnwell’s annual report on Form 10-K for the last fiscal year and Barnwell’s other filings with the Securities and Exchange Commission. Investors should not place undue reliance on the forward-looking statements contained in this press release, as they speak only as of the date of this press release, and Barnwell expressly disclaims any obligation or undertaking to publicly release any updates or revisions to any forward-looking statements contained herein. CONTACT: Alexander C. Kinzler Chief Executive Officer and President Russell M. Gifford Executive Vice President and Chief Financial Officer Tel: (808) 531-8400
NEWS_76
FOUNTAIN VALLEY, Calif., January 23, 2023--(BUSINESS WIRE)--Moving iMage Technologies (NYSE American: MITQ) ("MiT"), the leading provider of custom-designed and 3rd Party technology and services for cinema exhibition and an emerging business in live entertainment venues and Esports, today named William "Bill" Greene as interim chief financial officer, effective immediately. Greene brings an extensive background in public accounting, SEC reporting, capital raising, M&A due diligence and internal controls working as a CFO, Big 8 auditor and financial consultant for both public and private companies. Greene holds a B.S. in Business Administration, with a concentration in Accounting from the California State University - Dominguez Hills. About Moving iMage Technologies MOVING iMAGE TECHNOLOGIES (NYSE American: MITQ) is a leading provider of technology, products, and services to the Motion Picture Exhibition industry and is expanding into live entertainment venues and Esports. We sell proprietary products, which we design and manufacture in-house, and are developing, introducing, and supporting a wide range of disruptive technologies that will bring SaaS and subscription-based products. Our Caddy brand of proprietary manufactured products is a leading provider of cup holders, trays, and other products to entertainment and sports venues. For more information, visit www.movingimagetech.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005639/en/ Contacts Moving iMage Technologies Investor Relations and Media Contacts: Brian Siegel, IRC®, M.B.A. Senior Managing Director Hayden IR (346) 396-8696 brian@haydenir.com
NEWS_77
MKS Instruments, Inc. ANDOVER, Mass., Jan. 23, 2023 (GLOBE NEWSWIRE) -- MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of enabling technologies that transform our world, today announced that the Company will release fourth quarter and full year 2022 financial results after market close on Monday, February 13, 2023. A conference call with management will be held on Tuesday, February 14, 2023 at 8:30 a.m. (Eastern Time). A live and archived webcast of the call will be available on the company’s website at https://investor.mks.com/. To participate in the call by phone, participants should register online by clicking here, where dial in details will be provided. We encourage participants to register and dial in to the conference call at least 15 minutes before the start of the call to ensure a timely connection. About MKS Instruments MKS Instruments enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies. Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed and feature enhancement for optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at www.mks.com. Company Contact: David Ryzhik Vice President, Investor Relations Telephone: (978) 557-5180 Email: david.ryzhik@mksinst.com Press Relations : Bill Casey Senior Director, Marketing Communications Telephone: (630) 995-6384 Email: press@mksinst.com Story continues Tom Davies / Jeremy Fielding Kekst CNC Emails: tom.davies@kekstcnc.com / jeremy.fielding@kekstcnc.com
NEWS_78
Shares of Martin Marietta Materials Inc. MLM, +0.36% inched 0.36% higher to $348.93 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX, +1.19% rising 1.19% to 4,019.81 and the Dow Jones Industrial Average DJIA, +0.76% rising 0.76% to 33,629.56. This was the stock's second consecutive day of gains. Martin Marietta Materials Inc. closed $57.92 below its 52-week high ($406.85), which the company achieved on March 29th. Trading volume (274,370) remained 70,795 below its 50-day average volume of 345,165.
NEWS_79
Shares of Cronos Group Inc. CRON, +0.80% inched 0.80% higher to $2.52 Monday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index COMP, +2.01% rising 2.01% to 11,364.41 and the Dow Jones Industrial Average DJIA, +0.76% rising 0.76% to 33,629.56. This was the stock's second consecutive day of gains. Cronos Group Inc. closed $1.79 below its 52-week high ($4.31), which the company achieved on March 30th. Trading volume (1.3 M) remained 400,970 below its 50-day average volume of 1.7 M.
NEWS_80
AUSTIN, Texas, January 23, 2023--(BUSINESS WIRE)--CrowdStrike Holdings, Inc. (Nasdaq: CRWD), a leader in cloud-delivered protection of endpoints, cloud workloads, identity and data, today announced the appointment of Johanna Flower to the company’s board of directors. A renowned cybersecurity, go-to-market and modern governance expert, Ms. Flower currently sits on the boards of cloud leaders like Freshworks (Nasdaq: FRSH) and ForgeRock (NYSE: FORG), as well as several high-growth private SaaS companies. She also has direct experience working closely with CrowdStrike’s leadership team and board, having served as the company’s first chief marketing officer and having played a key role in taking the company public in 2019. "Johanna’s reputation as a critical advisor and world-class executive speaks for itself. Her direct understanding of our team and passion for our business will certainly be advantageous, but it’s her experience helping guide other hyper-growth companies and their executive teams that will be invaluable to CrowdStrike and our board," said George Kurtz, co-founder and CEO of CrowdStrike. "She’s already played a key role in CrowdStrike’s early success as a market disruptor turned market leader, and I believe her best contributions are yet to come." "CrowdStrike continues to be the company to beat in cybersecurity and one of the fastest growing SaaS companies ever – a market leader that innovates and operates with the speed and attitude of a disruptor," said Flower. "I welcome the opportunity to work with familiar and new faces alike on CrowdStrike’s board and management team as the company continues to redefine modern security and scales into a truly generational business." Forward-Looking Statements This press release contains forward-looking statements that involve risks and uncertainties. There are a significant number of factors that could cause actual results to differ materially from statements made in this press release, including risks and uncertainties that could affect the forward-looking statements in this press release, which are included under the captions "Risk Factors" and "Management’s Discussion and Analysis of Financial Condition and Results of Operations" set forth from time to time in our filings and reports with the Securities and Exchange Commission ("SEC"), including our Quarterly Report on Form 10-Q for the quarter ended October 31, 2022. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of such risks and uncertainties. All forward-looking statements in this press release are based on information available to us as of the date hereof, and we do not assume any obligation to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made. Story continues About CrowdStrike CrowdStrike (Nasdaq: CRWD), a global cybersecurity leader, has redefined modern security with the world’s most advanced cloud-native platform for protecting critical areas of enterprise risk — endpoints and cloud workloads, identity and data. Powered by the CrowdStrike Security Cloud and world-class AI, the CrowdStrike Falcon® platform leverages real-time indicators of attack, threat intelligence, evolving adversary tradecraft and enriched telemetry from across the enterprise to deliver hyper-accurate detections, automated protection and remediation, elite threat hunting and prioritized observability of vulnerabilities. Purpose-built in the cloud with a single lightweight-agent architecture, the Falcon platform delivers rapid and scalable deployment, superior protection and performance, reduced complexity and immediate time-to-value. CrowdStrike: We stop breaches. Learn more: https://www.crowdstrike.com/ Follow us: Blog | Twitter | LinkedIn | Facebook | Instagram Start a free trial today: https://www.crowdstrike.com/free-trial-guide/ © 2023 CrowdStrike, Inc. All rights reserved. CrowdStrike, the falcon logo, CrowdStrike Falcon and CrowdStrike Threat Graph are marks owned by CrowdStrike, Inc. and registered with the United States Patent and Trademark Office, and in other countries. CrowdStrike owns other trademarks and service marks, and may use the brands of third parties to identify their products and services. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005170/en/ Contacts Investors: CrowdStrike Holdings, Inc. Maria Riley investors@crowdstrike.com 669-721-0742 Media: Kevin Benacci CrowdStrike Corporate Communications press@crowdstrike.com
NEWS_81
CrowdStrike Holdings Inc. Cl A CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011, and is headquartered in Austin, TX.
NEWS_82
Conversations with people in retail indicate the Shopify Plus platform is likely to be used more widely this year, according to Deutsche Bank. Dreamstime This could be the toughest year for enterprise software companies in a long time, Deutsche Bank analyst Brad Zelnick said, cutting his ratings on a slew of stocks. “We expect 2023 to be another volatile year for software stocks with investors seeking confirmation of a bottom as fundamentals likely deteriorate further,” Zelnick wrote in a research note on Monday. “This is the most difficult outlook piece we’ve written in our combined decades covering the sector. With the weightiness of macro factors, more dimensions to the analysis and a wider range of outcomes, we struggle to have conviction near-term, though ironically, we couldn’t be more resolute in our thinking about the long term.”
NEWS_83
Please try again later. (Bloomberg) -- The Qatar Investment Authority boosted its stake in Credit Suisse Group AG to 6.87%, according to a filing from the sovereign wealth fund. Most Read from Bloomberg Scroll to continue with content Ad ADVERTISEMENT With the purchase, QIA becomes the Swiss bank’s second largest shareholder — just behind the Saudi National Bank — after Credit Suisse issued new shares as part of a 4 billion Swiss franc ($4.3 billion) capital raise it completed in December. Earlier this month, the Swiss lender’s longtime largest shareholder Harris Associates, which once held a stake of about 10%, reported a holding of below 3%. Credit Suisse’s Shareholder Harris Associates Falls Below 3% The Saudi National Bank, 37% owned by the nation’s sovereign wealth fund, was an anchor investor in Credit Suisse’s capital raise and now holds a near 10% stake in the firm, making it the top shareholder. Advertisement Advertisement Credit Suisse has long counted on wealthy Middle Eastern investors as top shareholders and they’ve often invested in times of need. QIA participated in Credit Suisse’s approximately $2 billion convertible note issuance in April 2021. That helped shore up the balance sheet after the bank lost $5.5 billion tied to the collapsed hedge fund Archegos Capital Management. A representative for Credit Suisse declined to comment. The Financial Times first reported the news. Credit Suisse is undergoing a strategic revamp which includes plans to spin out its capital markets, advisory and leveraged finance businesses into a boutique unit under the Credit Suisse First Boston branding, while integrating its remaining trading businesses more closely with the wealth management business. Most Read from Bloomberg Businessweek Advertisement ©2023 Bloomberg L.P.
NEWS_84
The Qatar Investment Authority has doubled its stake in Credit Suisse, becoming the second-biggest shareholder after the Saudi National Bank and underlining the growing importance of Middle Eastern investors to the ailing Swiss bank. The move comes as US shareholders sell down their stakes in the lender, with Chicago-based Harris Associates, which was the bank’s biggest shareholder just a few months ago with a 10 per cent stake, now owning less than 5 per cent.
NEWS_85
Analyst Report: CoStar Group, Inc. CoStar Group is a leading provider of commercial real estate data and marketplace listing platforms. Its data offering contains in-depth analytical information on over 5 million commercial real estate properties related to various subsectors including office, retail, multifamily, healthcare, industrial, self-storage, and data centers. It operates many flagship brands such as CoStar Suite, LoopNet, Apartments.com, BizBuySell, LandsofAmerica, and so on with more than 75% of its revenue classified as subscription-based. The company has also recently expanded its presence in Canada, the United Kingdom, Spain, and France.
NEWS_86
Canadian Solar (CSIQ) closed the most recent trading day at $42.68, moving +1.89% from the previous trading session. The stock outpaced the S&P 500's daily gain of 1.19%. Meanwhile, the Dow gained 0.76%, and the Nasdaq, a tech-heavy index, added 0.29%. Prior to today's trading, shares of the solar wafers manufacturer had gained 35.04% over the past month. This has outpaced the Oils-Energy sector's gain of 5.68% and the S&P 500's gain of 4.06% in that time. Investors will be hoping for strength from Canadian Solar as it approaches its next earnings release. The company is expected to report EPS of $0.33, up 94.12% from the prior-year quarter. Meanwhile, our latest consensus estimate is calling for revenue of $1.84 billion, up 20.57% from the prior-year quarter. Any recent changes to analyst estimates for Canadian Solar should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. Canadian Solar currently has a Zacks Rank of #2 (Buy). Looking at its valuation, Canadian Solar is holding a Forward P/E ratio of 7.38. Its industry sports an average Forward P/E of 33.18, so we one might conclude that Canadian Solar is trading at a discount comparatively. The Solar industry is part of the Oils-Energy sector. This industry currently has a Zacks Industry Rank of 12, which puts it in the top 5% of all 250+ industries. Story continues The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Canadian Solar Inc. (CSIQ) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_87
FRIENDSWOOD, Texas, January 23, 2023--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that the Company’s medical director, Matthew Goldberg, M.D., F.A.A.D., board-certified dermatologist and dermatopathologist, will present at the Precision Medicine World Conference (PMWC®) 2023, being held Jan. 25-27 in Santa Clara, California. Dr. Goldberg’s presentation, titled "Using Molecular Diagnostics to Inform Cancer Management Decisions," will take place on Wednesday, Jan. 25, at 2:30 p.m. Pacific time as part of Track 3: Diagnostics and Molecular Profiling in the Clinic. Dr. Goldberg will highlight several tests within Castle’s skin cancer and gastroenterology portfolios, including DecisionDx®-Melanoma, DecisionDx®-SCC and the TissueCypher® Barrett’s Esophagus test, and demonstrate how the personalized information the tests provide can help clinicians make more informed treatment decisions in the care of their patients to potentially improve patient outcomes. "Castle Biosciences is a leading company in the precision medicine space that is committed to transforming disease management for skin cancers and Barrett’s esophagus," said Dr. Goldberg. "By focusing on disease states with significant unmet clinical need, we leverage our innovative in-house testing platforms to provide meaningful improvements to diagnostic or risk stratification approaches across the various disease states where we offer molecular testing. "While there is much discussion about the promise of personalized medicine, Castle’s tests have the potential to improve patient outcomes and reduce costs to the healthcare system. I am looking forward to sharing concrete examples during my discussion of how molecular testing technologies can be clinically accessed for the benefit of patient care today." Dr. Goldberg has served as Castle’s medical director since 2020 and supports Castle’s commercialized and pipeline tests. He graduated summa cum laude from Princeton University and received his medical degree from the Icahn School of Medicine at Mount Sinai. Dr. Goldberg completed his dermatology residency at the University of California, San Francisco, and completed a dermatopathology fellowship at the University of Texas Southwestern. Story continues Conference presentation content will be available to registered attendees only. Visit https://www.pmwcintl.com/ for more information and registration details. About Precision Medicine World Conference PMWC, the "Precision Medicine World Conference," is the largest and original annual conference dedicated to precision medicine. PMWC’s mission is to bring together recognized leaders, top global researchers and medical professionals, and innovators across healthcare and biotechnology sectors to showcase practical content that helps close the knowledge gap between different sectors, thereby catalyzing cross-functional fertilization and collaboration in an effort to accelerate the development and spread of precision medicine. Since 2009, PMWC has been recognized as a vital cornerstone for all constituents of the health care and biotechnology community, providing an exceptional forum for the exchange of information about the latest advances in technology, in clinical implementation, research and in all aspects related to the regulatory and reimbursement sectors. About Castle Biosciences Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors. Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions. Additionally, the Company has active research and development programs for tests in other diseases with high clinical need, including its test in development to predict systemic therapy response in patients with moderate-to-severe psoriasis, atopic dermatitis and related conditions. To learn more, please visit www.CastleBiosciences.com and connect with us on LinkedIn, Facebook, Twitter and Instagram. DecisionDx-Melanoma, DecisionDx-CMSeq, DecisionDx-SCC, MyPath Melanoma, DiffDx-Melanoma, DecisionDx-UM, DecisionDx-PRAME, DecisionDx-UMSeq, TissueCypher and IDgenetix are trademarks of Castle Biosciences, Inc. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which are subject to the "safe harbor" created by those sections. These forward-looking statements include, but are not limited to, statements concerning: the potential of our tests and the personalized information they provide to help clinicians make more informed treatment decisions in the care of their patients to potentially improve patient outcomes, reduce costs to the healthcare system, and be clinically accessed for the benefit of patient care today. The words "can," "potential" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation: subsequent study or trial results and findings may contradict earlier study or trial results and findings, including with respect to the diagnostic and prognostic tests discussed in this press release; actual application of our tests may not provide the aforementioned benefits to patients; insufficient coverage of or reimbursement for our tests from government and commercial payors could limit our ability to reduce costs to the healthcare system; and the risks set forth under the heading "Risk Factors" in our Quarterly Report on Form 10-Q for the three months ended September 30, 2022, and in our other filings with the SEC. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements, except as may be required by law. View source version on businesswire.com: https://www.businesswire.com/news/home/20230123005080/en/ Contacts Investor Contact: Camilla Zuckero czuckero@castlebiosciences.com Media Contact: Allison Marshall amarshall@castlebiosciences.com
NEWS_88
CSW Industrials, Inc. DALLAS, Jan. 23, 2023 (GLOBE NEWSWIRE) -- CSW Industrials, Inc. (NASDAQ: CSWI) announced that it will release its earnings results for the fiscal third quarter ended December 31, 2022 on Thursday, February 2, 2023, before the market opens. The Company will host a conference call the same day at 10:00 am Eastern Time to discuss the results. Participants may access the call at 1-877-407-0784, international callers may use 1-201-689-8560, and request to join the CSW Industrials earnings call. A live webcast will also be available at https://cswindustrials.gcs-web.com. A telephonic replay will be available shortly after the conclusion of the call and until February 16. Participants may access the replay at 1-844-512-2921, international callers may use 1-412-317-6671, and enter access code 13735274. An archived replay of the call will also be available on the Investors portion of the CSWI website at www.cswindustrials.com. About CSW Industrials CSW Industrials is a diversified industrial growth company with industry-leading operations in three segments: Contractor Solutions, Engineered Building Solutions, and Specialized Reliability Solutions. CSWI provides niche, value-added products with two essential commonalities: performance and reliability. The primary end markets we serve with our well-known brands include: HVAC/R, plumbing, general industrial, architecturally-specified building products, energy, mining, and rail. For more information, please visit www.cswindustrials.com. Investor Relations James E. Perry Executive Vice President and Chief Financial Officer 214-884-3777 info@cswindustrials.com
NEWS_89
Shares of CSX Corp. CSX, +0.12% inched 0.12% higher to $32.05 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX, +1.19% rising 1.19% to 4,019.81 and the Dow Jones Industrial Average DJIA, +0.76% rising 0.76% to 33,629.56. This was the stock's second consecutive day of gains. CSX Corp. closed $6.58 short of its 52-week high ($38.63), which the company reached on March 7th. The stock underperformed when compared to some of its competitors Monday, as Union Pacific Corp. UNP, +0.70% rose 0.70% to $210.13. Trading volume (9.3 M) remained 3.8 million below its 50-day average volume of 13.1 M.
NEWS_90
Castellum, Inc. Castellum, Inc. Announces the Award of NAVAIR Contract for ALRE V2MMS Castellum, Inc. (NYSE-American: CTM) announces the award of the NAVAIR Aircraft Launch & Recovery Equipment (ALRE) V2 Maintenance Management System (V2MMS) contract to its subsidiary Specialty Systems, Inc. (SSI). This award extends the duration and scope of an existing contract and is worth a total of $1.9 million including $1.1 million to be recognized in calendar 2023 - https://www.navair.navy.mil/organization/PMA-251& http://castellumus.com. BETHESDA, Md., Jan. 23, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) announces the award of the NAVAIR Aircraft Launch & R ecovery Equipment (ALRE) V2 Maintenance Management System (V2MMS) contract to its subsidiary Specialty Systems, Inc. (SSI). This award extends the duration and scope of an existing contract and is worth a total of $1.9 million including $1.1 million to be recognized in calendar 2023. The V2MMS software application will be integrated into the existing Aviation Data Management and Control System (ADMACS ) used on all active US Navy aircraft carriers , answering the Navy carrier fleet’s heavy demand for the capabilities to be delivered. Under this contract, SSI will introduce its NAVAIR customer to a new paradigm for the rapid development and deployment of software applications, paving the way for addressing additional demand for the redesign of many legacy Navy software applications. “We are thrilled that NAVAIR continues to value the work that we have done and are pleased to have received this extended and expanded scope of work,” said Mark Fuller, President, and CEO of Castellum . “Castellum continues to work closely with NAVAIR on multiple fronts to provide the necessary expertise to meet mission critical requirements.” “Our relationship with this valuable customer has extended for more than two decades,” said Emil Kaunitz, President of SSI . “We have consistently delivered a high caliber of work for NAVAIR and look forward to continuing to grow this relationship.” About Castellum, Inc.: Castellum, Inc. (NYSE-American: CTM) is a defense-oriented technology company which is executing strategic acquisitions in the cyber security, information technology and software, information warfare, and electronic warfare and engineering services space - http://castellu m us.com/ . Forward-Looking Statements: This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters disclosed at www.sec.gov. These risks and uncertainties could cause the company's actual results to differ materially from those indicated in the forward-looking statements. Story continues Contact: Skyline Corporate Communications Group, LLC Lisa Gray, Senior Account Manager One Rockefeller Plaza, 11th Floor New York, NY 10020 Office: 646.893.5835 x1 Email: lisa@skylineccg.com ; info@castellumus.com A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4a4555b7-ecfc-46a0-aaee-ab914e60d125
NEWS_91
PRINCETON, N.J., Jan. 23, 2023 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announced that it has received regulatory approval from Health Canada allowing inclusion of Canadian sites into the pivotal Safe and Timely Antithrombotic Removal – Ticagrelor (STAR-T) randomized, controlled trial. CytoSorbents Corporation (NASDAQ: CTSO) is a leader in the treatment of life-threatening conditions using blood purification. CytoSorbents’ flagship product, CytoSorb®, is approved in the European Union and distributed in over 70 countries worldwide. CytoSorbents is conducting trials to support FDA marketing approval of DrugSorb™-ATR for antithrombotic drug removal during cardiothoracic surgery. (PRNewsfoto/CytoSorbents Corporation) Health Canada Approval to Expand STAR-T Pivotal Trial to Canadian Sites Expected to Accelerate Completion of Study Richard Whitlock, M.D., Ph.D., FRCSC, Professor of Surgery at McMaster University Medical School and the Population Health Research Institute, Canada Research Chair in Cardiovascular Surgery and Canada Principal Investigator for the STAR-T trial stated, "Canadian cardiac surgery centers are excited to join the STAR-T trial. Ticagrelor is a potent antiplatelet agent with strong evidence of clinical benefit in acute coronary syndromes and is commonly used in the Canadian system. However, managing patients on ticagrelor when they need urgent cardiac surgery is challenging because of the increased bleeding risk. STAR-T will provide definitive evidence whether the DrugSorb-ATR system can effectively remove ticagrelor during surgery and improve clinical outcomes by reducing bleeding. The Population Health Research Institute has successfully completed several of the largest randomized trials in cardiac surgery and will coordinate the STAR-T trial in several of their most successful collaborating sites in Canada. These centers will provide high volume recruitment with high quality data to help answer this important question in a timely manner. Canada is excited to begin recruitment in the pivotal STAR-T trial." Dr. Efthymios N. Deliargyris, Chief Medical Officer of CytoSorbents commented, "We are very pleased to receive regulatory approval to expand STAR-T into Canada and are now working closely with our partners at the Population Health Research Institute to onboard up to 7 Canadian sites as soon as possible. We anticipate these high performing sites will contribute meaningfully to study enrollment and help us execute on our stated goals of reaching the next milestones of 80 enrolled patients this Spring and full enrollment of 120 patients by Summer 2023." Story continues About CytoSorbents Corporation (NASDAQ: CTSO) CytoSorbents Corporation is a leader in the treatment of life-threatening conditions in the intensive care unit and in cardiac surgery through blood purification. Its lead product, CytoSorb®, is approved in the European Union and distributed in 75 countries worldwide. It is an extracorporeal cytokine adsorber that reduces "cytokine storm" or "cytokine release syndrome" in common critical illnesses that can lead to massive inflammation, organ failure and patient death. In these diseases, the risk of death can be extremely high, and there are few, if any, effective treatments. CytoSorb is also used during and after cardiothoracic surgery to remove inflammatory mediators that can lead to postoperative complications, including multiple organ failure. As of September 30, 2022, more than 186,000 CytoSorb devices have been used cumulatively. CytoSorb was originally launched in the European Union under CE mark as the first cytokine adsorber. Additional CE mark extensions were granted for bilirubin and myoglobin removal in clinical conditions such as liver disease and trauma, respectively, and for ticagrelor and rivaroxaban removal in cardiothoracic surgery procedures. CytoSorb has also received FDA Emergency Use Authorization in the United States for use in adult critically ill COVID-19 patients with impending or confirmed respiratory failure. The DrugSorb™-ATR antithrombotic removal system, based on the same polymer technology as CytoSorb, also received two FDA Breakthrough Device Designations, one for the removal of ticagrelor and another for the removal of the direct oral anticoagulants (DOAC) apixaban and rivaroxaban in a cardiopulmonary bypass circuit during urgent cardiothoracic procedures. The Company is currently conducting the FDA-approved, randomized, controlled STAR-T (Safe and Timely Antithrombotic Removal-Ticagrelor) study of 120 patients at approximately 30 centers in U.S. and Canada to evaluate whether intraoperative use of DrugSorb-ATR can reduce the perioperative risk of bleeding in patients receiving ticagrelor and undergoing cardiothoracic surgery. This pivotal study is intended to support FDA and Health Canada marketing approval in the United States and Canada, respectively, for DrugSorb-ATR in this application. CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of approximately $48 million from DARPA, the U.S. Department of Health and Human Services (HHS), the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), the U.S. Army, the U.S. Air Force, U.S. Special Operations Command (SOCOM), Air Force Material Command (USAF/AFMC), and others. The Company has numerous marketed products and products under development based upon this unique blood purification technology protected by many issued U.S. and international patents and registered trademarks, and multiple patent applications pending, including ECOS-300CY®, CytoSorb-XL™, HemoDefend-RBC™, HemoDefend-BGA™, VetResQ®, K+ontrol™, DrugSorb™, DrugSorb™-ATR, ContrastSorb, and others. For more information, please visit the Company's websites at www.cytosorbents.com and www.cytosorb.com or follow us on Facebook and Twitter. Forward-Looking Statements This press release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, future targets and outlooks for our business, expectations regarding the future impacts of COVID-19 or the ongoing conflict between Russia and the Ukraine, representations and contentions and are not historical facts and typically are identified by use of terms such as "may," "should," "could," "expect," "plan," "anticipate," "believe," "estimate," "predict," "potential," "continue" and similar words, although some forward-looking statements are expressed differently. You should be aware that the forward-looking statements in this press release represent management's current judgment and expectations, but our actual results, events and performance could differ materially from those in the forward-looking statements. Factors which could cause or contribute to such differences include, but are not limited to, the risks discussed in our Annual Report on Form 10-K, filed with the SEC on March 10, 2022, as updated by the risks reported in our Quarterly Reports on Form 10-Q, and in the press releases and other communications to shareholders issued by us from time to time which attempt to advise interested parties of the risks and factors which may affect our business. We caution you not to place undue reliance upon any such forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, other than as required under the Federal securities laws. Please Click to Follow Us on Facebook and Twitter CytoSorbents Contact: Kathleen Bloch (732) 398-5429 kbloch@cytosorbents.com Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cytosorbents-announces-health-canada-regulatory-approval-for-pivotal-star-t-trial-301727818.html SOURCE CytoSorbents Corporation
NEWS_92
Advertising-technology company Innovid Corp. CTV, +5.94% disclosed Monday afternoon that it intends to lay off roughly 10% of its staff. Innovid had 396 full-time employees as of Dec. 31, 2021, according to its most recent 10-K filing. The cuts come as Innovid strives for “sustainable and profitable growth,” according to its Monday filing with the Securities and Exchange Commission. The company expects that it will be finished with its job cuts by the end of the first quarter of fiscal 2023. Its shares were up more than 7% in after-hours trading Monday. They’ve fallen 64% over the past 12 months as the S&P 500 SPX, +1.19% has lost 9%.
NEWS_93
Cue Biopharma, Inc. Matteo Levisetti, M.D., promoted to Chief Medical Officer, effective January 17, 2023 Acting CMO Kenneth Pienta, M.D., to transition to a clinical advisory role BOSTON, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body, announced today that Matteo Levisetti, M.D., senior vice president (SVP) of clinical development at Cue Biopharma, has been promoted to Chief Medical Officer (CMO) effective January 17, 2023. Current acting CMO Kenneth Pienta, M.D., has transitioned from his current role and will serve as a clinical advisor to the company effective as of the same date. “We are very pleased to announce the appointment of Dr. Levisetti as our new chief medical officer,” said Daniel Passeri, chief executive officer of Cue Biopharma. “Throughout his tenure as SVP of clinical development and having worked alongside Dr. Pienta for almost two years, Dr. Levisetti has contributed much to our progress in the clinical development of CUE-101 and CUE-102. Dr. Levisetti has also been responsible for building a strong team of dedicated professionals within the clinical group. We have tremendous confidence that as newly appointed CMO, Dr. Levisetti will continue to build on the foundational principles that Dr. Pienta helped to establish, positioning our company to achieve additional key clinical milestones, and supporting our continued progress forward throughout the coming year and beyond.” Mr. Passeri, added, “I also want to take the opportunity to personally thank Dr. Pienta for providing his depth of experience and expertise in oncology since the early stages of Cue Biopharma’s corporate development in 2016. His clinical leadership and advice have been a cornerstone to the company’s evolution and progress. As acting CMO, Dr. Pienta not only helped bring two cancer drug candidates to the clinic, CUE-101 and CUE-102, but also established a network of top tier clinical sites in collaboration with leading clinicians, principal investigators and key opinion leaders. On behalf of Cue Biopharma, we thank him for his invaluable service and tremendous contributions as well as his profound commitment to patients. We are fortunate to have continuity to access Ken’s guidance and clinical expertise in his new advisory role.” Story continues Dr. Levisetti stated, “It is with great honor that I take this new role as CMO. I am grateful to have worked with Dr. Pienta these past two years which will help to ensure a seamless and smooth transition. I look forward to leading the advancement of Cue Biopharma’s promising oncology pipeline, as I believe the company’s unique platform assets and derivatives could be a breakthrough development with great potential to change the current treatment landscape for people with cancer.” Dr. Pienta added, “I would like to thank Dan, the leadership team and the many employees I had the privilege of working with these past years for their meaningful work and dedication. I am immensely proud to have helped advance the company’s promising Immuno-STAT™ platform into the clinic and I am excited to continue seeing great progress in potentially making Cue Biopharma’s therapies available to patients who need them most. Dr. Levisetti has been invaluable to the clinical development process, and I strongly believe that the company is in the best hands for its next phase of growth.” Dr. Levisetti holds extensive experience leading global clinical development for mid and large-size pharmaceutical companies. Prior to joining Cue Biopharma in 2021, he held CMO positions at DNAtrix and previously at Dauntless Pharmaceuticals, where he directed and managed clinical development and operations, and regulatory strategy for a number of endocrinology and oncology assets. Previously, he directed immuno-oncology programs as executive director of clinical development at Mirati Therapeutics. Before joining Mirati, Dr. Levisetti served as global head & vice president, Translational Medicine, Immunology and Inflammation at Roche Pharma Research & Early Development. Prior to that, he held several senior clinical development positions at Pfizer, where he led multiple early clinical development programs across several therapeutic areas, including endocrinology, immunology and oncology. Dr. Levisetti received his medical degree from the University of Chicago Pritzker School of Medicine and served on the faculty at Washington University School of Medicine prior to his transition to leadership roles in industry. About Cue Biopharma Cue Biopharma, a clinical-stage biopharmaceutical company, is developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells directly within the patient’s body. The company’s proprietary platform, Immuno-STAT™ (Selective Targeting and Alteration of T cells) and biologics are designed to harness the body’s intrinsic immune system as T cell engagers without the need for ex vivo manipulation or broad systemic modulation. Headquartered in Boston, Massachusetts, we are led by an experienced management team and independent Board of Directors with deep expertise in immunology and immuno-oncology as well as the design and clinical development of protein biologics. For more information please visit www.cuebiopharma.com and follow us on Twitter at https://twitter.com/CueBiopharma. Forward-Looking Statements This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be covered by the safe harbor created by those sections. Such forward-looking statements include, but are not limited to, those regarding the company’s business strategies, plans and prospects. Forward-looking statements, which are based on certain assumptions and describe the company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the company’s limited operating history, limited cash and a history of losses; the company’s ability to achieve profitability; potential setbacks in the company’s research and development efforts including negative or inconclusive results from its preclinical studies, its ability to secure required U.S. Food and Drug Administration (“FDA”) or other governmental approvals for its product candidates and the breadth of any approved indication; adverse effects caused by public health pandemics, including COVID-19, including possible effects on the company’s trials; negative or inconclusive results from the company’s clinical trials or preclinical studies or serious and unexpected drug-related side effects or other safety issues experienced by participants in clinical trials; delays and changes in regulatory requirements, policy and guidelines including potential delays in submitting required regulatory applications to the FDA; the company’s reliance on licensors, collaborators, contract research organizations, suppliers and other business partners; the company’s ability to obtain adequate financing to fund its business operations in the future; operations and clinical the company’s ability to maintain and enforce necessary patent and other intellectual property protection; competitive factors; general economic and market conditions and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of the company’s most recently filed Annual Report on Form 10-K and any subsequently filed Quarterly Report(s) on Form 10-Q. Any forward-looking statement made by the company in this press release is based only on information currently available to the company and speaks only as of the date on which it is made. The company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. Investor Contact Marie Campinell Senior Director, Corporate Communications Cue Biopharma, Inc. mcampinell@cuebio.com Media Contact Maya Romanchuk LifeSci Communications mromanchuk@lifescicomms.com
NEWS_94
VALENCIA, Calif., Jan. 23, 2023 /PRNewswire/ -- Luxury cruise line Cunard is offering guests the opportunity to experience the world-famous Rocky Mountaineer train when they sail through Alaska on Queen Elizabeth this summer. Extend a Cunard voyage in Alaska with Rocky Mountaineer Cunard and Rocky Mountaineer offer guests the chance to enjoy the spectacular Alaska landscape both by land and by sea. Guests will be able to extend their Alaska voyage with either a four-night pre-voyage train experience or a three-night post-voyage package, depending on the sailing date. The three-night Rocky Mountaineer tour takes guests on an eastbound journey from Vancouver to Calgary, while the four-night train tour goes the opposite direction and gives guests an additional day of sightseeing in Banff, where the highlight is an impressive trip on the Banff Gondola. Rocky Mountaineer Pre- and Post-Cruise Tours: The three-night post-voyage tours starts at $2,850 per person based on double occupancy, available on two Japan to Alaska voyages (Q318A, Q319) and four Alaska voyages roundtrip out of Vancouver ranging from 10 to 11 nights (Q323, Q324, Q325, Q326). The four-night pre-voyage tour starts at $3,250 per person based on double occupancy, available on three Alaska voyages roundtrip out of Vancouver ranging from seven to 10 nights (Q321, Q322, Q323). Guests traveling on the legendary Rocky Mountaineer train – the only passenger rail service on this historic rail route – will experience expansive glass-dome windows and luxurious coaches. Breathtaking 180-degree panoramic views of snow-capped mountains, shimmering lakes and winding canyons are offered from all angles. Renowned for its GoldLeaf Service, Rocky Mountaineer offers an onboard dining room where guests can indulge in culinary delights inspired by the region with a new 2023 menu as well as full complimentary bar service. "We are excited to partner with Rocky Mountaineer so our passengers can enjoy the spectacular scenery and Alaskan wildlife in the utmost of luxury both by land and by sea," said Matt Gleaves, VP Commercial, Cunard, North America. Story continues Queen Elizabeth's summer in Alaska will be a season full of adventure and discovery, with the onboard Insights program featuring experts from the Royal Canadian Geographical Society, TV personality Bear Grylls, and famed explorer Mensun Bound, to name a few. Other highlights on Queen Elizabeth include the bespoke Alaska Afternoon Tea, the elegant Ice White Ball and a new dining concept called Frontier, which offers a taste of Alaska. For more information about Cunard, or to book a voyage, contact your Travel Consultant, call Cunard Line at 1-800-728-6273 or visit www.cunard.com . For Travel Advisors interested in further information, please contact your Business Development Manager, visit OneSource Cruises.com or call Cunard at 1-800-528-6273. About Cunard Cunard is a luxury British cruise line, renowned for creating unforgettable experiences around the world. Cunard has been a leading operator of passenger ships on the North Atlantic, since 1840, celebrating an incredible 182 years of operation. A pioneer in transatlantic journeys for generations, Cunard is world class. The Cunard experience is built on fine dining, hand-selected entertainment and outstanding service. From five-star restaurants and in-suite dining to inspiring guest speakers, the library and film screenings, every detail has been meticulously crafted to make the experience unforgettable. Destinations include Europe, the Caribbean, the Far East and Australia. There are currently three Cunard ships, Queen Mary 2, Queen Elizabeth and Queen Victoria and a fourth ship, Queen Anne, will be entering service in early 2024. This investment is part of the company's ambitious plans for the future of Cunard globally and will be the first time since 1999 that Cunard will have four ships in simultaneous service. Cunard is based at Carnival House in Southampton and has been owned since 1998 by Carnival Corporation & plc (NYSE/LSE: CCL; NYSE:CUK). Social Media Facebook: www.facebook.com/cunard Twitter: www.twitter.com/cunardline YouTube: www.youtube.com/wearecunard Instagram: www.instagram.com/cunardline For additional information about Cunard, contact: Jackie Chase, Cunard, 310-926-7686, jchase@cunard.com Cindy Adams, MGA Media Group, cindy@mgamediagroup.com Cunard Logo (PRNewsfoto/Cunard Line) Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cunard-to-offer-legendary-rocky-mountaineer-train-tours-for-guests-visiting-alaska-this-summer-301727175.html SOURCE Cunard
NEWS_95
Bank of Hawaii (BOH) came out with quarterly earnings of $1.50 per share, beating the Zacks Consensus Estimate of $1.45 per share. This compares to earnings of $1.55 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 3.45%. A quarter ago, it was expected that this bank holding company would post earnings of $1.43 per share when it actually produced earnings of $1.28, delivering a surprise of -10.49%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. Bank of Hawaii , which belongs to the Zacks Banks - West industry, posted revenues of $181.91 million for the quarter ended December 2022, surpassing the Zacks Consensus Estimate by 0.46%. This compares to year-ago revenues of $168.96 million. The company has topped consensus revenue estimates two times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Bank of Hawaii shares have added about 1.2% since the beginning of the year versus the S&P 500's gain of 3.5%. What's Next for Bank of Hawaii? While Bank of Hawaii has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Story continues Ahead of this earnings release, the estimate revisions trend for Bank of Hawaii: mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. It will be interesting to see how estimates for the coming quarters and current fiscal year change in the days ahead. The current consensus EPS estimate is $1.26 on $174.75 million in revenues for the coming quarter and $5.56 on $722.14 million in revenues for the current fiscal year. Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Banks - West is currently in the bottom 25% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1. One other stock from the same industry, CVB Financial (CVBF), is yet to report results for the quarter ended December 2022. This bank holding company is expected to post quarterly earnings of $0.47 per share in its upcoming report, which represents a year-over-year change of +34.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. CVB Financial's revenues are expected to be $148.17 million, up 29.1% from the year-ago quarter. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bank of Hawaii Corporation (BOH) : Free Stock Analysis Report CVB Financial Corporation (CVBF) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
NEWS_96
Does the January share price for Cavco Industries, Inc. (NASDAQ:CVCO) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the forecast future cash flows of the company and discounting them back to today's value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow. Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model. See our latest analysis for Cavco Industries Is Cavco Industries Fairly Valued? We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To start off with, we need to estimate the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years. A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, and so the sum of these future cash flows is then discounted to today's value: 10-year free cash flow (FCF) estimate 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 Levered FCF ($, Millions) US$209.8m US$197.8m US$202.4m US$206.9m US$211.4m US$215.8m US$220.2m US$224.7m US$229.3m US$233.9m Growth Rate Estimate Source Analyst x1 Analyst x1 Est @ 2.33% Est @ 2.22% Est @ 2.15% Est @ 2.10% Est @ 2.06% Est @ 2.04% Est @ 2.02% Est @ 2.01% Present Value ($, Millions) Discounted @ 8.4% US$193 US$168 US$159 US$150 US$141 US$133 US$125 US$118 US$111 US$104 ("Est" = FCF growth rate estimated by Simply Wall St) Present Value of 10-year Cash Flow (PVCF) = US$1.4b Story continues The second stage is also known as Terminal Value, this is the business's cash flow after the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.0%. We discount the terminal cash flows to today's value at a cost of equity of 8.4%. Terminal Value (TV)= FCF 2032 × (1 + g) ÷ (r – g) = US$234m× (1 + 2.0%) ÷ (8.4%– 2.0%) = US$3.7b Present Value of Terminal Value (PVTV)= TV / (1 + r)10= US$3.7b÷ ( 1 + 8.4%)10= US$1.6b The total value, or equity value, is then the sum of the present value of the future cash flows, which in this case is US$3.0b. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of US$258, the company appears a touch undervalued at a 25% discount to where the stock price trades currently. Remember though, that this is just an approximate valuation, and like any complex formula - garbage in, garbage out. dcf The Assumptions We would point out that the most important inputs to a discounted cash flow are the discount rate and of course the actual cash flows. Part of investing is coming up with your own evaluation of a company's future performance, so try the calculation yourself and check your own assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Cavco Industries as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 8.4%, which is based on a levered beta of 1.073. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business. SWOT Analysis for Cavco Industries Strength Earnings growth over the past year exceeded the industry. Debt is not viewed as a risk. Weakness No major weaknesses identified for CVCO. Opportunity Trading below our estimate of fair value by more than 20%. Threat Annual earnings are forecast to decline for the next 2 years. Looking Ahead: Although the valuation of a company is important, it shouldn't be the only metric you look at when researching a company. It's not possible to obtain a foolproof valuation with a DCF model. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. What is the reason for the share price sitting below the intrinsic value? For Cavco Industries, we've put together three further factors you should further examine: Risks: For example, we've discovered 1 warning sign for Cavco Industries that you should be aware of before investing here. Future Earnings: How does CVCO's growth rate compare to its peers and the wider market? Dig deeper into the analyst consensus number for the upcoming years by interacting with our free analyst growth expectation chart. Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered! PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the NASDAQGS every day. If you want to find the calculation for other stocks just search here. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Join A Paid User Research Session You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here
NEWS_97
By Nia Williams and Steve Scherer Ottawa, Jan 23 (Reuters) - The chief executive of Cenovus Energy, which is part of alliance of Canada's biggest oil sands producers, on Monday said friction between the federal and Alberta governments was making it more difficult to hold meaningful discussions on funding carbon capture and storage (CCS) technology needed to decarbonize the oil and gas sector. The Pathways Alliance, a collaboration between Canada's six largest oil sands producers targeting net-zero emissions by 2050, is planning to develop a CCS hub in northern Alberta, expected to cost C$16.5 billion ($12.3 billion) by 2030. The group wants public money to fund 66%, or roughly $10.9 billion, of that. So far the federal government has unveiled an investment tax credit worth C$2.6 billion over the next five years, but both Ottawa and Alberta say the other should contribute more. "It's very hard to have meaningful discussions with another party when you're lobbing rocks at each other," Alex Pourbaix, CEO of Pathways member Cenovus Energy, told Reuters in an interview. "I would like to see the temperature turned down a little bit." (Reporting by Nia Williams Editing by Marguerita Choy)
NEWS_98
Shares of Cenovus Energy Inc. CVE, +0.82% inched 0.82% higher to C$25.68 Monday, in what proved to be an all-around positive trading session for the Canadian market, with the S&P/TSX Composite Index GSPTSE, +0.63% rising 0.63% to 20,631.58. Cenovus Energy Inc. closed C$5.51 short of its 52-week high (C$31.19), which the company achieved on June 8th. Trading volume of 5.1 M shares eclipsed its 50-day average volume of 4.9 M. Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
NEWS_99
(Adds details, quote from Pathways executive) By Nia Williams and Steve Scherer Ottawa, Jan 23 (Reuters) - The chief executive of Cenovus Energy, which is part of an alliance of Canada's biggest oil sands producers, on Monday said friction between the federal and Alberta governments was making it difficult to hold meaningful discussions on funding carbon capture and storage (CCS) technology needed to decarbonize the oil and gas sector. The Pathways Alliance, a collaboration between Canada's six largest oil sands producers targeting net-zero emissions by 2050, is planning to develop a CCS hub in northern Alberta, expected to cost C$16.5 billion ($12.3 billion) by 2030. The group wants public money to fund 66%, or roughly C$10.9 billion, of that and says government support would speed up decarbonisation and help establish a competitive clean-tech industry in Canada. So far the federal government has unveiled an investment tax credit worth C$2.6 billion over the next five years, but both Ottawa and Alberta say the other should contribute more. Alberta's conservative Premier Danielle Smith is a vocal critic of Liberal Prime Minister Justin Trudeau and has slammed many aspects of federal climate policy, accusing Ottawa of trying to cripple the western province's energy sector. Trudeau told Reuters in an interview earlier this month the sooner Alberta's "political class" understood the future is not to be feared, the better. "It's very hard to have meaningful discussions with another party when you're lobbing rocks at each other," Alex Pourbaix, chief executive of Pathways member Cenovus, told Reuters in an interview. "I would like to see the temperature turned down a little bit." Pourbaix said there still needs to be a "significant discussion" between the federal and provincial governments and industry, and Pathways has set a target for that to happen early this year. Story continues "I've had both levels of government telling me that they're supportive of doing that and engaging on that. I think it has not occurred yet to the level it needs to resolve the differences that the groups may have," he added. Canada is the world's fourth-largest producer of crude, most of which comes from Alberta's oil sands. The oil and gas sector is the country's highest-polluting industry and needs to drastically cut emissions if Canada is to achieve its international climate commitments. The Pathways Alliance has already said Ottawa's goal of cutting oil and gas emissions 42% by 2030, equivalent to a 35-megatonne reduction, is impossible. The group could achieve a 22-megatonne reduction in carbon emissions by 2030, said Pathways President Kendall Dilling, but that depends on key components like public funding being agreed and a smooth regulatory approval process for the CCS project. "We don't have time to slip," Dilling said. "Canada's track record on major infrastructure development in the last decade has been abysmal," Dilling said. " If we run into those same kind of troubles, then 2030 will not be realized." ($1 = 1.3383 Canadian dollars) (Reporting by Nia Williams in British Columbia and Steve Scherer in Ottawa; Editing by Marguerita Choy and Jonathan Oatis)